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I. Cobalt-Catalysed Alkylative Aldol Cyclisations Using Trialkylaluminium 
Reagents 
 
The cobalt-catalysed alkylative aldol cyclisations of ,-unsaturated amides with an 
appendant ketone were studied using a range of trialkylaluminium reagents. 
Investigations revealed that Co(acac)2·2H2O acts as an effective precatalyst for this 
transformation and the reaction provides -hydroxylactam products containing three 
contiguous stereocentres with high levels of diastereoselection. The substrate scope 
of the reaction was explored and attempts were made to develop an asymmetric 
variant of this process. Two plausible reaction mechanisms have been proposed; the 
first invokes a -allylcobalt species as a key intermediate in the reaction mechanism 
and the second involves a radical-mediated pathway. A stereochemical rationale for 
the observed relative stereochemistry of the -hydroxylactam products has been 
discussed. 
 
II. Rhodium-Catalysed Carbometallations of Ynamides in the Preparation of 
Multisubstituted Enamides 
 
A highly stereo- and regioselective rhodium-catalysed carbozincation of ynamides 
using organozinc reagents has been disclosed. A careful examination of ligand 
effects on the rhodium catalyst yielded a complementary set of hydrozincation 
conditions. The alkenylzinc intermediates produced during the course of these 
reactions have been harnessed in further transformations with electrophilic species 
and in cross-couplings, thus providing access to multisubstituted enamides in a 
stereo- and regioselective fashion. Additionally, a rhodium-catalysed tandem 
carbometallation−conjugate addition with ortho-boronate substituted cinnamic acid 
derivatives has been described. The enamide−indene products were obtained in good 
yields and regioselectivities. Preliminary work has been undertaken on an 
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Transition metal-catalysed domino reactions initiated by conjugate additions are a 
powerful set of transformations in organic synthesis; these reactions potentially allow 
rapid increases in complexity in a single step with high levels of stereocontrol.1 The 
alkylative aldol cyclisation, which involves the conjugate addition of an 
organometallic reagent to an ,-unsaturated carbonyl compound and subsequent 
trapping of the resultant metallaoenolate with an aldehyde or ketone, is an important 
subset of these. Most protocols utilise enones as the Michael acceptor, alongside 
dialkylzinc or organoborons as the carbon-based nucleophile. Expansion to other 
types of ,-unsaturated acceptor and nucleophiles would result in a wider variety of 
products which is highly desirable. In the following chapter we report a cobalt-
catalysed alkylative aldol cyclisation using trialkylaluminium reagents. Accordingly, 
we will first examine transition metal-catalysed conjugate additions of 
trialkylaluminium reagents to ,-unsaturated acceptor substrates and then review the 











The carbon–carbon bond-forming reaction is arguably one of the most important 
synthetic transformations in organic chemistry. The metal-catalysed introduction of 
an alkyl or aromatic group onto an ,-unsaturated system via conjugate addition is 
an effective way of achieving this goal. Classically, Grignard and organolithium 
reagents were employed to effect this reaction. However, a high level of reactivity 
renders them unsuitable for substrate classes that are more highly functionalised. 
Consequently there has been a significant volume of literature on transition metal-
catalysed conjugate additions of less reactive organometallic reagents and their 
asymmetric variants. In particular, the copper-catalysed conjugate addition of 
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dialkylzinc reagents2,3 and the complementary rhodium-catalysed conjugate addition 
of aromatic boronic acids4,5 to ,-unsaturated carbonyl compounds have been 
extensively studied. 
 
Surprisingly, the metal-catalysed conjugate additions of trialkylaluminium reagents 
have been less well documented, despite a ready availability of trialkylaluminium 
reagents commercially and facile preparation of more exotic variants.6 The greater 
Lewis acidity of these reagents in comparison with dialkylzinc reagents, offers a 
wealth of potential in developing catalytic conjugate addition reactions to a wider 
variety of more challenging substrates. 
 
1.1.1 Non-Enantioselective Conjugate Addition  
 
The focus of this review is on the metal-catalysed conjugate addition of 
trialkylaluminium reagents to ,-unsaturated carbonyl compounds; however, a large 
proportion of the early literature in this area concerned the uncatalysed reaction. This 
topic will not be discussed here but a recent review by von Zezschwitz6 gives an 
extensive overview of the subject. 
 
Mole and co-workers made the first report of a metal-catalysed conjugate addition of 
trialkylaluminium reagents to enones7 and it was quickly followed by a study of the 
same reaction by Ashby and Heinsohn.8 Both groups observed that a combination of 
Ni(acac)2 and trimethylaluminium (Me3Al) gave exclusively the 1,4-addition 
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The only side-products observed were oligomeric products arising from the Michael 
reaction of the intermediate aluminium enolates onto the starting enone. It naturally 
followed that yields increased with steric hindrance around the -carbon, as these 
provided more sterically hindered aluminium enolates that would not form oligomers 
as easily. In spite of the success of this catalytic system with cyclohexenone 
substrates, attempts to extend the methodology to cyclopentenones failed as the 
respective aluminium enolates polymerised rapidly. Mole’s group reported that 
alternative acetylacetonate salts were also suitable as potential catalysts (including 
copper (II), cobalt (III), iron (II) and iron (III) salts) although the observed yields 
were lower. However, Heinsohn and co-workers only obtained unreacted starting 
material in the presence of the cobalt catalyst. 
 
 
In 1993, Westermann and Nickisch drew inspiration from Mole’s early work when 
they were attempting to effect a conjugate addition of a methyl group onto the 
steroidal enone to give 4b (Scheme 1.2). They had previously observed that copper-
catalysed additions of organolithiums and Grignard reagents to these steroids 
predominantly resulted in the 1,2-addition product. Fortuitously, the use of Me3Al in 
conjunction with a copper bromide catalyst cleanly gave the desired 1,4-addition 
product.9  Earlier studies by the group had found that nickel catalysts were not as 





Expansion of this methodology was successful and the conjugate addition products 
of a variety of acyclic, cyclic and steroidal enones were obtained in moderate to high 
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yields after reaction with either trimethyl- or triethylaluminium (Me3Al or Et3Al). 
Later studies revealed that the conjugate addition reaction of higher 





Yields remained high for cyclic enones but were far lower for the acyclic examples. 
The presence of a TMSCl additive was found to increase the rate of reaction and it 
allowed significantly lower loadings of copper catalyst (0.1 mol%).11 
 
1.1.2 Enantioselective Conjugate Addition  
  
At this stage, the use of trialkylaluminium reagents was emerging as a potential 
solution to the problematic issue of conjugate additions to more challenging ,-
unsaturated acceptors. However, there was a growing need for enantioselective 
variants of this transformation in order for it to become a truly viable alternative to 
the more commonly used organometallic reagents. 
 
The first example of an enantioselective metal-catalysed conjugate addition of a 
trialkylaluminium reagent to an ,-unsaturated carbonyl compound was reported by 
Iwata and co-workers.12 The group developed a system based on a copper triflate 
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Conjugate addition to cyclohexa-2,5-dienone 7 had previously been poor-yielding 
with other organometallic reagents due to their lower reactivity and had additionally 
given low enantioselectivities. This methodology, which utilised the more reactive 
Me3Al, provided the desired conjugate addition product in a good yield and a modest 
68% ee. The presence of the TBSOTf additive was essential to raise the 
enantioselectivity to this level. In addition to providing a silyl activation of the 
dienone 7, it was hypothesised that an interaction of the triflate anion with the copper 

























Woodward’s group next published in this area, reporting a series of papers on three 
different sulfur-based ligands (Scheme 1.4).13,14,15 All three classes of ligand were 
screened with the model system 10 and in all three cases the substrate scope was 
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The chiral thiourethane ligand 12 generally resulted in low enantioselectivities (the 
highest obtained was 50%) but it was notably the first report of a chiral thiourethane 
in an asymmetric catalytic process.13 When Me3Al was replaced with the more 
reactive Et3Al, it had a deleterious effect on both the yield and enantioselectivity of 
the reaction. The modified thiourethane ligand 13 resulted in a slight improvement to 
these results but the enantioselectivities still remained moderate.14 Further studies 
revealed that both the 2-naphtholic directing group and the soft sulfur ligation site 
featured in 12 and 13 were critical in achieving the observed yields and levels of 
enantioselectivity. 
 
A concurrent publication by the same group detailed a set of chiral dithioether 
ligands with a xylofuranose backbone (see ligand 14, Scheme 1.4).15 These ligands 
were easily prepared from xylose and gave high yields and reasonable levels of 
asymmetric induction for the 1,4-addition of Et2Zn to cyclohexenone. Unfortunately 
the corresponding conjugate addition of Me3Al to the model substrate 10 was limited 
to a maximum ee of 34%. 
 
In 2000, van Leeuwen et al successfully developed the synthesis of a new class of 
phosphine–phosphite ligands and applied them to a number of asymmetric 
transformations. It had been shown previously that the contrasting nature of the two 
donor atoms in these ligands, namely an electron-donating phosphine and an 
electron-withdrawing phosphite, was able to affect the reactivity and selectivity of a 
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catalyst. These ligands were used advantageously in conjunction with a copper 





A small library of the phosphine–phosphite ligands was studied in this model system 
with both Et3Al and Et2Zn; the structural variations that were investigated included 
different substituents at both the phosphorus atom of the phosphine moiety and at the 
stereogenic carbon adjacent to the phosphite and, additionally, the chain length of the 
linker. However, the group did not investigate any other type of phosphite moiety 
other than that featured in 17. The best result obtained was a relatively moderate 62% 
ee with the phosphine−phosphite ligand 17. Increasing the linker by one carbon 
resulted in a dramatic fall in enantioselectivity, as did the diastereomeric variations 
of 17. The paper concluded that the configuration of the phosphine, the stereogenic 
centre next to the phosphite, the catalytic precursor and nature of the alkylating agent 
were significant in determining the enantioselectivity.  
 
Subsequent investigations in this area by Chan and his group resulted in a new 
family of chiral aryl diphosphite ligands for the conjugate addition of Me3Al to 
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In this paper, exceptionally high levels of enantioselectivity were obtained for the 
model substrate cyclohexenone 15. This result was a major improvement on the 
enantioselectivities previously obtained for the asymmetric conjugate addition 
reaction of trialkylaluminium reagents. Screenings of these types of ligand revealed 
that the asymmetric induction was dominated by the end groups of the chiral ligands. 
The same standard of results was achieved in the conjugate addition of Et3Al to 2-




Unfortunately, despite these highly promising results, the substrate scope of these 
reactions was never explored and the biaryl phosphite ligands have relatively 
complex structures that require an involved synthesis. However, the high 
enantioselectivities observed for these catalytic systems established that 
trialkylaluminiums could be a truly viable alternative to the more commonly used 
dialkylzinc reagents in asymmetric conjugate addition reactions. 
 
To gain acceptance from the synthetic community and attain widespread popularity it 
is important that the transformation in question is technically simple and preferably 
uses commercially available materials. At this juncture, the conjugate addition of 
trialkylaluminium reagents had reached a high level of selectivity with a relatively 
simple procedure; unfortunately the highly specialised ligands, essential to achieving 
the high selectivity, were a major drawback. Therefore it was critical to create a 
catalytic system based on less complex ligands. In 2005, Alexakis and Woodward 
realised this ambition when they published their research into the asymmetric 
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conjugate additions of organoaluminium reagents to enones using simple 





After screening a variety of different phosphoramidite ligands, they concluded that 
Feringa’s ligand 2320 was the most effective with both cyclic and acyclic ketones.  
The catalytic system could be applied to the conjugate addition of both Me3Al and 
Et3Al and provided high yields of the desired products with good to excellent levels 
of enantioselectivity. 
 
In the continued search for simpler ligands, Alexakis et al have also recently 
published a study on the hemilabile heterobidentate ligand BINPO 31 in the metal-
catalysed 1,4-addition reaction (Scheme 1.6).21 It was hypothesised that the 
coordination of the soft phosphorus atom to the copper catalyst and the hard oxygen 
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In the event, this ligand proved to be unsuitable for use in conjunction with Et2Zn, as 
low levels of enantiomeric excess were observed. Conversely, the screenings with 
Me3Al met with greater success and enantioselectivities of over 70% were generally 
achieved with a range of both cyclic and acyclic ketones; although trials with Et3Al 
resulted in lower yields and enantioselectivities. Isolated yields of the conjugate 
products were frequently low and this was attributed to the competing 
polymerisations of the intermediate aluminium enolates.  The group asserted that the 
heterobidentate nature of the BINPO ligand was essential for the high levels of 
stereoselectivity observed. They evidenced this claim with the fact that the closely 
related homobidentate BINAP was a poor ligand for inducing enantioselectivity in 
conjugate additions.  
 
In 2007, Woodward and co-workers published a set of investigations they had 
undertaken on a library of sugar–phosphite–oxazoline and phosphite–
phosphoramidite ligands.22 Inspired by earlier literature work in the area, they 
systematically screened two sugar-based libraries of phosphite–phosphoramidite and 
phosphite–oxazoline ligands to explore the effect of altering the electronic and steric 






The libraries were based around a 4,5-O-protected glucopyranoside backbone with a 
phosphite moiety at the C3 position and either an oxazoline or phosphoramidite 
group attached, as shown in Fig 1.2. Selected results have been shown for the two 
model substrates 15 and 10, in the presence of the most successful ligands (34a and 
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The paper concluded that for cyclic enone substrates, the enantioselectivity of the 
step was significantly affected by substitutions and configuration at the biaryl 
phosphite moiety, whereas the reaction was largely unaffected by changes to the 
oxazoline moiety. It was reported that replacing the oxazoline with the 
phosphoramidite group had a deleterious effect on both the yield and ee of the 
reaction. This latter observation was repeated for the acyclic enone but in this case, 
changes at both the biaryl phosphite and the oxazoline moieties had significant 
effects on the yield and enantioselectivity of the reaction. It is important to note that, 
despite extensive screening, this library did not produce any ligands capable of 
delivering superior levels of asymmetric induction to those systems previously 
reported.  
 
Despite their dominance in the field of enantioselective conjugate additions, the 
copper-catalysed conjugate addition of Et2Zn
2 and the rhodium-catalysed conjugate 
addition of aromatic boronic acids4 have certain critical shortcomings that have not 
yet been overcome. A notable example is the asymmetric synthesis of quaternary 
centres, which are problematic due to the low reactivity of -trisubstituted enones. 
Alexakis et al reasoned that the stronger Lewis acidity of the organoaluminium 
reagents would effect a better activation of these sterically hindered substrates 
compared with the corresponding zinc reagents.  Their hypothesis was happily 
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fulfilled and a catalytic system was developed for the construction of stereogenic 






A range of -trisubstituted cyclic enones successfully underwent the conjugate 
addition with exceptionally high enantiomeric excess, although no acyclic enones 
were reported. A full paper in 2007 described further optimisation of the catalytic 
system and demonstrated its compatibility with even more demanding substrates, 
including -trisubstituted cyclopentenones.24 Additionally, the same type of catalytic 
system was successfully applied to the construction of aryl-substituted quaternary 





Previously there had been no general method for the introduction of a wide range of 
aryl groups onto a -trisubstituted enone but the preparation of the aryl alanes via the 
transmetallation from an aryl lithium circumvented this problem and provided an 
extensive range of aryl alanes. Under these conditions the aryl group was transferred 
preferentially and the competing ethyl addition was not observed. 
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In 2006, the same group also described an N-heterocyclic carbene ligand for the 
copper-catalysed asymmetric conjugate addition of Et3Al to 3-methylcyclohex-2-
enone.26  The reaction went to 94% conversion but only with a relatively low 
enantiomeric excess of 54%.  This type of ligand was found to be more successful 
with Grignard reagents which were the main focus of the paper. 
 
Hoveyda and co-workers have also been working on the problematic issue of the 
asymmetric synthesis of quaternary stereocentres using conjugate addition reactions. 
Their main objective was the notoriously challenging substrate class of -substituted 
cyclopentenones. They applied the group’s recently developed bidentate N-










The methodology was successful in promoting the conjugate addition of both 
trialkylaluminium reagents and aryl alanes to a variety of -trisubstituted 
cyclopentenones and larger ring size substrates (Scheme 1.10). The major drawback 
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of the system is that the complex ligands required are not yet commercially available 
and have to be prepared in-house in five to six steps. 
 
In conclusion to this section, it is only relatively recently that the enantioselective 
conjugate addition of trialkylaluminium reagents to ,-unsaturated ketones has 
become more widely studied. Initially the asymmetric variants of this conjugate 
addition were less successful than the more common copper-catalysed conjugate 
additions of Et2Zn and rhodium-catalysed additions of aromatic boronic acids. In 
early studies, the ligands required for respectable levels of asymmetric induction 
were complex; fortunately the advent of the commercially available Feringa’s ligand 
has meant that a high degree of enantiomeric excess can now be obtained for the 
conjugate addition of trialkylaluminiums to enones using relatively simple 
phosphoramidite ligands. For the more challenging and less reactive substrates such 
as -trisubstituted cyclopentenones, novel catalytic systems have been reported, 
although the complexity of the ligands required will currently hamper rapid 
development in this area. 
 
1.1.3 Conjugate Addition to Other ,-Unsaturated Acceptors 
 
The studies discussed previously have been concerned with the metal-catalysed 
conjugate addition of trialkylaluminium reagents to enone-type substrates. The utility 
of the transformation would be greatly enhanced if it could be applied to a wider 
range of ,-unsaturated acceptors. In this way, we potentially have access to a rich 









During studies on -amino acids, workers at ChiroBlock were investigating the 
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After a small amount of optimisation including variation of ligand, solvent and 
temperature they were able to synthesise the desired product on a 200 g scale. 
However, they did report that prior reduction of the copper catalyst with a small 
amount of Et2Zn was essential to achieve reproducible results. This report appears to 
be the first literature example of a conjugate addition of a trialkylaluminium reagent 
to a non-enone ,-unsaturated substrate. Interestingly, the reaction was highly 
selective and no conjugate addition was observed at the -position of the ester group 
of these two-fold Michael acceptors. 
 
Alexakis and Polet reported the asymmetric conjugate addition of Me3Al to simple 
nitroalkenes in 2005 (Scheme 1.11).29 Previous work had involved phosphoramidite 
ligands in the copper-catalysed conjugate addition of Et2Zn to nitrostyrenes.
30 
However, attempts to extrapolate this protocol to Me2Zn were unsuccessful due to 






A range of acyclic conjugate addition products were obtained in moderate to high 
yields and enantioselectivities; superior results to those obtained with Me2Zn. It was 
also observed that electron-donating groups on the aromatic ring increased the 
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enantioselectivity of the reaction whereas electron-withdrawing groups had the 
opposite effect. This methodology was validated in the synthesis of (+)-ibuprofen as 





The copper-catalysed conjugate addition of Me3Al to the nitroalkene 48 was 
achieved in 81% ee and a functional group manipulation provided the carboxylic 









In addition, Alexakis reported one example of enantioselective conjugate addition of 





This copper-catalysed reaction had been optimised for the addition of Et2Zn and 
those results formed the main body of the paper, but the methodology was also 
successfully applied with the aluminium reagent. The reaction had a high ee of 94% 
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Pineschi et al reported the enantioselective conjugate addition of Me3Al to aliphatic 





The catalytic system comprising of a copper triflate catalyst and the commercially 
available phosphoramidite ligand 23 gave exceptionally high enantioselectivities for 
the addition of Et2Zn to these imides. However, only two examples involving the 







The paucity of literature on the conjugate additions of trialkylaluminium reagents to 
other ,-unsaturated acceptors indicates that it is a non-trivial transformation. 
Significantly, in relation to the proposed project (vide infra), there are no previous 






The tandem conjugate addition–aldol reaction facilitates the formation of multiple 




molecular complexity with great stereocontrol. For the purposes of this review we 
will examine those reactions in which a carbon-based nucleophile is involved in the 
conjugate addition step, concentrating on metal-catalysed, organocatalysed and 
radical-mediated transformations.  
 






Heterobimetallic catalysis can sometimes offer advantages over traditional catalytic 
systems based on one metal because of positive cooperation between different 
metals. In fact it was one such example by Shibasaki and co-workers that became the 




The AlLi-(R)-BINOL complex 59 (or (R)-ALB) is able to deprotonate the diethyl 
methylmalonate 56 to give the corresponding lithium enolate. The coordination of 
the cyclopentenone 20 to the aluminium centre activates the enone and also fixes its 
position, resulting in the high facial selectivity that is observed in the subsequent 
conjugate addition reaction with the lithium enolate. The heterobimetallic complex 
59 is one of the few catalysts that allowed the subsequent aldol reaction to take place; 
other lanthanum-based heterobimetallic catalysts, effective for simple conjugate 
additions, did not allow the three-component coupling to occur. It was thought that 




protonation was able to take place. The broad synthetic utility of this methodology 






Initially the conjugate addition−aldol reaction is followed by a dehydration reaction 
to give compound 63 with exceptionally high enantioselectivity. The target 






The earliest example of a copper-catalysed conjugate addition–aldol reaction was 





The conjugate addition of Et2Zn was catalysed by a copper(I)-N-monosubstituted 




A mixture of the trans-threo and trans-erythro products, containing three contiguous 
stereocentres, were obtained with reasonable stereoselectivity.  
  
In subsequent years, Feringa and co-workers reported an asymmetric protocol using 
chiral phosphoramidite ligand 2336 for the tandem conjugate addition–aldol reaction 
with 2-cyclohexenone (Scheme 1.16) and ligand 7137 for the equivalent reaction with 








In both cases the aldol products were oxidised prior to the measurement of 
enantioselectivity and this neatly removed the issue of low diastereoselectivities.  
 
Feringa’s group went on to report studies on the tandem reaction of monoprotected 








A number of examples were described and the reaction conditions yielded 
exclusively the trans-substituted cyclopentanones in moderately high yields. Good 
stereocontrol was observed in the reaction; diastereomeric ratios of higher than 95:5 
were obtained for the -hydroxyketones and exceptionally high levels of 
enantioselectivity were reported. 
 
This new methodology was utilised to great effect in the total synthesis of the 
polyoxygenated fatty acid (-)-prostaglandin E1 methyl ester (Scheme 1.19).








The key multicomponent coupling step was effective, providing the aldol product 76 
in a reasonable yield with respectable diastereoselectivity. 
 
An intramolecular variant of this transformation by Krische describes the first use of 
ketones (in addition to nitriles and esters) as the electrophilic trap in a domino 





The keto−enone precursors gave cyclisation products in exceptionally high yields, 
although the diastereoselectivity of the reaction was variable. The group additionally 
reported the alkylative aldol reaction of a set of enone substrates containing 1,3-
diones as the electrophilic trap (Scheme 1.21). These precursors provided bicyclic 









One asymmetric example was reported using a chiral phosphoramidite ligand in 
place of the triethylphosphite; high levels of asymmetric induction were observed 
although the diastereoselectivity was reduced (eq 1.8). 
 
 
During studies on copper-catalysed enantioselective conjugate addition–trapping 
reactions, Alexakis and Li reported a similar intramolecular conjugate addition–aldol 




In their sole example, the reaction proceeded with exceptionally high 
diastereoselectivity and low levels of asymmetric induction, which was obtained with 
a biphenol-based phosphoramidite ligand 86. It is clear that controlling both the 
absolute and relative stereochemistry of the products, whilst maintaining high 
conversions, is a non-trivial matter in this transformation. 
 
The majority of the protocols described thus far utilise an enone as the initial 
Michael acceptor. Expansion of the substrate scope to include a wider range of ,-
unsaturated acceptors would powerfully enhance the utility of the reaction, as a far 





Hoveyda et al reported the first general protocol for asymmetric conjugate addition 
to unsaturated furanones and pyranones using amino acid-based phosphane ligands 





Yields of the conjugate addition product were very low in the absence of the 
aldehyde, as the intermediate zinc enolate is highly reactive and so can form 
intermolecular Michael adducts. The aldol products were oxidised in situ to the 
corresponding diketones, which were obtained in reasonable yields with exceptional 
levels of enantioselectivity. 
 
In 2006, Feringa and co-workers reported the first catalytic asymmetric methodology 
for the tandem conjugate addition–aldol reaction of acyclic substrates using 
organometallic nucleophiles.43 The copper-catalysed process employed the Josiphos 









The tandem aldol products were obtained in good yields and with excellent control of 
the absolute and relative stereochemistry. A major advantage of this novel system 
was that the aldol reaction of the more reactive magnesium enolate took place in 
under a minute at –78 oC.  Previous reactions involving zinc species required 
extended reaction times, often over 24 hours. 
 
Feringa successfully employed these conditions in the first catalytic asymmetric 





The key tandem conjugate addition–aldol reaction in the concise five-step synthesis 
proceeded in a good yield, with outstanding levels of diastereoselectivity and 
enantioselectivity. 
 
More recently Shibasaki utilised allenic esters as the initial Michael acceptor in the 




dialkylzincs, allenic esters and ketones produced highly functionalised -lactones 





During initial screening it was observed that the Lewis base (either DMSO or 
HMPA) and molecular sieves were essential to obtain high product yields. After the 
initial conjugate addition reaction, the resultant enolate can either undergo the aldol 
reaction at the -position or the desired -position. In the absence of the 
aforementioned additives a significant amount of the kinetic -aldolate was formed. 
The group surmised that the combination of molecular sieves and Lewis base has a 
‘proof-reading’ effect and facilitates the retro-aldol reaction of the undesired -
aldolates back to the initial enolate. Conversely, the formation of the -aldolates is 






The group of Hayashi pioneered the use of a rhodium catalyst in the tandem 
conjugate addition–aldol reaction. They described the three-component coupling of a 








The conjugate addition−aldol products were obtained in excellent yields and with 
good to high levels of diastereoselectivity. In contrast to the previously described 
copper-catalysed systems, the rhodium catalyst controls both of the two C−C bond-
forming steps. One asymmetric example (Scheme 1.26, 103e and 103f) was also 
reported and the formation of enantiomerically enriched products excluded the 
possibility of a boron enolate intermediate. The proposed catalytic cycle has been 








Conjugate addition of the organorhodium species 104 to the vinyl ketone gives the 
(oxa--allyl)rhodium intermediate 105. Aldol reaction with an aldehyde produces the 
Rh-aldolate 106 which then transmetallates to liberate the boron aldolate 107 and 
regenerate the organorhodium intermediate. The high syn selectivity is attributed to a 
Zimmerman-Traxler transition state46 of the Z-Rh enolate at the aldol reaction. 
 
In 2003, a particularly effective protocol for a tandem intramolecular conjugate 





The conditions yielded both five- and six-membered ring products containing three 
contiguous stereocenteres as single diastereomers.  The observed stereochemistry 
was again accounted for by the formation of a Z-enolate and a Zimmerman-Traxler46 
transition state. A minimal amount of water was used to ensure that the electrophilic 
trapping of the rhodium enolate in the aldol cyclisation was faster than enolate 
protonation. The addition of non-racemic chiral ligands established an 
enantioselective transformation, which was applied successfully to a number of 







The same group then reported an elegant desymmetrisation reaction using similar 
conditions and appendant 1,3-diones as the terminal electrophile (Scheme 1.29).48 In 
these reactions the conjugate addition–aldol cyclisation of the enone−dione 
substrates results in the formation of two new C−C bonds and four contiguous 





The rhodium enolate generated upon enone carbometallation effectively 
discriminates between the four diastereotopic -faces of the appendant dione. 
Although potentially sixteen stereoisomers could be formed in this step, the high 
efficacy of the catalytic system provided a single stereoisomer in all cases. A 
reported limitation was that the system was only effective for ,-unsaturated 
ketones, attempts with the corresponding esters resulted in the 1,4-addition but no 
subsequent cyclisation. 
 
The potential use of this reaction was further demonstrated in the parallel kinetic 







The absolute stereochemistry of the substrate dictates which of the two non-
equivalent carbonyl moieties of the appendant dione participates in the aldolisation 
step. 
 
Although most of the rhodium protocols utilise a boron derivative as the 
organometallic species, Nicolaou explored the conjugate addition–aldol reaction of 
an alkenylzirconium reagent, during a programme of work directed towards the total 





The methodology was applied effectively to five-, six-, and seven-membered ring 
enones and one acyclic substrate. The reactions proceeded in moderate yields with 
reasonable levels of diastereoselectivity, an issue that was removed in a subsequent 
dehydration step. The proposed mechanism bore marked similarities to Hayashi’s 





The group harnessed their conditions in the synthesis of a complex spirocyclic 





The multicomponent coupling gave the aldol product 119 in a modest yield, although 
the diastereoselectivity of the reaction was not reported as the substrate was 
dehydrated at the next stage in the synthesis. A short sequence of transformations 






The abundance of chiral ligands available for copper and rhodium catalysis has been 
highly advantageous for the development of the asymmetric tandem conjugate 
addition–aldol reaction. The rhodium-catalysed conjugate addition–aldol reaction 
offers a complementary alternative to the analogous copper-catalysed transformation, 
in that the carbon-based nucleophile that adds to the -position of the initial Michael 
acceptor is an aromatic or alkenyl group rather than an alkyl group. Unfortunately, in 
terms of substrate scope, both systems are limited to ,-unsaturated ketones as the 
initial Michael acceptor. 
 
1.2.2 Organocatalytic Reactions 
 
Jørgenson’s group reported the first asymmetric organocatalytic domino Michael–
aldol reaction in 2004. The highly diastereoselective reaction of ,-unsaturated 
ketones with -ketoesters,50 -diketones51 and -ketosulfones51 was catalysed by an 








The optically active cyclohexanone products contained up to four contiguous 
stereocentres and precipitated from the reaction mixture, circumventing the use of 
column chromatography. The proposed mechanism for this transformation is 





It was postulated that the imidazolidine catalyst has three major roles in the reaction: 
activation of the Michael acceptor by iminium ion formation, generation of the active 
carbon nucleophile via deprotonation of the -keto substrate 122 and as a base in the 





From a green chemistry perspective an organocatalytic process is generally more 
attractive than conventional metal-catalysed approaches. The use of potentially toxic 
metals is avoided, the catalysts are usually cheaper and conditions milder. The use of 
organocatalytic chemistry for the tandem conjugate addition–aldol has yielded some 
elegant results but the expansion of the substrate scope and the reduction of the 
currently extended reaction times (>100 h) remain a challenge for the future. 
 
1.2.3 Radical-Mediated Reactions 
 
In recent years radical-mediated transformations have emerged as a new subset of the 
conjugate addition–aldol reaction. Bertrand and co-workers were the first to describe 
a Et2Zn-mediated addition of alkyl radicals to N-enoyloxazolidinones in the presence 





In the absence of tert-butyl iodide the ethyl adduct was formed, conversely when it 
was present in the reaction mixture, a tert-butyl radical added to the -position of the 
Michael acceptor. The group also obtained di- and trisubstituted -lactones from 








A conjugate radical addition, aldol reaction and lactonisation result in the observed 
products. The use of Me2Zn in place of Et2Zn allowed a greater range of alkyl radical 
precursors. The diastereoselectivity of the reaction was not high, in most cases four 
diastereomers were observed, this was improved in most cases via epimerisation of 
the enolisable centres. The methodology enabled the group to complete a racemic 



































































Initially an iodine atom transfer to the methyl radical produces the alkyl radical 140, 
this can add to the -position of the Me2Zn-activated Michael acceptor. Homolytic 
substitution at the dialkylzinc leads to the zinc enolate 143. An ensuing aldol reaction 
and lactonisation results in the -lactone 145. 
 
More recently other groups have begun to explore the area of radical-mediated 
conjugate addition–aldol reactions. Tamioka demonstrated that the Me2Zn-mediated 
addition of ether radicals could provide tandem conjugate addition–aldol products in 








The tandem reaction provided indane products in moderate yields and 
diastereoselectivities. The use of bis(8-phenylmenthyl) 2-
formylbenzylidenemalonate as a chiral Michael acceptor resulted in the adduct 148b 
as a mixture of four diastereomers. 
 
In addition to dialkylzinc-mediated radical transformations, Renaud’s group has 
demonstrated that a B-propylcatecholborane-mediated radical addition–aldol 
cyclisation gives polysubstituted cyclic alcohols in a highly diastereoselective 





The reaction to form cyclohexanols was generally effective, although yields were 




when an aldehyde trap replaced the ketone. The radical addition of other B-
alkylcatecholboranes was not examined and so the scope of the reaction remains 
limited. After mechanistic studies were carried out, the group surmised that a borane-
mediated radical addition of the propyl group is followed by an aldol cyclisation of 
the boron enolate. 
 
The majority of radical-mediated transformations do not offer huge advantages over 
the more conventional conjugate addition–aldol reactions in terms of 
stereoselectivity and substrate scope. In spite of this fact, the recent flurry of 
publications in this area has demonstrated some effective routes into certain classes 




There is a significant range of tandem conjugate addition–aldol methodologies 
available to access an array of relatively complex products from comparatively 
simple starting materials. Currently the majority of protocols rely on the use of ,-
unsaturated ketones as the initial Michael acceptor; expansion to different types of 

















Reductive aldol cyclisations have been a key research interest of the Lam Group for 
a number of years. Our earliest examples comprised of copper-catalysed systems that 
employed siloxanes as the stoichiometric reductant (Scheme 2.1).57 The use of chiral 





Further investigations revealed that the copper-catalysed methodology was effective 
for substrates containing an amide tether. However, the scope of the reaction was 
limited to those possessing a hydrogen or a methyl group at the -position of the ,-









The copper-catalysed methodology was used to prepare a series of 4-
hydroxypiperidin-2-ones in a highly diastereoselective fashion. The presence of a 
pre-existing stereocentre in the substrate did not adversely affect the 
diastereoselectivity of the reductive aldol reaction. A reductive removal of the 
carbonyl group provided access to piperidine structures, which feature in many 





Research in the group was then directed towards a catalytic system that would be 
effective for a wider range of amide-tethered substrates. The result was a novel 










The cobalt-catalysed reaction offered a broader scope for amide-tethered substrates 
compared to the previously described copper-based method. It was successful with 
two different nitrogen-protecting groups (-PMP and -Bn), tolerated both aromatic 
and alkyl substitutions at the -position, as well as at the tethered ketone and 
provided a route to both five- and six-membered -hydroxylactams. 
 
The use of a Ni(acac)2 precatalyst in conjunction with Et2Zn presented a more 





These conditions allowed the expansion of the substrate scope to include ester tethers 
(163a), as well as -substituted (163b) and ,-disubstituted ,-unsaturated amides 
(163c). A -ester substituted ,-unsaturated amide (164) underwent the reductive 





2.6). Many of these substrates had been inert under the previously reported cobalt 





During investigations in this area, a competing alkylative aldol reaction was 
occasionally detected for particular catalyst−reagent−substrate combinations. For 
example, it was observed that in the cobalt-catalysed reductive aldol reaction, -
unsubstituted acrylamides underwent alkylative aldol cyclisation to a small degree 





The same phenomenon was observed for -unsubstituted acrylamides; in the 
presence of Ni(acac)2 and Et2Zn the alkylative aldol product 172 was isolated in 61% 




The aim of the proposed programme of work was to exploit these initial results and 
develop a fully alkylative aldol cyclisation that would complement our existing 
reductive aldol methodologies. The two previous alkylative aldol reactions were the 
first examples of conjugate addition of trialkylaluminium reagents to ,-unsaturated 





2.2). Conjugate addition of an alkyl group followed by a highly diastereoselective 
ring closure results in the creation of three new contiguous stereocentres in a single 
step. An additional goal was to render the protocol enantioselective, as the synthetic 
utility of the reaction would be further enhanced. Potentially, a relatively complex 
molecule could be created in one step from simple achiral substrates with a high 







The development of a complementary alkylative aldol reaction began with the 
screening of various catalyst and ligand combinations with the model substrate 173 
(Table 2.1). Our aim was to favour the formation of the alkylative aldol cyclisation 
product 174 over the reductive aldol product 161a, whilst maintaining the high 












In the first instance, nickel-based precatalysts were examined. In the absence of 
ligand, a Ni(acac)2 precatalyst resulted in the preferential formation of the reductive 
aldol product 161a. The presence of bidentate (entry 2) or monodentate (entry 3) 
phosphine ligands did not offer any improvements on this selectivity and the reaction 
conditions continued to favour the reductive aldol product. It was hoped that perhaps 
the oxazoline ligand 175 would offer a reversal in the selectivity, as Ikeda had 
successfully applied an oxazoline ligand to enantioselective [2+2+2] cycloadditions 






entry metal salt (10 mol%) ligand (10 mol%) 174:161a 
a,b
 
1 Ni(acac)2 / 10:90 
2 Ni(acac)2 rac-BINAP 8:92
c 
3 (PPh3)2NiBr2 / <5:95
c 
4 Ni(acac)2 175 5:95
d 
5 CoCl2 Cy2PPh 25:75 
6 Co(acac)2·2H2O 175 >95:5
d 
7 Co(acac)2·2H2O / >95:5 
a All reactions proceeded to >95% conversion. b Determined by 1H NMR analysis of the 
unpurified reaction mixture. c Small quantities of unidentified side products were observed. d No 





However, the reductive aldol cyclisation remained the pathway of choice in the 
presence of the oxazoline ligand and so our focus turned to cobalt-based precatalysts. 
It was found that a combination of CoCl2 and Cy2PPh (entry 5) resulted in a higher 
proportion of the desired alkylative aldol product. Moreover, Co(acac)2 gave 174 as 
the sole product in the presence of the oxazoline ligand 175 (entry 6). To our delight 
this result was repeated in the absence of any ligand (entry 7) and so these optimised 
conditions were then applied to a range of different substrates to explore the scope 
and limitations of the process. 
2.2.2 Preparation of Cyclisation Precursors 
 
A range of nitrogen-tethered cyclisation precursors, containing an ,-unsaturated 
amide and a pendant ketone, were prepared according to the general method shown 








  yield (%)
a
 
1 Ph 173 48 
2 PMP 181 55 
3 4-methylphenyl 182 38 
4 4-chlorophenyl 183 37 
5 2-furyl 184 42 
6 2-thiophenyl 185 30 
7 OMP 186 47 
8 
 
Et 187 49 
9 Ph 188 23 
10 
 
PMP 189 34 





The cyclisation precursors were obtained in moderate yields over the two steps. The 
yields of substrates 188 and 189 (entries 9 and 10) were slightly lower than those 
substrates derived from methyl vinyl ketone (entries 1-8). The purification of these 
ethyl-substituted ketones 188 and 189 by column chromatography was also more 
difficult due to co-running impurities. 
 
The substrate 192,i which contains a phenyl-substituted pendant ketone was prepared 
as described in the literature (Scheme 2.7).61 
 
Scheme 2.7 
2.2.3 Cobalt-Catalysed Alkylative Aldol Cyclisations Using Et3Al 
 
The optimised conditions for the alkylative aldol cyclisation using Et3Al were then 
applied to a range of ,-unsaturated amides containing aromatic, heteroaromatic and 
alkyl groups at the -position (Table 2.3).  
 
                                                 












1 173 R = H 174 98 
2 181 R = OMe 193a 91 
3 182 R = Me 193b 71 
4 
 
183 R = Cl 
 
193c 48 
5 184 X = O 193d 76 



























a dr >19:1 unless otherwise stated. dr determined by 1H NMR analysis of the unpurified reaction mixtures. 
dr = (major isomer):Σ(other isomers). b The reductive aldol product 193k was obtained in 28% yield. c 
Unreacted starting material (16%) was recovered. d Unreacted starting material (35%) was recovered. e dr = 
1:1 in the crude reaction mixture. Combined yield of both isolated diastereomers. f The reductive aldol 







The reaction conditions were well tolerated by substrates containing aromatic 
(entries 1-4, 7 and 9-11) or heteroaromatic (entries 5 and 6) groups at the -position 
of the ,-unsaturated amide. A study of different substituents on the aromatic ring 
indicated that more electron-donating groups favoured the reaction (entries 2-4). 
However, an ortho-substitutuent hindered the reaction; the low yield was accounted 
for by the formation of the reductive aldol product in addition to a poor conversion 
from the starting material (entry 7). An alkyl group at the -position of the ,-
unsaturated amide proved to be a less reactive substrate and resulted in a low yield of 
the desired product (entry 8). In addition, replacement of the pendant methyl ketone 
with an ethyl ketone was compatible with the reaction conditions (entries 9 and 10). 
In these substrates the reactions proceeded with uniformly high diastereoselectivities. 
Unfortunately, a pendant aromatic ketone appeared to have a deleterious effect on the 
selectivity of the reaction (entry 11). In this case, the alkylative aldol product was 
obtained as a 1:1 mixture of diastereomers, along with the reductive aldol product. 
 
2.2.4 Cobalt-Catalysed Alkylative Aldol Cyclisation Using Me3Al 
 
With a view to expanding this new methodology, we applied our optimised reaction 
conditions to the alkylative aldol cyclisation of a similar range of substrates using 










The cobalt-catalysed alkylative aldol cyclisations using Me3Al were less 
synthetically useful than those employing Et3Al, as the products were generally 
obtained in lower yields. This observation was partly attributed to the lower 
reactivity of Me3Al. In certain cases (entries 1, 2 and 5) full conversion of the 
starting material to the desired product was observed from the crude NMR spectra, 
which contained only minor impurities. For these examples, a full mass recovery was 
obtained after work-up and yet, following column chromatography, lower yields than 
those predicted were consistently observed. Unfortunately, attempts to improve these 
 





1 173 R= H 194a 43 
2 181 R = OMe 194b 48 
3 182 R = Me 194c 46 
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a All dr >19:1 unless otherwise stated. dr determined by 1H NMR analysis of the unpurified reaction mixtures. 





yields via variation of chromatography solvents were not successful. As was 
observed with Et3Al (Table 2.3), variation of the aromatic substituents (entries 2-4) 
affected the transformation, with the more electron-donating groups favouring the 
alkylative aldol reaction. Replacing the pendant methyl ketone with either an ethyl 
group or an aromatic group had a detrimental effect on the diastereoselectivity of the 
reaction (entries 8 and 9). 
 
2.2.5 Cobalt-Catalysed Alkylative Aldol Cyclisation Using Higher R3Al 
 
In order to probe the wider applications of this reaction, we attempted cyclisations 
employing higher trialkylalumiunium reagents. To our gratification, both tri-n-











Substrates containing a phenyl-substituent (173, entries 1 and 2) and a para-
methoxyphenyl-substituent (181, entries 3 and 4) at the -position of the ,-
unsaturated amide both underwent the alkylative aldol cyclisation with nPr3Al and 
nHex3Al. High levels of diastereoselectivity were maintained under these conditions 
and the products were isolated in good yield.  
 
2.2.6 Substrate Scope  
 
At this stage it became desirable to explore the scope of the reaction further by 
testing substrates whose structures were substantially different to those previously 
examined under our reaction conditions (Fig 2.1). 
 






















a All dr >19:1. dr determined by 1H NMR analysis of the unpurified reaction mixtures. dr = 










The general substrate structure contains a benzyl-protected amide as the tether, a 
ketone as the appendant electrophile and has the appropriate skeleton to result in the 
six-membered cyclic lactam products observed. The variations investigated included 
different skeletal arrangements, different types of tether and variation of the 
electrophilic trap, in the hope of accessing a more diverse range of cyclic products.  
 
The first variation investigated was a substrate with one methylene group less in the 
carbon backbone, to provide a potential route into pyrrolidinones via our alkylative 
aldol approach. The amide substrate (197) was made via an alkylation reaction with a 





Under our standard conditions, the reaction did not proceed to conversion and 
provided a complex mixture of products. It was not possible to isolate all of these 
products but 15% of the reductive aldol product was obtained along with 20% of 
what appeared to be a mixture of the alkylative aldol diastereomers. 
 
The electrophilic trap was next examined and a substrate possessing a pendant ester 
group was prepared. Alkylation of benzylamine with methyl acrylate and a 
subsequent acylation provided the desired substrate 200 in 84% yield over the two 









Application of our standard Co(acac)2 and Et3Al conditions to 200 resulted in a 
complex mixture of products; containing no trace of any alkylative aldol cyclisation 
product (Scheme 2.9). 
 
The next variation investigated involved a significant change to the core skeleton of 
the general structure; substrate 203, containing an aromatic group in the backbone 
was synthesised via a Heck-type reaction from the aryl bromide 202 and the ,-




Under our alkylative aldol conditions of Co(acac)2 and Me3Al, it appeared that direct 
addition to the appendant ketone had occurred, although the product 204 was never 
isolated. 
 
Finally, a substratei containing an ,-unsaturated ketone as the initial Michael 
acceptor and a 1,3-dione as the electrophilic trap (205)63 was subjected to our 
reaction conditions (eq 2.4). 
 
                                                 







The conjugate addition–aldol reaction proceeded smoothly for the highly reactive 
precursor 205 and the desired bicyclic product 206 was isolated in a good yield with 
excellent diastereoselectivity. The relative stereochemistry of the product has been 
assumed based on similar transformations that have been reported by Krische and co-
workers.48 
 
2.2.7 Screening for Enantioselectivity 
 
The synthetic utility of this reaction protocol would be powerfully enhanced if the 
conjugate addition step could be rendered enantioselective, since three new 
contiguous stereocentres could be created with absolute stereocontrol. Therefore a 
concerted effort was directed at screening different metal catalyst and ligand 
combinations to achieve this goal. 
 
The substrate 173 was used as our model system in the alkylative aldol cyclisation 
using Et3Al. In the initial examination, a range of the more commonly available 
chiral non-racemic ligands were screened in conjunction with Co(acac)2 









Unfortunately none of these ligands offered any levels of asymmetric induction. 
Furthermore, the results indicated that bis-phosphines such as (S)-MeO-Biphep and 
(S,S)-Et-DuPhos appeared to suppress the catalytic activity. 
 
It was postulated that perhaps more specialised ligands would be required to effect 
the desired transformation. The literature provided two possible ligand systems that 
we hoped would meet with greater success. The first was Ikeda’s chiral monodentate 
oxazoline 175, which was used during the optimisation studies (vide supra).62 The 
second was the monophosphine ligand, (+)-NMDPP, that Jamison used in the 
reductive coupling of alkynes and aldehydes in the presence of Ni(cod)2 and Et3B (eq 
2.5).64   
 
 
These two ligands were screened for enantioselectivity using both nickel and cobalt 








The combination of the Co(acac)2 catalyst and Et3Al with both the oxazoline 175 and 
the (+)-NMDPP ligands did provide 100% conversion to the desired alkylative aldol 
product but no asymmetric induction was detected. Unfortunately the other 
conditions proved to be even less successful and the combination of the nickel 
catalyst and Et3Al resulted in the reductive cyclisation product 161a in both cases.  
 
At this stage, screening for asymmetric induction was suspended. Although the 
reasons for the lack of enantioselectivity were unclear, we postulated that these chiral 
non-racemic ligands were not coordinating sufficiently to the cobalt centre. It was 
also possible that the cobalt catalyst was not directly involved in the stereochemical 
determining step (i.e. the delivery of the ethyl group) but instead ethyl addition may 
have been occuring via a radical mechanism (vide infra). 
 
2.2.8 Plausible Reaction Mechanism 
 
The generation of -allylmetal species by Lewis acid-promoted oxidative addition of 
low-valent transition metals to ,-unsaturated carbonyl compounds is well 
documented in the literature. For example, Mackenzie’s group have described 
allylnickel reagents65,66 and, more recently, Ogoshi and co-workers have published a 
number of papers on palladium -allyl species.67,68 During an investigation into the 
roles of Lewis acids in transition metal-catalysed conjugate additions, they used 
NMR studies to deduce that the treatment of Pd(PhC=CHCOMe)(PPh3)2 with AlMe3 
leads to a palladium complex containing 3-allyl coordination. Based on this 
observation they suggest the following mechanism for the palladium catalysed 









Initially, intermediate 216 is formed after coordination of Me3Al to the palladium-
enone complex 215. A subsequent oxidative addition and transmetallation give the 
key 3-allyl(methyl)palladium intermediate 217. Reductive elimination liberates the 
conjugate addition product 220 (after work-up) and coordination of further enone to 
the palladium centre completes the cycle. 
 
Drawing from these precedents we suggest the participation of a -allylcobalt species 
in our catalytic cycle. The proposed mechanism has been depicted using substrate 









In the presence of Et3Al it is supposed that Co(acac)2 is reduced in situ to a Co(I) 
species. In the presence of excess Et3Al, Co(I) can coordinate to the ,-unsaturated 
amide to give intermediate 221, which contains a three-centre-two-electron bridging 
interaction between the cobalt, aluminium and ethyl ligand. Both Montgomery69 and 






The group of Montgomery conducted a series of experimental and computational 
studies on the role of Me2Zn in the nickel-catalysed coupling of an enone and an 
alkyne. They concluded that the Me2Zn plays a dual Lewis basic/Lewis acidic role in 
these reactions; Lewis acidic activation of the carbonyl and Lewis basic activation of 
the Ni(0) species via a three-centre-two-electron bridging interaction of the Zn−Me 
bond with the nickel (225, Fig 2.2).68 In addition, Ogoshi reported the crystal 
structure of 226, containing a bridging methyl group.69 In our case we have replaced 
the nickel with cobalt, and Me2Zn or Me3Al with Et3Al, but the principle remains the 
same. Oxidative addition of Co(I) to the ,-unsaturated amide, with subsequent 
transmetallation results in 222, which undergoes a hapticity change from 1 to 3 to 
give 223. At this stage reductive elimination provides the Z-aluminium enolate 224 
and the active Co(I) catalyst is regenerated. It is supposed this species undergoes the 
diastereoselective aldol cyclisation to result in the -hydroxylactam product upon 
work-up.         
 
In light of the recent work carried out by Bertrand and co-workers on the dialkylzinc-
mediated radical conjugate addition–aldol reactions (see Chapter 1), it is unwise to 









In the presence of Co(acac)2 or trace amounts of oxygen in the reaction vessel, it is 
possible that an ethyl radical is produced from Et3Al. This species can then attack at 
the -position of the Lewis acid-activated ,-unsaturated amide to produce 
intermediate 228. Drawing precedent from the dialkylzinc-mediated transformations, 
it is fair to assume that homolytic substitution can take place at aluminium and form 
the aluminium enolate 224 and regenerate the ethyl radical in the catalytic cycle. The 
aluminium enolate can then be supposed to cyclise as discussed previously. If a 
radical-mediated mechanism were indeed in operation this could account for the lack 
of asymmetric induction observed during the screening for enantioselectivity. 
 
There is evidence to suggest that the situation is perhaps more complex than the 
scenarios outlined above. The cobalt-catalysed conjugate additions of R3Al to the 
simpler amide substrates 229 and 230 containing no tethered ketones were 
unsuccessful (eq 2.7 and eq 2.8). In both cases, it appeared that oligomerisation of 









Furthermore, the decreased levels of diastereoselectivity observed in the case of the 
pendant phenyl ketone (entry 11, Table 2.3), which is accompanied by an increased 
proportion of the competitive conjugate reduction, implies that some participation or 
activating coordination of the pendant ketone cannot be ruled out. 
 
2.2.9 Stereochemical Rationale 
 
The relative stereochemistry of the major diasteromer of the -hydroxylactam 
products was confirmed by X-ray crystallography of the products 174 and 193h (Fig 
2.3 and Fig 2.4). The relative stereochemistries of the remaining products were 
assigned by analogy. 








        
Figure 2.4 
 
Initially, the exceptionally high levels of diastereoselectivity observed for the 
majority of substrates were slightly surprising, as the new stereogenic centre formed 
upon conjugate addition was outside of the six-membered ring formed upon 
cyclisation. If we assume that the aldol cyclisation of 173 occurs via a chelated 






In route (a), cyclisation through 231 minimises unfavourable syn-pentane 






the enolate. Based on these arguments it appears that minimisation of syn-pentane 
interactions dominates and so 174 is obtained as the sole product in the majority of 
cases. 
 
Again, as discussed previously, the situation could be more complex if the 
coordination of the pendant ketone to the cobalt and/or aluminium centres occurs in 
any of the intermediates 221-223, as this coordination would fix the ketone on one 






A novel cobalt-catalysed alkylative aldol cyclisation of ,-unsaturated amides with 
a pendant ketone has been described, using a range of different trialkylaluminium 
reagents. It is significant that, prior to our work, there were no literature reports of 
metal-catalysed conjugate addition of trialkylaluminium reagents to ,-unsaturated 
amides. The reaction generally proceeds with high levels of diastereoselection and 
provides -hydroxylactam products in good yields. Attempts to further expand the 
substrate scope have been discussed and the use of chiral non-racemic ligands has 
not imparted any enantioselectivity to the reaction, although the reasons for this have 
not yet been elucidated. Various mechanistic pathways have been postulated 
including one involving a -allylcobalt species and the other comprising of a radical-
mediated pathway. A stereochemical rationale has been proposed to account for the 
high diastereoselectivity of the reaction, which suggests syn-pentane strain is the 











The synthetic community has utilised silyl enol ethers as effective intermediates in a 
wide range of transformations for many decades.73 Despite their widespread 
popularity, they often have to be directly prepared before use as they are relatively 
unstable, being prone to hydrolysis and protonolysis. Additionally, the 
stereoselective synthesis of more highly substituted silyl enol ethers is often non-
trivial.73a The closely related enamines are also recognised as useful enolate 
equivalents and play significant roles in asymmetric organocatalytic reactions.74 
Enamines are more highly reactive than silyl enol ethers but suffer a low stability due 
to their propensity to hydrolyse. Enamides offer a potential solution to this problem, 
as they possess a degree of nucleophilicity due to their enaminic character, yet the 
presence of an electron-withdrawing group on the nitrogen tempers this reactivity 
and increases the stability of the enamide.75 This feature allows them to be purified 
by column chromatography and stored for long periods of time. Therefore, enamides 





In addition to its importance as a synthetic intermediate, the enamide functionality is 
present in several biologically active natural products such as TMC-95A-D,76 
croacins A, B and D77 and the salicylihalamides and related compounds.78 










Enamides, as synthetic intermediates, offer a diverse range of chemistry; they are 
able to act as both nucleophiles and electrophiles and participate in pericyclic, radical 
and transition metal-catalysed reactions. They can also be applied in the synthesis of 
heterocycles and the preparation of optically active amines and amino acid 
derivatives. Recent reviews by Carbery79 and Kobayahsi80 have covered most of 
these topics in some detail and the work is too wide-ranging to cover it 
comprehensively within the remits of this discussion. Thus we will examine the key 
areas, highlighting recent examples to appreciate the depth and breadth of enamide 
applications across organic synthesis. 
 
3.2.1 Asymmetric Hydrogenation of Enamides 
 
The preparation of optically active amines and their derivatives is arguably the best-
known application of enamides. Extensive research has been undertaken on the 
rhodium catalyst, in conjunction with both chelating and monodentate phosphine 
ligands.81 Recently, Doherty and Knight described a Rh-(R)-Me-Catphos complex as 
an effective catalyst for the asymmetric hydrogenation of (E)--aryl--
enamidophosphonates (Scheme 3.1).82 The -amidophosphonates products 235 can 
act as precursors to -aminophosphonic acids, which are substrates that exhibit 









Furthermore, the group discovered a complementary Rh-(R)-(S)-Josiphos catalyst for 
the reaction of (Z)-enamides.82 In both cases, exceptionally high conversions and 
levels of asymmetric induction were observed. 
 
It is possible to utilise other transition metals as catalytic species in the asymmetric 
hydrogenation reaction. For example, Beller and co-workers demonstrated the use of 






Employing NaClO4 as an additive was found to increase the enantioselectivity of the 
reaction. Since iridium species can form active dimeric complexes, it was surmised 
that the addition of this non-coordinating anion stabilises the more selective 






In addition, there have been reports of non-metal-catalysed hydrogenation reactions 
involving enamides. In the last year, Antilla has devised a dual chiral−achiral acid-
catalysed enantioselective reduction of enamides, using the Hantzsch ester84 as the 





In the absence of the achiral acid additive, the reaction rate was intolerably slow at 
lower catalyst loadings and this was attributed to the slow formation of the iminium 
ion. Acetic acid was employed to facilitate iminium ion formation whilst being 
inactive in the hydrogenation step, thus the high levels of enantioselectivity were 
maintained. 
 
3.2.2 The Enaminic Character of Enamides 
  
Despite the electron-withdrawing group attached to the nitrogen, enamides possess a 
degree of enaminic character and so are able to act as nucleophiles. Additionally, this 
trait allows them to form iminium ions in the presence of acid and thus they can also 









Consequently, enamides have been successfully exploited as both electrophilic and 
nucleophilic reagents by a number of groups in recent years. 
 
Kobayashi pioneered the use of enamides as nucleophiles in a number of 
enantioselective reactions with various electrophiles such as iminophosphonates,86 
ethyl glyoxyate87 and azodicarboxylates88 under copper catalysis. One of the latest 
examples to emerge from their laboratories has been the copper-catalysed 





The initial adducts formed in the Michael reaction are imines and in the majority of 





NaBH4 provided an effective route to amino ester products albeit with modest 




Dake and co-workers demonstrated the use of enamides as nucleophiles in platinum-





This methodology allowed easy access to spiro-piperidine structures. However, when 
the tethered alkyne was substituted with an aromatic group an alternative pathway 
resulted in the tetracyclic product 253 (Route b, Scheme 3.6).90b In this instance, 
nucleophilic attack of the enamide on the Pt(II)-activated alkyne is followed by a 
Friedel−Crafts ring closure. This methodology has been employed by Zhai and co-
workers as a route to the tetracyclic core found in the natural product nakadomarin.91 
 
As demonstrated in the previous Friedel−Crafts ring closure (Route b, Scheme 3.6), 
in the presence of acid, enamides can be converted into their iminium ion 
counterparts. These electrophilic species can participate in other types of 
Friedel−Crafts reactions. For example, Zhou described a chiral Brønsted acid-









The transformation elegantly allows the assembly of enantioenriched indoles, which 
contain a nitrogen-bearing quaternary stereocentre. 
 
3.2.3 Chiral Enamides in Stereoselective Synthesis 
 
The preparation of chiral enamides is relatively facile and these substrates can 
function effectively as inducers of enantioselectivity in a number of transformations. 
For example, Davies and co-workers recently devised a route to homochiral 1,2-diols 





The highly diastereoselective epoxidation using dimethyldioxirane is followed with a 
ring opening using mCPBA and a subsequent reductive cleavage provides the desired 
1,2-diols with high levels of enantioselectivity. 
 
Hsung has also undertaken work on the epoxidation of enamides, subsequent 





enamides. In recent years, they have reported the Simmons−Smith cyclopropanation 
of enamides as being highly stereoselective for a variety of enantiopure (E)- and (Z)-





The enantiopure aminocyclopropane 263 is accessible via the removal of the chiral 
amide moiety from the major diastereomeric product 262 of the Simmons−Smith 
cyclopropanation. Hsung has also lately described an additional stereoselective 
cyclopropanation of enamides which utilises rhodium carbenoid species.95 
 
An additional example of chiral enamides inducing enantioselectivity is a hetero-





The resultant bicyclic heteroadducts offer an asymmetric approach to 4-aryl-









3.2.4 Enamides in Heterocycle Synthesis 
 
Enamides have been employed in the synthesis of a multitude of heterocycles 
including pyridines,97 oxazoles,98 indoles and indolines.99 Wang and colleagues have 






This work allows the preparation of 1H-pyrrol-2(3H)-one derivatives containing a 
hydroxy-bearing quaternary stereocentre with high levels of enantioselectivity. The 
reaction additionally constitutes the first example of an asymmetric nucleophilic 
addition of a tertiary enamide to a carbonyl compound.  
 
3.2.5 Pericyclic Reactions 
 
Enamides are successful participants in a range of pericyclic transformations 
including sigmatropic rearrangements (e.g. an Ireland−Claisen rearrangement101) and 
cycloadditions (e.g. a [2+2] cycloaddition102 and a hetero-Diels−Alder reaction96).  
 
Hsung recently reported an enamide−benzyne [2+2] cycloaddition to construct 









A range of ynamide substrates underwent the [2+2] cycloaddition reaction, including 
yne-sulfonamides and those containing an oxazolidinone moiety.  
 
Moreover, further investigations revealed that a tandem process was possible when 





The reaction involves a [2+2] cycloaddition, pericyclic ring opening and a 
subsequent [4+2] cycloaddition to give the aza-tricyclic product 278. This 




As synthetic intermediates, enamides are clearly valuable substrates willing to 
participate in a wide range of reactions. In addition to those mentioned (vide supra), 
enamides are able to take part in transition metal-catalysed reactions such as 
metathesis103 and Heck reactions,104 as well as radical105 and photochemical106 





flourish as their uses in organic synthesis are further explored. Thus the preparation 




Traditional methods of preparing enamides include the Curtius rearrangement of ,-
unsaturated acyl azides followed by reaction with an alcohol,107 the acylation of 
imines,108 the olefination of aldehydes109 and the direct condensation of carbonyl 







































































The Curtius reaction, imine acylation and amide olefination entail multiple steps in 
the preparation of starting materials and the yields of the desired enamides are often 
low. Moreover, the condensation method requires high temperatures and harsh 
conditions, which often resulted in unwieldy mixtures of regio- and stereoisomers. 
For the purposes of the proposed project, we will examine the latest advances in the 






3.3.1 Transition Metal-Catalysed Cross-Coupling 
 
Recent innovations in transition metal-catalysed cross-coupling technologies have 
naturally meant that a great deal of attention has been focused on the N-alkenylation 







In 1991, Ogawa described the first copper-promoted direct vinylic substitution of a 





Stoichiometric amounts of copper and high temperatures gave the desired enamides 
with a high degree of stereoisomeric purity, although the observed yields were low. 
 
Nearly a decade had elapsed before this methodology was rendered catalytic by the 
Porco group.113 The use of copper (I) thiophenecarboxylate (CuTC) in conjunction 
with a polar, aprotic solvent and a carbonate base led to higher yields of the enamide 










These catalytic conditions were applied directly to the synthesis of O-methyloxime 
enamide side chains, moieties present in salicylate antitumour macrolides. Extension 
of this protocol to the coupling of β-iodoacrylates was made possible by the use of 






The robust nature of this methodology was demonstrated in the total synthesis of the 
antibiotic CJ-15,801 (288, Scheme 3.17). The key cross-coupling step between the 
amide 285 and the β-iodoacrylate 286 to give the intermediate 287 was achieved in 
an exceptionally high yield as one stereoisomer. 
 
In 2003, Buchwald reported a more general procedure for the copper-catalysed cross-










Both vinyl bromides and vinyl iodides could be coupled with amides and carbamates 
in the high-yielding reaction. The mild conditions tolerated a range of functionalities 
and preserved the double bond geometry of the initial vinyl halides. 
 
Shortly afterwards, Ma and co-workers reported similar results in the presence of 





Buchwald’s group had found this ligand to be ineffective in toluene but in dioxane 
N,N-dimethylglycine was an efficient promoter of the coupling reaction. Moreover, 
under these conditions it was possible for the cross-coupling of some substrates to 
take place at room temperature. 
 
The work of Porco, Buchwald and Ma stimulated a flurry of publications that 





enamide-containing natural products117 including oximidines I and III,118 apicularen 





In an attempt to unify these strategies in a general procedure, Coleman and Liu 
reported the coupling of a Z- and an E-vinyl iodide with a protected maleimide 





The substrates 298a and 298b can act as universal starting materials to the (E)- and 
(Z)-enamide side chains of a range of biologically active compounds including 
oximidines I, II and III, salicylihalamides A and B, lobatamides A and D and CJ-
12,950. 
 
Additional examples of this type include an intramolecular vinylation of amides to 









It has also been possible to prepare optically enriched chiral allenamides via the 




The reactions were carried out at a lower temperature due to the low thermal stability 
of the allenamides. The diastereomeric allenyl iodide 304 was coupled to the 
carbamate 303 with maintenance of the axial stereochemistry, indicating the 
stereospecificity of the transformation. At present the synthetic utility of this reaction 
is limited by the arduous preparation of optically enriched chiral allenyl iodides. 
 
Lam and co-workers extended the scope of the copper-catalysed N-alkenylation of 
amides to include vinyl boronic acid coupling partners (Scheme 3.22).125 In their 
report they described a procedure to oxidatively couple both N−H and O−H 









Although lacking in generality (only three examples of amide-like substrates were 
coupled with the same alkenyl boronic acid) the reaction conditions were extremely 
mild. Replacement of the boronic acid with a potassium alkenyltrifluoroborate salt 





This modification greatly improved the scope of the reaction and it was possible to 







The majority of metal-catalysed cross-coupling reactions to form enamides are based 
on copper but a small number of palladium-catalysed protocols are also in existence. 
Mori made the first report of one such reaction in an intramolecular coupling to form 









The intramolecular coupling of a vinyl bromide with an amide resulted in a high 
conversion into a carbapenem skeleton for a small number of examples. 
 
Researchers at Merck developed a more universal procedure for the palladium-
catalysed cross-coupling of enol triflates with amides, carbamates and sulfonamides 





At elevated temperatures isomerisation of the double bond geometry was observed 
for those substrates where isomerisation was possible. Therefore these examples 
were carried out at room temperature to obtain products of high stereoisomeric purity 
(316b, Scheme 3.25). Pleasingly the presence of a bromide in the coupling partner 
did not interfere with the desired transformation, highlighting the potential of this 
strategy in a multi-step synthesis. An advantage of employing enol triflates as 
coupling partners is that their stereoselective preparation is more facile than for their 
vinyl halide analogues. The construction of a single enol triflate from a ketone relies 





can be controlled by the appropriate choice of base and solvent. In a later paper the 
same group also reported the use of enol tosylates as coupling agents under slightly 
modified conditions.129 
 
Stahl and co-workers published a novel formation of enamides via the palladium-





The formal cross-coupling reaction was successful with oxazolidinones, 
pyrrolidinones, primary amides and sulfonamides. The vinyl ether substrate was used 
in vast excess as the solvent in the reaction. No other vinyl ethers were subjected to 
the reaction conditions and so the methodology was restricted to the assembly of 
non-substituted enamides. 
 
The palladium-catalysed coupling reaction was further developed to include a 
hydrogen bond-directed oxidative amidation of conjugated olefins (Scheme 3.27).131 
A variety of primary amides were reacted with acrylic esters, amides, alkyl vinyl 









Tetramethylenediphosphonate notably increased the reaction rates for the Pd/Cu 
cocatalytic system, as it suppressed the formation of palladium black. An additional 
benefit of this additive was that it inhibited the formation of an unwanted side 
product. The preferential formation of the Z-enamide was attributed to an 
intramolecular hydrogen bond between the amido N−H and the carbonyl group 
(Scheme 3.28). In the stereochemical-determining reductive elimination step the 
energy level of the transition state leading to the Z-enamide (324) was calculated to 
be significantly lower than that leading to the E-enamide (326), due to this 
intramolecular hydrogen bond. This finding may account for the lower selectivity 
observed when carbamates were employed as the N−H coupling partner; the lower 








Another class of enamide-like compounds accessible via the palladium-catalysed 





The palladium-catalysed coupling of tert-butyl carbazate with a range of vinyl 
halides proceeds regioselectively through the N-Boc nitrogen to furnish an array of 
N-alkenylhydrazines in good yield. 
 
The metal-catalysed cross-coupling approach has proven to be an effective way of 
accessing enamides stereoselectively. In particular, the robust nature of the copper-
catalysed methodology has been demonstrated in its relatively widespread use in 
natural product syntheses over the last decade. However, the preparation of the 
requisite vinyl halide coupling partners is often non-trivial and imposes limitations 
on the synthesis of more highly substituted enamides. 
 
3.3.2 Hydroamidation of Terminal Alkynes 
 
Enamides can be accessed via the addition of an N−H bond across an alkyne; Kondo 
and co-workers described the earliest catalytic example of one such reaction. The 
ruthenium-catalysed hydroamidation of an unactivated alkyne took place under high 
temperature and pressure conditions to yield a narrow range of N-aryl substituted E-









In subsequent years, the Gooßen group has carried out a great deal of work in this 
area. In their first example they described the ruthenium-catalysed hydroamidation of 
a variety of secondary amides, anilides, lactams, ureas, bislactams and carbamates to 





The first set of conditions yielded the E-enamide with a high level of 
stereoselectivity. However, the presence of an electron-rich chelating phosphane 
ligand and water was found to reverse the selectivity of the reaction to preferentially 









The scope of this reaction was later extended to include primary amides135 and 
imides136 via the use of lanthanide-based Lewis acids. The group also addressed the 
issue of the prohibitive price of the first generation catalyst and soon afterwards 
reported a new protocol based on RuCl3·3H2O as the catalytic precursor.
137 
 
A rhenium-catalysed hydroamidation has also proved to be effective for the reaction 




Scheme 3.33  
 
From a green chemistry perspective, the hydroamidation of terminal alkynes is an 
ideal route to enamides, as the reaction is atom economic and additionally uses 
readily available starting materials. Unfortunately, although the stereoselectivity of 
the reaction can be carefully controlled, an inherent limitation of this methodology is 
that the use of terminal alkynes restricts the reaction scope to the preparation of β-
monosubstituted enamides.  
 
3.3.3 Use of Ynamide Starting Materials 
 
Ynamides139 are versatile synthetic intermediates that can undergo a variety of 
synthetic transformations to form enamides. Recently there has been increased 
interest in this approach to enamides, as ynamide synthesis has become more 
straightforward in light of developments in alkynyliodonium salt chemistry140 and 






Representative intramolecular examples include the domino Heck−Suzuki−Miyaura 
reaction.143 This transformation was used to great effect in the total synthesis of 





The palladium-catalysed intramolecular Heck reaction is followed by a cross-
coupling with a boronic acid, which produces the intermediate 349. The 
stereoselectivity of the reaction was not especially high but this was not an issue as a 
subsequent step involved the hydrogenation of the double bond isomers. 
 
Another example of enamide synthesis via intramolecular transformations of 
ynamide substrates is the Brønsted acid-catalysed keteniminium cyclisation, a variant 
of the Pictet−Spengler cyclisation.144 Application of this methodology to the 









The critical Pictet−Spengler-type cyclisation takes place to give the tricyclic product 
352 in 56% yield under Brønsted acid catalysis. Lewis acids were found to be 
ineffective in the desired transformation.  
 






Platinum dichloride catalyses a formal [2+2] cycloaddition reaction to give a fused 
bicyclic system of low stability (355).145 Conversely, Grubbs’ second generation 
ruthenium catalyst146 results in the ring closing metathesis products, containing 
dienamide moieties that were subsequently used in Diels-Alder investigations to 
construct polycyclic systems (356).147  
 
In addition, it is possible to access enamides via intermolecular reactions of 
ynamides; reductive coupling reactions are such an example. Both titanium-
mediated148 and nickel-catalysed transformations149 have been reported in recent 
years. In the titanium example (Scheme 3.37), an ynamide-titanium alkoxide 358 is 
formed, which can then undergo hydrolysis to produce the β-monosubstituted 









In the later nickel-based system, a catalytic multicomponent coupling of ynamides, 
aldehydes and silanes proceeds to yield the corresponding γ-siloxyenamides in a 





In many cases, reactions of ynamides can result in the formation of enamide 
derivatives that possess non-carbon substituents, such as boranes and halide groups. 
These derivatives can be interesting in themselves or can undergo further reaction to 
yield more highly all-carbon substituted enamides. 
 
For instance, Witulski and co-workers described a hydroboration of ynamides 
followed by a Suzuki−Miyaura cross-coupling with aryl halides (Scheme 3.39).150 In 
this case, it was unfavourable to isolate the hydroborated enamide intermediates and 









Moreover, the homologation of enamide boronates was possible in the presence of 






The Cintrat group have published a series of papers on the palladium-catalysed 






In the majority of cases, the reactions proceed with high levels of regio- and 





couplings and lithiation-electrophilic trapping reactions to give more highly 





The hydrohalogenation of ynamides is able to take place under exceptionally mild 
conditions.153 The resultant -haloenamide products smoothly undergo Sonogashira 





Completely anhydrous conditions resulted in poor conversions to the desired 
products and the group hypothesised that HX is generated in situ via the reaction of 
the magnesium halide salt with trace amounts of water present in the solvent. 
 
Recently Evano and co-workers described the formation of ketene N,N-acetals, a 









In this instance, copper-catalysed monocoupling of 1,1-dibromo-1-alkenes with an 
amide and a subsequent dehydrobromination result in the formation of the ynamide. 
Under the reaction conditions, a hydroamidation then gives the observed enamide-
like products. 
 
It is clear from the review that although a plethora of effective methods exist for the 
synthesis of enamides from ynamide precursors, the majority are restricted to the 







An alternative route to access enamides is the carbometallation155 of ynamides; as the 
majority of carbometallation reactions proceed in a syn-selective manner,155a 
selectivity issues are reduced to those of regioselectivity (provided that no E/Z 
isomerisation occurs under the reaction conditions). In addition, there exists the 
potential to utilise the alkenyl metal intermediates in further functionalisation 










Marek and co-workers pioneered the strategy of carbometallation of ynamides when 
they described the first carbocupration and the first copper-catalysed 
carbomagnesiation of yne-sulfonamides.156 As previously surmised, the reaction was 
highly regioselective and this was attributed to the coordination of the copper to the 





Consequently other groups used this novel technology in the copper-catalysed 
carbomagnesiation of ynamides, to produce intermediates that undergo aza−Claisen 





More recently the Marek group have exploited their methodology in a novel 










Regioselective carbometallation of an enantiomerically pure ynamide results in the 
formation of the vinyl copper intermediate 390 that is readily homologated with an 
organozinc reagent and then allylated to give the aldol derivative 391. The presence 
of R3SiCl in the reaction mixture prevents an undesired side reaction and the 
enamide products are isolated as silyl enol ethers, which give the alcohol derivatives 





It is clear from this review that enamides are valuable commodities in organic 
synthesis thanks to their long-term stability and wide-ranging reactivity. 
Furthermore, the enamide motif is present in many biologically active compounds. 
Consequently their synthesis is an important area of study. Recent strategies of 
enamide preparation include transition metal-catalysed N-alkenylation and 
hydroamidation reactions. Despite the ready preparation of enamides in a 
stereoselective fashion, both methods suffer drawbacks; the cross-coupling method 
necessitates the often non-trivial stereoselective preparation of vinyl halides and the 
hydroamidation route is inherently restricted to the synthesis of -monosubstituted 
enamides. After pioneering work by the Marek group, ynamide carbometallation is 
clearly emerging as an effective route to access multisubstituted enamides, although 
there remains scope for improvement. The current methods rely on the use of 





nucleophile-sensitive functional groups on both the substrate and the organometallic 
reagent itself.159 Therefore the development of alternative carbometallation 


















Our group recently reported a highly efficient rhodium-catalysed carbozincation of 





In the initial study, dialkylzinc reagents were employed as the organometallic species 
and this allowed the highly regio- and stereoselective preparation of a range of ,-
disubstituted enamides containing oxazolidin-2-one, pyrrolidin-2-one and urea 
moieties. The use of dialkylzinc reagents limited the methodology to the small 
number that were commercially available; a wider variety of products were 
accessible via the in situ preparation of diorganozinc species from Grignard reagents 
and zinc chloride (Scheme 4.2).160 
                                                 
i The work in this chapter was carried out in collaboration with Benoit Gourdet. The experiments to make 394b, 394c, 394g 
and 395c (Scheme 4.3), 396f (entry 6, Table 4.1), 400a and 400b (Method A, Scheme 4.5), 412 (Scheme 4.9) and 416a and 
416b (Scheme 4.10) were carried out by him. In all cases, these experiments have been denoted with an asterix (*) and a 










Aromatic, heteroaromatic, alkenyl and benzyl groups were all successfully 
introduced under rhodium catalysis, although in some examples (393c and 393e) the 
reactions were carried out at –78 oC to achieve satisfactory regioselectivities. 
 
These initial results were highly promising and it was considered worthwhile to fully 
explore the scope and limitations of this catalytic system, in terms of the 





4.2.1 Preparation of Ynamide Substrates 
 
Recent advances in copper-catalysed coupling reactions of amides with 
bromoalkynes or terminal alkynes have greatly increased the range of ynamides that 
are easily prepared.162 The ynamides examined in the current investigation and the 










The majority of ynamides were synthesised using method A,* in which a 
bromoalkyne is coupled to an amide.162a Despite being an effective method for the 
synthesis of a wide range of ynamides, we observed a lack of reproducibility in the 
yields, a trend that has been reported by other groups.163 A recent investigation into 
the reasons for these irregularities has attributed the lower yields to ‘wet’ potassium 
phosphate reagents i.e. those contaminated with significant amounts of 
K3PO41.5H2O and K3PO47H2O.
164 Detailed studies revealed that pure and 
anhydrous K3PO4 provides higher yields of the desired ynamide.
164 Stahl devised an 
alternative route to ynamides via the coupling reaction of amides with terminal 
alkynes, under oxidative conditions.162c The scope of this reaction is slightly more 
restricted than Hsung’s protocol and requires five equivalents of the amide 
component, but it was effectively employed for the urea-containing ynamide 394i.  
 
4.2.2 Expansion to Organozinc Halide Reagents 
 
The reliance of the rhodium-catalysed carbozincation reaction on commercially 
available dialkylzinc reagents had initially restricted the scope of the reaction; the in 
                                                 






situ preparation of diorganozinc reagents from ZnCl2 and Grignard reagents had 
partly resolved this issue and enlarged the pool of enamides that could be synthesised 
using this methodology. Unfortunately the use of Grignard reagents limits the 
presence of base- and nucleophile-sensitive functional groups on the organometallic 
species. Therefore, it was highly desirable to extend the scope of the organometallic 









                                                 






































a rr = Regioisomeric ratio as determined by 1H NMR analysis of the unpurified reaction 
mixtures. b Isolated yield of major regioisomer.  c The hydrometallation product 401 was also 
isolated in 12% yield. d The ratio of isomers could not be determined due to the complexity of 
the unpurified reaction mixture.  e Result obtained using [Rh(cod)Cl]2 (5 mol%) and rac-






Fortuitously, the reaction conditions were compatible with the use of organozinc 
halides and we applied them to a range of ynamide substrates (Table 4.1). Aromatic 
zinc iodide reagents bearing an ester group or a chloro group resulted in the desired 
enamides in good to high yields with excellent regioselectivities (entries 1-5). In 
addition, aliphatic zinc bromides could be employed as the organometallic 
component (entries 6 and 7). However, a relatively low yield of the desired enamide 
was observed when the nitrile-containing zinc bromide 397d was employed. This 
was attributed to the low regioselectivity observed during the carbometallation 
reaction and the formation of the hydrometallation side-product. A slight 
modification of the reaction conditions (including a higher temperature) was required 
when the cyanobenzyl zinc bromide 397e was used as the carbometallating agent. 
Despite these adjustments, the crude reaction contained a complex mixture of 
unidentified products and the desired enamide 396h was isolated in a low yield.  
 
In the case of the pyrrolidin-2-one-derived ynamide 394h, the rhodium-catalysed 
carbozincation conditions resulted in a significant degree of the hydrometallation 
product 399 along with other unidentified products. Replacing the rhodium catalyst 
with a copper catalyst allowed the clean preparation of the enamide 398 with high 





However, the copper catalyst did not function effectively in the carbometallations 
involving aromatic zinc halide reagents and in these cases unreacted starting 







X-ray crystallography of the ,-diaryl substituted enamide 396b established the 
regioselectivity of the carbometallation reaction with the arylzinc halide 397a (Fig 





4.2.3 Acyclic Ynamides 
 
To increase the utility of our methodology, it was desirable to investigate our 
rhodium-catalysed carbozincation conditions in conjunction with a more diverse 
range of ynamides. The methodology had proven its effectiveness with ynamides 
containing oxazolidin-2-one, pyrrolidin-2-one and urea moieties, in which the amide 
functionality was fixed in a five-membered ring. We next chose to evaluate acyclic 






Ynamide substrates containing an aliphatic substituent at the -position (such as 
395a) appeared to be largely inert under our standard rhodium-catalysed conditions 
with Et2Zn, although a small degree of substrate decomposition was observed over 






and the carbozincation reactions went to full conversion rapidly, even at decreased 
temperatures (395b and 395c). Unfortunately the reactions suffered from low 
regioselectivities, despite these lower temperatures. For the Boc-protected ynamide 
(395b) the corresponding enamides were isolated as a regioisomeric mixture, 
marginally in favour of the unexpected regioisomer 400b (Method A, Scheme 4.5).* 





Fortunately, a Cu(acac)2 catalyst, which had previously been used advantageously in 
partnership with the aliphatic zinc bromide 397c (vide supra), provided the desired 
enamide with high regioselectivity; although reaction times were extended 
significantly. However, it offered no further improvement for the other ynamide 
substrates 395a and 395c, which both remained unchanged when subjected to the 
new conditions. 
 
The isomeric composition of the carbometallation reactions depicted in Scheme 4.5 
was determined via acidic hydrolysis of the enamide products. The enamide 400a 
(isolated from Method B, Scheme 4.5) provided the aldehyde 400c after treatment 
with HCl (eq 4.1).  
 
 
However, hydrolysis of the mixture of enamides 400a and 400b (obtained via 
method A, Scheme 4.5) resulted in both the aldehyde 400c and the ketone 400d (eq 
4.2). 
                                                 









These results indicated the relationship between the enamides 400a and 400b was 
regioisomeric rather than stereoisomeric. 
 
Attempts to extend the carbozincation of the ynamide 395b to the use of aliphatic 
organozinc halides with either Rh(cod)(acac) or Cu(acac)2 catalysts were 
unsuccessful. Complex mixtures of products were obtained in both cases and, for the 
copper-based procedure, low conversions were observed. Employing aromatic zinc 
halides as the organometallic species for the carbometallation of acyclic ynamides 
gave no reaction. 
 
It is reasonable to assume that the high regioselectivity previously observed for the 
cyclic ynamides is due to the directing group effect of the carbonyl group with the 
rhodium (and/or zinc) centre in the carbometallation step (see later for a full 
mechanistic discussion). The acyclic ynamides 395a, 395b and 395c all possess a 
greater degree of rotational freedom and this may lessen the ability of the carbonyl 
(or sulfonyl) group to direct the metal centre, thus resulting in a lower 
regioselectivity for these substrates. 
 
4.2.4 Ligand Effects 
 
During the course of these investigations, hydrometallation products were observed 
in the reactions of certain organozinc species containing a -hydrogen (see Table 4.1, 
entry 7 and Scheme 4.4, 399). Development of a completely complementary 
rhodium-catalysed hydrometallation procedure was highly desirable. Although other 
routes to access -monosubstituted (Z)-enamides exist,131, 134 further reaction of an 
alkenyl zinc intermediate would allow the preparation of multisubstituted enamides 










Preliminary studies assessed the activity of different rhodium sources in comparison 
to the standard Rh(cod)(acac) catalyst with the model substrate 394a. Both 
[Rh(cod)Cl]2 and the cationic [Rh(cod)(MeCN)2]BF4 resulted in full conversion to 
the carbometallation enamide product (Table 4.2, entries 2 and 3). However, in the 
presence of Wilkinson’s catalyst, a 5:1 mixture of the hydrometallation and 
carbometallation products was obtained (entry 4). It was hypothesised that the 
presence of the phosphine ligands on the rhodium centre moderated its catalytic 
activity to favour the hydrometallation pathway. Therefore a series of phosphine 
ligands were examined in conjunction with [Rh(cod)Cl]2 in the reaction of the model 





























Triphenylphosphine-modified [Rh(cod)Cl]2 further favoured the formation of the 
hydrometallation product (entry 5). However, the use of the strongly -donating 
ligand (Bu3P, entry 6) and a bidentate ligand (rac-BINAP, entry 7) reversed the 
selectivity of the reaction back towards the carbometallation product. Further 
investigations revealed that good -acceptor ligands (entries 8-10) facilitated the 
desired hydrometallation pathway with high selectivity. The use of (p-F-Ph)3P (entry 
8) and (2-thienyl)3P (entry 9) both produced minor quantities of the (E)-isomer of 
401. (2-Fur)3P (entry 10) gave the cleanest reaction and was selected for further 
study. Additional optimisation studies were carried out which included variation of 
solvent, temperature and ligand-to-metal ratios; unfortunately it was not possible to 




 Rh Cat. ligand 401:392b
b 
1 Rh(cod)(acac) — <1:19 
2 [Rh(cod)(MeCN)2]BF4 — <1:19 
3 [Rh(cod)Cl]2 — <1:19 
4 RhCl(PPh3)3 — 5:1 
5 [Rh(cod)Cl]2 Ph3P 9:1
d
 
6 [Rh(cod)Cl]2 Bu3P <1:19 
7 [Rh(cod)Cl]2 (rac)-BINAP <1:19 
8 [Rh(cod)Cl]2 (p-F-Ph)3P >19:1
c 
9 [Rh(cod)Cl]2 (2-Thienyl)3P >19:1
c 
10 [Rh(cod)Cl]2 (2-Fur)3P 12:1 
11 — — <1:19d 
a All reactions proceeded to complete conversion. Carbometallation 
product 392b was generally obtained in 19:1 regioisomeric ratio. b Ratios 
determined by 1H NMR analysis of the unpurified reaction mixtures. c 
Hydrometallation product 401 had a stereoisomeric composition of ca. 






diminished in the presence of the phosphine-modified catalysts (up to 6 h for 
complete conversion). Therefore it is possible that a slow uncatalysed background 
reaction is responsible for the small amounts of 392b observed in some of these 
hydrometallation reactions (entry 11).   
 
With the optimised hydrometallation conditions in hand, the scope of the reaction 










401 12:1 60c 
2 394c 
 
402a 11:1 46 
3 394d n = 1  402b 9:1 58 
4 394e n = 2 402c 6:1 58d 
5 394f  n = 3 402d 6:1 42 
6 394b 
 
402e 6:3(:1)e –f 
7 394g 
 
402f 16:1 53d 
a Selectivity = ratio of hydrometallation (R2 = H) to carbometallation (R2 = Et) as 
determined by 1H NMR analysis of the unpurified reaction mixtures. b Unless otherwise 
stated, isolated yield of an inseparable mixture of hydrometallation and carbometallation 
product in a ratio identical to that measured from the unpurified reaction mixtures. c
Isolated yield of a 9:1 mixture of hydrometallation product 401 and carbometallation 
product 392b. d Isolated yield of pure hydrometallation product. e The E-hydrometallation 








Ynamide substrates with an aliphatic group at the -position were well tolerated 
under the reaction conditions, providing the hydrometallation products in good 
selectivities and reasonable yields (entries 1-5 and 7). An aromatic -substituent 
unfortunately resulted a dramatic decrease in the selectivity of the reaction and a 
significant quantity of the (E)-isomer of the hydrometallation product was also 
formed (entry 6). Both oxazolidin-2-one (entry 1-6) and pyrrolidin-2-one (entry 7) 
moieties in the ynamide substrate were compatible with the reaction conditions.  
Unfortunately, in the majority of cases it was not possible to completely separate the 
hydrometallation product from the carbometallation product via column 
chromatography and so these substrates were isolated as mixtures. 
 
4.2.5 Mechanistic Discussion 
 
Our proposed mechanisms for the rhodium-catalysed carbometallation and 
hydrometallation of ynamides are outlined in Scheme 4.7 and Scheme 4.8 






Reaction of the Rh(cod)(acac) precatalyst with the zinc reagent generates the 
organorhodium intermediate 403 which undergoes a syn-carbometallation of the 
ynamide. It is presumed that the regioselectivity of the carbometallation step is 






Transmetallation with an organozinc species allows regeneration of the active 






In the complementary hydrometallation reaction (Scheme 4.8), it is assumed that 
when a -hydrogen is present in the organorhodium species 406, the altered electronic 
properties of the phosphine-modified rhodium centre facilitate a -hydride 
elimination to yield the rhodium hydride species 408, which is then able to execute 
the hydrometallation step in a syn-fashion. Transmetallation with an organozinc 
species regenerates the active catalyst and the alkenyl zinc intermediate 410. 
 
4.2.6 Elaboration of Alkenyl Zinc Intermediates 
 
In the proposed mechanisms for the rhodium-catalysed carbo- and hydrometallation 
of ynamides, the catalytic cycles liberate alkenyl zinc intermediates 405 and 410. In 
order to synthesise more highly substituted enamides it was desirable to engage these 
species in further functionalisation reactions. 
 
Initially the reaction of these alkenyl zinc species with electrophilic species was 
investigated. It was found that the carbozincation of ynamide 394b with 0.55 






chloride in a one-pot procedure to afford the ,,-trisubstituted enamide 412* 
(Scheme 4.9). In a similar fashion, post-carbometallation the ynamide 394a was 





Furthermore, alkenyl zinc species can participate in palladium-catalysed Negishi 
cross-coupling reactions.165 Within the context of carbozincations using Et2Zn, the 
tandem carbometallation−Negishi reaction proved to be effective with aromatic,* 
heteroaromatic and alkenyl iodides* to give the desired ,,-trisubstituted enamides 





Expansion of the tandem carbozincation−Negishi reaction to include the use of 
aromatic zinc iodides was feasible and the highly sterically hindered ,,-triaryl-
substituted enamide 418 was made in this way. The reaction was low yielding and a 
significant quantity of the uncoupled carbometallation product was also isolated; this 
                                                 






was not surprising considering the steric hindrance that must be overcome in order 





Finally, the tandem hydrozincation−Neghisi reaction was investigated; lower yields 






It was unclear what factor resulted in the low conversions of these hydrozincated 
intermediates in the Negishi coupling. Extensive optimisation studies on the model 






possible explanation could lie in the altered nature of the rhodium species in the 






We have developed a highly efficient stereo- and regioselective rhodium-catalysed 
carbozincation of ynamides as a method of preparing enamides. Studies have 
demonstrated that commercially available dialkylzinc reagents as well as those 
prepared in situ from Grignard reagents and organozinc halide reagents are able to 
act as effective carbometallating agents. Extension to acyclic ynamide substrates has 
been challenging as these reactions show a low regioselectivity under our rhodium-
catalysed conditions. Furthermore, investigations into ligand effects have revealed 
that -acceptor phosphine ligands mediate the catalytic activity of the rhodium metal, 
which then facilitates a hydrometallation pathway in preference to the 
carbometallation. We have been able to exploit the alkenylzinc intermediates 
produced during the course of these carbo- and hydrometallation processes in 
reactions with electrophilic species and in cross-coupling reactions, which has 

















The utility of the indene nucleus is widely recognised (Fig 5.1); indenylmetallocene 
complexes are active catalysts in olefin polymerisation,166,167 indene derivatives have 
been used in materials chemistry (in conducting polymers168 and discotic liquid 
crystals169) and it is present in a number of biologically active compounds,170 for 
example a series of 2,3-diarylindenes bind with high affinity to several estrogenic 






Highly substituted indene derivatives are commonly synthesised via transition metal-
catalysed multicomponent cyclisation reactions, frequently involving alkynes.171-175, 
178 An early example of one such reaction was reported by Yamamoto and co-
workers (eq 5.1).171 
                                                 
i The work in this chapter was carried out in collaboration with Benoit Gourdet. The experiments to prepare 443 (eq 5.2) and 
ligands 457a−e (Table 5.2) were carried out by him. In all cases, these experiments have been denoted with an asterix (*) and a 










In the mixed toluene/acetonitrile solvent, the benzyne precursor 271 reacts with two 
molecules of alkyne to provide the highly substituted indene derivative in a 
reasonable yield.  
 
The Larock group has also employed the palladium-catalysed carboannulation of 





A diverse range of alkynes was subjected to the reaction conditions and high 
regioselectivities were observed for the unsymmetrical alkyne substrates. 
 
A rhenium complex is able to catalyse the coupling reaction of aromatic aldimines 











Experimental evidence suggested that the reaction went via a C−H bond activation as 
the first step of the mechanism. 
 
In recent years, the Lauten group has made some valuable contributions to this field 
of chemistry. Previously, the group had developed a synthesis of indanes employing 
a tandem cyclisation of ortho-boronate cinnamic acid derivatives with strained 
olefins as the coupling partners.174 Building upon their initial results, they were able 
to expand the scope of the coupling partner to encompass acetylenes, thus providing 





A full examination of the acetylenic component was undertaken and alkynes bearing 
heteroatoms, as well propargylic-substituted alkynes were compatible with the 







Water was used as a co-solvent in the reaction and was thought to be essential for 





LnRh(OH) is believed to be the active catalyst and undergoes a transmetallation with 
the aryl boronate ester in the first stage of the cycle to give the organorhodium 
species 435. Coordination of the alkyne, followed by carborhodation produces the 
vinylic rhodium intermediate 436. Conjugate addition onto the pendant ,-
unsaturated acceptor results in the construction of the indene nucleus and the (oxa--
allyl)rhodium 437. Finally, protodemetallation regenerates the active catalyst and 
liberates the observed product. 
 
The asymmetric synthesis of indenes has been tackled by both resolution strategies176 
and chiral auxiliaries.177 In 2009, Lu reported an enantioselective variant of Lauten’s 
tandem cyclisation.178 A cationic palladium-catalysed tandem reaction of ortho-
boronate-substituted cinnamic ketones and internal alkynes yields optically active 
indenes and constitutes the first example of a transition metal-catalysed indene 











A range of activated alkynes gave the desired multisubstituted indene derivatives in 
outstanding yields and with excellent control of the absolute stereochemistry in this 
elegant transformation. The proposed mechanism was analogous to that suggested by 
Lautens and once more a water co-solvent was necessary for the reaction to take 
place. 
 
Drawing precedent from these reports, a carboannulation strategy was devised for the 
synthesis of indene−enamide products from ynamides and aromatic boronic acids (or 
boronate esters) bearing an electrophilic trap at the 2-position. After a small amount 
of optimisation a rhodium catalyst yielded indenol 443 from the reaction of 2-




The same set of conditions furnished the carboannulation product 445 from the 
ynamide 394b and the aromatic boronate ester bearing an ,-unsaturated ketone at 









This methodology offers a one-pot synthesis of relatively complex enamide−indene 
structures and complements the existing literature in this area. Moreover, the use of 
chiral non-racemic ligands could potentially generate an enantioselective procedure 
to allow the synthesis of optically active indenes. The pendant enamide moiety 
provides an additional functional handle on the indene core that can be used in a 
wide range of transformations (see Chapter 3 for a full discussion) to gain access to 
other indene derivatives. For these reasons we embarked upon a systematic study of 






5.2.1 Synthesis of Starting Materials 
 
The ynamides employed in the tandem carbometallation-conjugate addition reaction 
were prepared as described previously (Chapter 3). The synthesis of the aromatic 












Commercially available 2-formylphenyl boronic acid was protected using pinacol to 
give the pinacol ester 446 in quantitative yield. Wittig reactions with different ylides 
provided a diverse range of ,-unsaturated acceptors in high yields. An aromatic 
boronate ester bearing a pendant ,,,	-unsaturated ketone (448) was synthesised 




5.2.2 Rhodium-Catalysed Carbometallation−Conjugate Addition 
Reaction 
 
With a set of conditions in hand, a series of ynamide substrates were investigated 




















449b 7:1 75 
3 394c H 
 
449c 8:1 67 
4 394e Me 
 
449d 11:1 95d 
5 394d OMe 
 
449e 10:1c 96d 





449f 3.7:1 75 
8 394i Ph 
 
449g 2:1 55e 
9 395b OMe 
 
449h 2:1 95d 
a Regioisomeric ratio as determined by 1H NMR analysis of the unpurified reaction 
mixtures. b Isolated yield of major regioisomer. c 1H NMR indicated a mixture of 
regioisomers, although it was not possible to obtain the rr from the spectra. As 13C 
NMR indicated only one regioisomer, the rr is assumed to be 10:1). d Isolated yield of 
both regioisomers in the same ratio as the crude. e 28% of the minor regioisomer was 








The reactions rapidly go to completion for ynamides containing oxazolidinone and 
urea moieties, to give the desired indene products in good to high yields. Ynamides 
containing an aliphatic group at the R1-position generally gave the indene products 
with good regioselectivities (entries 1-5), whereas phenyl-substituted ynamides 
resulted in poorer regioselectivities (entries 6-9). A variety of electrophilic acceptors 
were tolerated on the boronate coupling partner including ,-unsaturated aromatic 
ketones (entries 1 and 8), ,-unsaturated aliphatic ketones (entries 4 and 6), ,-
unsaturated aldehydes (entries 2 and 3) and ,-unsaturated esters (entries 5, 7 and 
9). The aldehyde-containing enamide products 449b and 449c appeared to be slightly 
unstable and began to decompose upon standing at room temperature for prolonged 
periods of time.  
 
Attempts to use an ,-unsaturated nitrile group as the electrophilic trap were 
unsuccessful and unreacted starting material was observed even after prolonged 




A pendant ,,,	-unsaturated ketone proved to be an effective electrophilic acceptor 




The crude product mixture contained a mixture of regioisomers (2.3:1 rr), although it 









5.2.3 Reaction Mechanism 
 
Extrapolation from the work of Lautens174a and Lu178 prompts us to propose the 
following mechanism (Scheme 5.7). It has been depicted using ynamide 394b and 





The first stage of the catalytic cycle involves a transmetallation between the 
monohydroxo rhodium species 451 and the boronate ester to give the organorhodium 
species 452. Based on our previous work on carbonyl-directed syn-carbometallations 
(Chapter 4), we assume that the carbonyl group embedded in the enamide moiety 
directs the carborhodation step and affords the vinylic rhodium species 453 in a 
regioselective fashion. The regiochemistry of the indene product 449f was confirmed 
by X-ray crystallography and the rest of the indene products were assigned by 










Conjugate addition onto the pendant ,-unsaturated acceptor provides the (oxa--
allyl)rhodium intermediate 454. The observed indene product is obtained after a 
protodemetallation step that also regenerates the active catalyst.  
5.2.4 Development of an Asymmetric Reaction 
 
Once the scope of the reaction had been successfully explored, our endeavours were 
directed towards the development of an asymmetric variant, via the introduction of 
chiral non-racemic ligands into the catalytic system. Using ynamide 394b and the 
boronate ester 444 as the model system, a range of common chiral ligands was 











In initial screenings, bidentate and monodentate phosphine ligands, as well as a bis-
oxazoline ligand, were assessed for their ability to impart enantioselectivity. In the 
majority of cases, the ligands did not give any appreciable levels of asymmetric 
induction and the levels of regioselectivity obtained were approximately the same as 
were observed previously in the ligandless system. The best result was observed with 
the phosphoramidite ligand (R)-Monophos, which gave an ee of 20%.  
 
Recently, Hayashi and co-workers have published a significant volume of work on 
chiral diene ligands for use in rhodium catalysis.179, 180 We hoped that these types of 
ligands would prove amenable to our reaction conditions. A selection of diene 
ligands derived from (R)--phellandrene were prepared* and examined in the model 





                                                 

















5 457e  5.3:1 66 
a Regioisomeric ratio as determined by 1H NMR analysis of the unpurified reaction mixtures. b This 







Promising levels of enantioselectivity were obtained with these chiral diene ligands. 
In initial experiments, the use of amide-containing diene ligands (457a and 457b, 
entries 1 and 2) resulted in low regioselectivities and ee’s. The diene ligand 
containing a carboxylic acid group did give marked improvements in the 
regioselectivity and the enantioselectivity of the reaction. However, in all of these 
cases the reactions were sluggish and low conversions were observed. Employing a 
tertiary alcohol-derived diene (457d, entry 4) and an ester-derived diene (457e, entry 
5) resulted in good enantioselectivities and, in the case of the ester-containing diene 
we also obtained a good regioselectivity. Future work will be directed towards the 
further development of this asymmetric catalytic system by further investigations 





Multisubstituted indene derivatives are valuable substrates in a diverse range of 
chemistries. Transition metal-catalysed cyclisation reactions form effective routes 
into these compounds. Arguably one of the most efficient methodologies employs 
aromatic boronate esters bearing electrophilic traps at the 2-position. Building upon 
these literature precedents, we have developed a rhodium-catalysed tandem 
carbometallation−conjugate addition approach to indenes, utilising ynamides as the 
acetylenic component. The reaction conditions are compatible with a range of 
ynamides possessing aromatic and aliphatic groups at the -position. Furthermore, 
investigations revealed that ,-unsaturated esters, ketones and aldehydes could be 
used as the electrophilic trap in the reaction. A plausible reaction mechanism has 
been proposed that involves a carbonyl-directed syn-carbometallation as the key step. 
The results of early screening for an asymmetric protocol have been disclosed and 
currently a maximum ee of 67% has been achieved using a diene ligand. Future work 









All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH2Cl2 and THF were dried and purified by passage through 
activated alumina columns using a solvent purification system from 
www.glasscontour.com ‘Petrol’ refers to that fraction of light petroleum ether boiling 
in the range 40-60 °C. Commercially available CoCl2 was dried by heating under 
vacuum until it turned from purple to blue. All other commercially available reagents 
were used as received. Thin layer chromatography (TLC) was performed on Merck 
DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by UV 
light at 254 nm, and subsequently developed using potassium permanganate or ceric 
ammonium molybdate solution as appropriate. Flash column chromatography was 
carried out using silica gel (Fisher Scientific 60Å particle size 35-70 micron) 
employing the method of Still and co-workers.181 Melting points were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra were 
recorded on a Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride 
plates or as a dilute solution in CHCl3. 
1H NMR spectra were recorded on a Bruker 
DPX360 (360 MHz) spectrometer or a Bruker ARX250 (250 MHz) spectrometer. 
Chemical shifts (δ) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using residual protonated solvent as internal standard (CDCl3 at 
7.27 ppm). Abbreviations used in the description of resonances are: s (singlet), d 
(doublet), t (triplet), q, (quartet), app (apparent), br (broad). Coupling constants (J) 
are quoted to the nearest 0.1 Hz. Proton-decoupled 13C NMR spectra were recorded 
on a Bruker DPX360 (90.6 MHz) spectrometer or a Bruker ARX250 (62.9 MHz) 
spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using deuterated solvent as internal standard (CDCl3 at 77.0 ppm). 
Assignments were made using the DEPT sequence with secondary pulses at 90° and 
135°. High resolution mass spectra were recorded on a Finnigan MAT 900 XLT 
spectrometer or a Finnigan MAT 95XP spectrometer at the EPSRC National Mass 
Spectrometry Service Centre, University of Wales, Swansea, or on a Finnigan MAT 





Chemistry, University of Edinburgh. Stated calculated mass values refer to that of 








6.1.1 Preparation of Cyclisation Precursors 
 
Preparation of α,β-Unsaturated Acid Chlorides 
 
General Procedure A 
Oxalyl chloride (1.21 equiv) was added dropwise over 2 min to a solution of the 
appropriate α,β-unsaturated carboxylic acid (1.10 equiv) and DMF (0.25 equiv) in 
CH2Cl2 (0.55 M with respect to carboxylic acid) at 0
 °C. The mixture was stirred at 0 
°C until no more effervescence was observed (ca. 1 h) to give a solution of α,β-
unsaturated acid chloride which was used directly in the next step. 
 
Preparation of Cyclisation Precursors 
 
General Procedure B 
A solution of benzylamine (1.0 equiv) and methyl vinyl ketone or ethyl vinyl ketone 
(1.1 equiv) in CH2Cl2 (2.5 mL/mmol of benzylamine) was stirred at 0 °C for 18 h. 
Saturated aqueous Na2CO3 solution (2.5 mL/mmol of benzylamine) followed by the 
appropriate acid chloride (neat in the case of commercially available acid chlorides, 
or as a solution in CH2Cl2 prepared according to General Procedure A, 1.21 equiv) 
were then added dropwise or portionwise and the mixture was stirred at room 
temperature until TLC analysis showed the reaction to be complete. The reaction was 
partitioned between saturated aqueous NaHCO3 solution and CH2Cl2. The aqueous 
layer was separated and extracted with CH2Cl2 (x 3), and the combined organic 
layers were washed with 10% HCl solution (x 1), dried (MgSO4) and concentrated in 








(173).59 The title compound was prepared according to 
General Procedure B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine 
(2.18 mL, 20.0 mmol) and cinnamoyl chloride (4.03 g, 24.2 mmol) for a reaction 
time of 16 h. The product was purified by column chromatography (40% 
EtOAc/hexane) to give a white solid (2.78 g, 45%) as a 2:1 mixture of rotamers that 
displayed identical spectroscopic data to those reported previously.59 Rf = 0.20 (40% 
EtOAc/hexane); IR (CHCl3) 3027, 1713 (C=O), 1648 (C=C), 1426, 1203, 1161, 
1028, 978, 764, 700 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.79 (1H, 
d, J = 15.4 Hz, PhCH=), 7.61-7.26 (10H, m, ArH), 6.86 (1H, d, J = 15.4 Hz, 
PhCH=CH), 4.80 (2H, s, CH2Ph), 3.73 (2H, t, J = 6.7 Hz, CH2CH2N), 2.90 (2H, t, J 
= 6.7 Hz, CH2CH2N), 2.17 (3H, s, CH3C=O); (Minor rotamer) δ 7.85 (1H, d, J = 
15.3 Hz, PhCH=), 7.61-7.26 (10H, m, ArH), 7.01 (1H, d, J = 15.3 Hz, PhCH=CH), 
4.76 (2H, s, CH2Ph), 3.76 (2H, t, J = 7.1 Hz, CH2CH2N), 2.74 (2H, t, J = 7.1 Hz, 
CH2CH2N), 2.13 (3H, s, CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of 
rotamers – not fully assigned) δ 207.4 (C), 206.0 (C), 167.0 (C), 166.4 (C), 143.5 
(CH), 143.1 (CH), 137.5 (C), 137.0 (C), 135.0 (C), 129.6 (CH), 128.8 (CH), 128.6 
(CH), 128.5 (CH), 127.9 (CH), 127.7 (CH), 127.6 (CH), 127.3 (CH), 126.4 (CH), 
117.1 (CH), 116.9 (CH), 52.3 (CH2), 49.5 (CH2), 42.9 (CH2), 42.6 (CH2), 41.8 (2 x 
CH2), 30.2 (CH3), 30.0 (CH3). 
 
N-Benzyl-N-(3-oxobutyl)-(E)-3-(4-
methoxyphenyl)propenamide (181).  The title 
compound was prepared according to General 
Procedure B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine (2.18 
mL, 20.0 mmol) and the acid chloride (prepared according General Procedure A) 
derived from 4-methoxycinnamic acid (4.30 g, 24.2 mmol) for a reaction time of 20 
h. The product was purified by column chromatography (55% EtOAc/petrol) to give 
a yellow solid (3.79 g, 55%) as a 2:1 mixture of rotamers. Rf = 0.10 (50% 
EtOAc/hexane); m.p. 67-70 °C; IR (CHCl3) 2937, 1714 (C=O), 1645 (C=C), 1603, 
1512, 1173, 1028, 908, 736 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 
















6.69 (1H, d, J = 15.3 Hz, PhCH=CH), 4.74 (2H, s, CH2Ph), 3.80 (3H, s, OCH3), 
3.70-3.66 (2H, m, CH2CH2N), 2.85 (2H, t, J = 6.6 Hz, CH2CH2N), 2.13 (3H, s, 
CH3C=O); (Minor rotamer) δ 7.76 (1H, d, J = 15.6 Hz, PhCH=), 7.51-7.22 (7H, m, 
ArH), 6.92-6.80 (3H, m, ArH and PhCH=CH), 4.71 (2H, s, CH2Ph), 3.83 (3H, s, 
OCH3), 3.70-3.66 (2H, m, CH2CH2N), 2.69 (2H, t, J = 6.4 Hz, CH2CH2N), 2.08 (3H, 
s, CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully 
assigned) δ 207.5 (C), 167.4 (C), 160.9 (C), 143.3 (CH), 142.9 (CH), 137.2 (C), 
129.4 (CH), 128.8 (CH), 128.6 (CH), 127.8 (CH), 126.5 (CH), 114.7 (CH), 114.1 
(CH), 55.3 (CH3), 52.3 (CH2), 42.6 (CH2), 42.0 (CH2), 30.0 (CH3); HRMS (EI) Exact 
mass calcd for C21H23NO3 [M]
+: 337.1672, found: 337.1667. 
 
N-Benzyl-N-(2-oxobutyl)-3-(4-
methylphenyl)propenamide (182).  The title 
compound was prepared according to General 
Procedure B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine (2.18 
mL, 20.0 mmol) and the acid chloride (prepared according General Procedure A) 
derived from (E)-3-(4-methylphenyl)acrylic acid (3.97 g, 24.2 mmol) for a reaction 
time of 20 h. The product was purified by column chromatography (40% 
EtOAc/petrol) to give a yellow oil (which solidified to a cream solid on standing) 
(2.46 g, 38%) as a 2:1 mixture of rotamers. Rf = 0.15 (40% EtOAc/petrol); m.p. 99-
102 °C; IR (CHCl3) 3030, 1714 (C=O), 1646 (C=C), 1602, 1444, 1204, 907, 731, 
650 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.73 (1H, d, J = 15.3 Hz, 
PhCH=), 7.47-7.13 (9H, m, ArH), 6.78 (1H, d, J = 15.3 Hz, PhCH=CH), 4.76 (2H, s, 
CH2Ph), 3.70-3.67 (2H, m, CH2CH2N), 2.86 (2H, t, J = 6.7 Hz, CH2CH2N), 2.35 
(3H, s, CH3Ar), 2.14 (3H, s, CH3C=O); (Minor rotamer) δ 7.79 (1H, d, J = 15.5 Hz, 
PhCH=), 7.47-7.13 (9H, m, ArH), 7.73 (1H, d, J = 15.5 Hz, PhCH=CH), 4.72 (2H, s, 
CH2Ph), 3.70-3.67 (2H, m, CH2CH2N), 2.70 (2H, t, J = 6.7 Hz, CH2CH2N), 2.38 
(3H, s, CH3Ar), 2.10 (3H, s, CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of 
rotamers – not fully assigned) δ 207.5 (C), 167.3 (C), 143.3 (CH), 140.0 (C), 137.2 
(C), 132.4 (C), 129.5 (CH), 128.9 (CH), 128.6 (CH), 128.1 (CH), 127.8 (CH), 127.6 











(2 x CH3); HRMS (EI) Exact mass calcd for C21H23NO2 [M]




chlorophenyl)propenamide (183).  The title 
compound was prepared according to General 
Procedure B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine (2.18 
mL, 20.0 mmol) and the acid chloride (prepared according General Procedure A) 
derived from (E)-3-(4-chlorophenyl)acrylic acid (4.42 g, 24.2 mmol) for a reaction 
time of 20 h. The product was purified by column chromatography (40% 
EtOAc/petrol) to give an off-white solid (2.53 g, 37%) as a 2:1 mixture of rotamers. 
Rf = 0.18 (40% EtOAc/petrol); m.p. 91-93 °C; IR (CHCl3) 3032, 1714 (C=O), 1649 
(C=C), 1604, 1492, 1092, 908, 729, 650 cm-1; 1H NMR (360 MHz, CDCl3) (Major 
rotamer) δ 7.68 (1H, d, J = 15.4 Hz, PhCH=), 7.51-7.21 (9H, m, ArH), 6.78 (1H, d, J 
= 15.4 Hz, PhCH=CH), 4.75 (2H, s, CH2Ph), 3.73-3.66 (2H, m, CH2CH2N), 2.85 
(2H, t, J = 6.6 Hz, CH2CH2N), 2.13 (3H, s, CH3C=O); (Minor rotamer) δ 7.73 (1H, 
d, J = 15. 6 Hz, PhCH=), 7.51-7.21 (9H, m, ArH), 6.97 (1H, d, J = 15.6 Hz, 
PhCH=CH), 4.71 (2H, s, CH2Ph), 3.76-3.66 (2H, m, CH2CH2N), 2.68 (2H, t, J = 6.7 
Hz, CH2CH2N), 2.08 (3H, s, CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of 
rotamers – not fully assigned) δ 207.3 (C), 206.0 (C), 166.8 (C), 166.3 (C), 147.1 
(C), 142.1 (CH), 141.8 (CH), 137.0 (C), 135.4 (C), 133.6 (C), 133.5 (C), 129.6 (CH), 
129.3 (CH), 128.9 (CH), 128.6 (CH), 128.0 (CH), 127.7 (CH), 127.4 (CH), 126.4 
(CH), 117.8 (CH), 117.6 (CH), 114.8 (CH), 52.4 (CH2), 49.6 (CH2), 42.8 (CH2), 42.7 
(CH2), 41.9 (CH2), 30.3 (CH3), 30.0 (CH3); HRMS (EI) Exact mass calcd for 
C20H20ClNO2 [M]
+: 341.1177, found: 341.1171.  
 
N-Benzyl-N-(3-oxobutyl)-(E)-3-furan-2-ylpropenamide 
(184).59 The title compound was prepared according to the 
General Procedure B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine 
(2.18 mL, 20.0 mmol) and the acid chloride (prepared according General Procedure 
A) derived from (2-furyl)acrylic acid (3.34 g, 24.2 mmol) for a reaction time of 16 h. 

















give an orange-brown oil (2.49 g, 42%) as a 2:1 mixture of rotamers that displayed 
identical spectroscopic data to those reported previously.59 Rf = 0.17 (40% 
EtOAc/hexane); IR (film) 2923, 1713 (C=O), 1650 (C=C), 1423, 1214, 1161, 1016, 
815, 732, 698 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.55 (1H, d, J = 
15.1 Hz, CH=CHC=O), 7.50-7.24 (6H, m, ArH and CH), 6.78 (1H, d, J = 15.1 Hz, 
CH=CHC=O), 6.58 (1H, bs, CH), 6.46-6.45 (1H, m, CH), 4.77 (2H, s, CH2Ph), 3.69 
(2H, t, J = 6.4 Hz, CH2CH2N), 2.87 (2H, t, J = 6.4 Hz, CH2CH2N), 2.15 (3H, s, 
CH3C=O); (Minor rotamer) δ 7.61 (1H, d, J = 15.2 Hz, CH=CHC=O), 7.50-7.24 
(6H, m, ArH and CH), 6.84 (1H, d, J = 15.2 Hz, CH=CHC=O), 6.62-6.58 (1H, m, 
CH), 6.50-6.49 (1H, m, CH), 4.74 (2H, s, CH2Ar), 3.71 (2H, t, J = 6.9 Hz, 
CH2CH2N), 2.74 (2H, t, J = 6.9 Hz, CH2CH2N), 2.13 (3H, s, CH3C=O); 
13C NMR 
(62.9 MHz, CDCl3) (Mixture of rotamers – not fully assigned) δ 207.5 (C), 206.1 
(C), 166.9 (C), 166.3 (C), 151.5 (C), 143.9 (CH), 137.6 (C), 137.1 (C), 130.3 (CH), 
129.9 (CH), 128.8 (CH), 128.6 (CH), 128.0 (CH), 127.6 (CH), 127.4 (CH), 126.6 
(CH), 114.6 (CH), 114.3 (CH), 114.2 (CH), 114.0 (CH), 112.1 (CH) 52.2 (CH2), 49.6 
(CH2), 43.1 (CH2), 42.5 (CH2), 41.9 (CH2), 30.2 (CH3), 30.0 (CH3). 
 
N-Benzyl-N-(3-oxobutyl)-(E)-3-thiophen-2-
ylpropenamide (185).  The title compound was prepared 
according to General Procedure B from methyl vinyl 
ketone (0.48 mL, 5.3 mmol), benzylamine (0.52 mL, 4.8 mmol) and the acid chloride 
(prepared according General Procedure A) derived from (E)- 3-thiophen-2-ylacrylic 
acid (4.30 g, 24.2 mmol) for a reaction time of 16 h. The product was purified by 
column chromatography (10% acetone/petrol
25% acetone/petrol) to give a yellow 
oil (440 mg, 30%) as a 2:1 mixture of rotamers. Rf = 0.21 (40% EtOAc/hexane); IR 
(film) 1717 (C=O), 1642 (C=C), 1606, 1455, 1371, 1265, 1207, 1082, 905, 737 cm-1; 
1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.85 (1H, d, J = 15.0 Hz, ArCH=), 
7.38-7.16 (7H, m, ArH), 7.06-6.99 (1H, m, ArH), 6.63 (1H, J = 15.0 Hz, 
ArCH=CH), 4.72 (2H, s, CH2Ph), 3.67 (3H, t, J = 6.5 Hz, CH2CH2N), 2.83 (2H, t, J 
= 6.7 Hz, CH2CH2N), 2.13 (3H, s, CH3C=O); (Minor rotamer) δ 7.91 (1H, d, J = 
15.1 Hz, ArCH=), 7.38-7.16 (7H, m, ArH), 7.06-6.99 (1H, m, ArH), 6.73 (1H, d, J = 











(2H, t, J = 6.9 Hz, CH2CH2N), 2.09 (3H, s, CH3C=O); 
13C NMR (62.9 MHz, CDCl3) 
(Mixture of rotamers – not fully assigned) δ 207.5 (C), 166.9 (C), 166.8 (C), 140.3 
(C), 137.6 (C), 137.1 (C), 136.3 (CH), 135.9 (CH), 130.3 (CH), 128.9 (C), 128.7 
(CH), 128.6 (CH), 128.0 (CH), 127.7 (CH), 127.4 (CH), 126.6 (CH), 116.0 (CH), 
115.7 (CH), 52.4 (CH2), 49.6 (CH2), 43.1 (CH2), 42.6 (CH2), 42.0 (CH2), 41.9 (CH2), 
41.8 (CH2), 30.3 (CH3), 30.1 (CH3); HRMS (EI) Exact mass calcd for C18H19NO2S 
[M]+: 313.1131, found: 313.1131. 
 
N-Benzyl-N-(3-oxobutyl)-(E)-3-(2-
methoxyphenyl)propenamide (186).  The title compound 
was prepared according to General Procedure B from 
methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine (2.18 mL, 20 mmol) and 
the acid chloride (prepared according General Procedure A) derived from 2-
methoxycinnamic acid (4.30 g, 24.2 mmol) for a reaction time of 5 h. The product 
was purified by column chromatography (30% EtOAc/hexane) to give a yellow oil 
(3.19 g, 47%) as a 2:1 mixture of rotamers. Rf = 0.32 (50% EtOAc/hexane); IR (film) 
2925, 1718 (C=O), 1643 (C=C), 1599, 1461, 1369, 1254, 1165, 909, 736 cm-1; 
1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.99 (1H, d, J = 15.6 Hz, ArCH=), 
7.38-7.23 (7H, m, ArH), 6.97 (1H, d, J = 15.6 Hz, ArCH=CH), 6.92-6.85 (2H, m, 
ArH), 4.74 (2H, s, CH2Ph), 3.77 (3H, s, OCH3), 3.69 (2H, t, J = 6.8 Hz, CH2CH2N), 
2.85 (2H, t, J = 6.7 Hz, CH2CH2N), 2.12 (3H, s, CH3C=O); (Minor rotamer) δ 8.03 
(1H, d, J = 15.5 Hz, ArCH=), 7.38-7.23 (7H, m, ArH), 7.10 (1H, d, J = 15.5 Hz, 
ArCH=CH), 6.92-6.85 (2H, m, ArH), 4.72 (2H, s, CH2Ph), 3.87 (3H, s, OCH3), 3.69 
(2H, t, J = 6.8Hz, CH2CH2N), 2.69 (2H, t, J = 6.9 Hz, CH2CH2N), 2.07 (3H, s, 
CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully assigned) 
δ 207.5 (C), 206.1 (C), 167.7 (C), 167.0 (C), 158.2 (C), 158.1 (C), 139.2 (CH), 138.7 
(CH), 137.3 (C), 130.6 (CH), 129.4 (CH), 129.1 (CH), 128.7  (CH), 128.5 (CH), 
128.0 (CH), 127.4 (CH), 127.2 (CH), 126.4 (CH), 124.0 (C), 120.4 (CH), 118.2 
(CH), 117.8 (CH), 111.0 (CH), 55.2 (CH3), 52.3 (CH2), 49.5 (CH2), 42.9 (CH2), 42.6 
(CH2), 41.9 (CH2), 30.2 (CH3), 30.0 (CH3); HRMS (ES) Exact mass calcd for 
C21H24NO3 [M+H]












N-Benzyl-N-(3-oxobutyl)-(E)-3-pent-2-enamide (187). The 
title compound was prepared according to General Procedure 
B from methyl vinyl ketone (1.98 mL, 22.0 mmol), benzylamine (2.18 mL, 20 mmol) 
and the acid chloride (prepared according General Procedure A) derived from (E)-
pent-2-enoic acid (2.42 g, 24.2 mmol) for a reaction time of 4 h. The product was 
purified by column chromatography (55% EtOAc/hexane) to give a pale yellow oil 
(2.55 g, 49%) as a 2:1 mixture of rotamers. Rf = 0.11 (50% EtOAc/hexane); IR (film) 
3410, 1717 (C=O), 1650 (C=C), 1606, 1442, 1375, 1158, 976, 910, 732 cm-1; 
1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.34-7.14 (5H, m, ArH), 7.06-6.93 
(1H, m, CH2CH=), 6.16 (1H, d, J = 15.0 Hz, CH2CH=CH), 4.63 (2H, s, CH2Ph), 
3.58 (2H, t, J = 6.9 Hz, CH2CH2N), 2.78 (2H, t, J = 6.7 Hz, CH2CH2N), 2.25-2.11 
(2H, m, CH2CH=), 2.08 (3H, s, CH3C=O), 0.98 (3H, t, J = 7.4 Hz, CH3CH2); (Minor 
rotamer) δ 7.34-7.14 (5H, m, ArH), 7.06-6.93 (1H, m, CH2CH=), 6.25 (1H, d, J = 
14.9 Hz, CH2CH=CH) 4.63 (2H, s, CH2Ph), 3.58 (2H, t, J = 6.9 Hz, CH2CH2N), 
2.62 (2H, t, J = 6.9 Hz, CH2CH2N), 2.05 (3H, s, CH3C=O), 1.06 (3H, t, J = 7.5 Hz, 
CH3CH2); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully assigned) δ 
207.5 (C), 206.1 (C), 167.3 (C), 166.6 (C), 149.1 (CH), 148.6 (CH), 137.6 (C), 137.1 
(C), 128.7 (CH), 128.5 (CH), 127.9 (CH), 127.4 (CH), 127.3 (CH), 127.2 (CH), 
126.4 (CH), 119.1 (CH), 118.8 (CH), 52.1 (CH2), 49.2 (CH2), 42.7 (CH2), 42.2 
(CH2), 41.8 (CH2), 30.2 (CH3), 29.9 (CH3), 25.4 (CH2), 12.4 (CH3); HRMS (ES) 
Exact mass calcd for C16H22NO2 [M+H]
+: 260.1645, found: 260.1647. 
 
N-Benzyl-N-(3-oxopentyl)-(E)-3-phenylpropenamide (188). 
The title compound was prepared according to General 
Procedure B from ethyl vinyl ketone (1.09 mL, 11.0 mmol), benzylamine (1.09 mL, 
10 mmol) and cinnamoyl chloride (2.02 g, 12.1 mmol) for a reaction time of 17 h. 
The product was purified by column chromatography (40% EtOAc/hexane
18% 
acetone/petrol) to give a yellow solid (0.747 g, 23%) as a 2:1 mixture of rotamers. Rf 
= 0.34 (40% EtOAc/hexane);  m.p. 68-70 °C; IR (CHCl3) 3155, 1712 (C=O), 1648 
(C=C), 1602, 1452, 1377, 1206, 906, 735, 651 cm-1; 1H NMR (360 MHz, CDCl3) 
(Major rotamer) δ 7.75 (1H, d, J = 15.4 Hz, PhCH=), 7.57-7.23 (10H, m, ArH), 6.83 















CH2CH2N), 2.84 (2H, t, J = 6.7 Hz, CH2CH2N), 2.42 (2H, q, J = 7.4 Hz, 
CH3CH2C=O), 1.04 (3H, t, J = 6.9 Hz, CH3CH2C=O); (Minor rotamer) δ 7.81 (1H, 
d, J = 15.5 Hz, PhCH=), 7.57-7.23 (10H, m, ArH), 6.97 (1H, d, J = 15.2 Hz, 
PhCH=CH), 4.72 (2H, s, CH2Ph), 3.74-3.68 (2H, m, CH2CH2N), 2.66 (2H, t, J = 7.0 
Hz, CH2CH2N), 2.34 (2H, q, J = 7.2 Hz, CH3CH2C=O), 1.06-1.00 (3H, m, 
CH3CH2C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully 
assigned) δ 210.2 (C), 209.0 (C), 167.1 (C), 143.6 (CH), 143.2 (CH), 137.2 (C), 
135.1 (C), 129.6 (CH), 128.9 (CH), 128.7 (CH), 128. 1 (CH), 127.8 (CH), 127.6 
(CH), 126.5 (CH), 117.3 (CH), 52.4 (CH2), 49.6 (CH2), 42.8 (CH2), 42.1 (CH2), 41.7 
(CH2), 40.6 (CH2), 36.4 (CH2), 36.1 (CH2), 7.6 (CH3), 7.5 (CH3); HRMS (EI) Exact 
mass calcd for C21H23NO2 [M]
+: 321.7123, found: 321.1725. 
 
N-Benzyl-N-(3-oxopentyl)-(E)-3-(4-
methoxy)phenylpropenamide (189). The title 
compound was prepared according to General 
Procedure B from ethyl vinyl ketone (2.18 mL, 22.0 mmol), benzylamine (2.18 mL, 
20 mmol) and the acid chloride (prepared according General Procedure A) derived 
from 4-methoxycinnamic acid (4.30 g, 24.2 mmol) for a reaction time of 20 h. The 
product was purified by column chromatography (45% EtOAc/hexane
25% 
acetone/petrol) to give a white solid (2.36 g, 34%) as a 2:1 mixture of rotamers. Rf = 
0.23 (40% EtOAc/hexane); m.p. 71-73 °C; IR (CHCl3) 3033, 1712 (C=O), 1645 
(C=C), 1512, 1254, 1173, 1033, 902, 718, 650 cm-1; 1H NMR (360 MHz, CDCl3) 
(Major rotamer) δ 7.70 (1H, d, J = 15.3 Hz, ArCH=), 7.51-7.21 (7H, m, ArH), 6.91-
6.80 (2H, m, ArH), 6.69 (1H, d, J = 15.3 Hz, ArCH=CH), 4.75 (2H, s, CH2Ph), 3.79 
(3H, s, OCH3), 3.73-3.66 (2H, m, CH2CH2N), 2.82 (2H, t, J = 6.6 Hz, CH2CH2N), 
2.43-2.32 (2H, m, CH3CH2C=O), 1.02 (3H, t, J = 7.3 Hz, CH3CH2C=O); (Minor 
rotamer) δ 7.76 (1H, d, J = 15.6 Hz, ArCH=), 7.51-7.21 (7H, m, ArH), 6.91-6.80 
(3H, m, ArH and ArCH=CH), 4.71 (2H, s, CH2Ph), 3.82 (3H, s, OCH3), 3.73-3.66 
(2H, m, CH2CH2N), 2.65 (2H, t, J = 6.6 Hz, CH2CH2N), 2.43-2.32 (2H, m, 
CH3CH2C=O), 1.04-0.98 (3H, m, CH3CH2C=O); 
13C NMR (62.9 MHz, CDCl3) 
(Mixture of rotamers – not fully assigned) δ 210.2 (C), 209.0 (C), 167.3 (C), 166.7 











(CH), 128.5 (CH), 128.0 (CH), 127.8 (C), 127.5 (CH), 127.3 (CH), 127.3 (CH), 
126.4 (CH), 114.7 (CH), 114.1 (CH), 55.2 (CH3), 52.3 (CH3), 49.5 (CH2), 42.7 
(CH2), 42.0 (CH2), 41.7 (CH2), 41.5 (CH2), 40.6 (CH2), 36.4 (CH2), 36.0 (CH2), 7.5 
(CH3); HRMS (EI) Exact mass calcd for C22H25NO3 [M]





The title compound was prepared by Dr Pekka Joensuu.61 




Using Et3Al: General Procedure C 
A solution of the substrate (1 equiv) and Co(acac)2·2H2O (0.10 equiv) in THF (1.5 
mL) was stirred at room temperature for 15 min. The mixture was cooled to 0 °C and 
stirred for a further 15 min.  Et3Al (1 M solution in hexane, 2 equiv) was then added 
rapidly in one portion. The reaction was stirred at 0 °C for 1 h and then at room 
temperature until the reaction had stopped progressing as observed by TLC analysis. 
Workup was carried out according to one of the procedures described below. 
 
Using Me3Al: General Procedure D 
A solution of the substrate (0.20 mmol) and Co(acac)2·2H2O (2.6 mg, 0.01 mmol) in 
THF (1.5 mL) was stirred at room temperature for 15 min. The mixture was cooled 
to 0 °C and stirred for a further 15 min. Me3Al (2 M solution in hexane, 0.20 mL, 
0.40 mmol) was then added rapidly in one portion. The reaction was stirred at 0 °C 





observed by TLC analysis. Workup was carried out according to one of the 




Pr3Al: General Procedure E 
A solution of the substrate (0.20 mmol) and Co(acac)2·2H2O (2.6 mg, 0.01 mmol) in 
THF (1.5 mL) was stirred at room temperature for 15 min. The mixture was cooled 
to 0 °C and stirred for a further 15 min.  nPr3Al (0.7 M solution in hexane, 0.57 mL, 
0.40 mmol) was then added rapidly in one portion. The reaction was stirred at 0 °C 
for 1 h and then at room temperature until the reaction had stopped progressing as 
observed by TLC analysis. Workup was carried out according to one of the 




Hex3Al : General Procedure F 
A solution of the substrate (0.20 mmol) and Co(acac)2·2H2O (2.6 mg, 0.01 mmol) in 
THF (1.5 mL) was stirred at room temperature for 15 min. The mixture was cooled 
to 0 °C and stirred for a further 15 min.  nHex3Al (0.4 M solution in hexane, 1 mL, 
0.40 mmol) was then added quickly. The reaction was stirred at 0 °C for 1 h and then 
at room temperature until the reaction had stopped progressing as observed by TLC 




Saturated aqueous Rochelle’s salt (potassium sodium tartrate) solution (2 mL) was 
added carefully and the resulting mixture was stirred vigorously for 30 min. The 
mixture was then further diluted with Rochelle’s salt solution (20 mL) and the 
aqueous layer was separated and extracted with CH2Cl2 (3 x 15 mL). The combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Purification of the 
residue by column chromatography afforded the cyclised product. 
 
Workup B 
10% HCl solution (1 mL) was added carefully and the resulting mixtures was stirred 





saturated NH4Cl solution and 10% HCl solution (10 mL). The aqueous layer was 
separated and extracted with CH2Cl2 (3 x 15 mL). The combined organic layers were 
dried (MgSO4) and the filtrate was concentrated in vacuo. Purification of the residue 
by column chromatography afforded the cyclised product. 
 
Workup C 
The reaction mixture was filtered through a short plug of SiO2 (ca. 4 cm high x 2 cm 
diameter) using EtOAc as eluent (ca. 50 mL) and the filtrate was concentrated in 




phenylpropyl]piperidin-2-one (174). The title compound was 
prepared according to General Procedure C from 173 (31 mg, 0.10 
mmol) for a reaction time of 16 h followed by Workup C to give an off-white solid 
(33 mg, 98%) that required no further purification. Slow diffusion of hexane into a 
solution of 174 in EtOAc gave colourless crystals that were suitable for X-ray 
crystallography. Rf = 0.34 (50% EtOAc/hexane); m.p. 155-156 °C; IR (CHCl3) 3390 
(OH), 2967, 1631 (C=O), 1495, 1453, 1381, 908, 733, 650, 622 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.45 (2H, dd, J = 8.1, 1.1 Hz, ArH), 7.36-7.28 (7H, m, ArH), 7.21 
(1H, t, J = 7.3 Hz, ArH), 4.67 (1H, d, J = 14.4 Hz, NCH2Ar), 4.59 (1H, d, J = 14.4 
Hz, NCH2Ar), 3.34 (1H, ddd, J = 12.4, 6.8, 4.2 Hz, CH2CH2N), 3.09-3.01 (2H, m, 
CH2CH2N and CHCH2CH3), 2.86 (1H, app dd, J = 4.7, 1.7 Hz, CHC=O), 2.06-1.85 
(2H, m, CH2), 1.72-1.64 (3H, m, CH2 and OH), 1.22 (3H, s, CH3COH), 0.71 (3H, t, 
J = 7.6 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.3 (C), 145.8 (C), 137.1 
(C), 128.8 (2 x CH), 128.5 (4 x CH), 128.4 (2 x CH), 127.4 (CH), 126.3 (CH), 71.3 
(C), 59.7 (CH), 50.2 (CH2), 46.2 (CH), 43.4 (CH2), 32.4 (CH2), 28.4 (CH3), 27.3 



















The title compound was prepared according to General 
Procedure C from 181 (67 mg, 0.20 mmol) for a reaction time of 3 h followed by 
Workup C to give a white solid (67 mg, 91%) that required no further purification. Rf 
= 0.31 (50% EtOAc/hexane); m.p. 144-146 °C; IR (CHCl3) 3019 (OH), 2962, 1631 
(C=O), 1511, 1426, 1216, 1032, 929, 768, 669 cm-1; 1H NMR (360 MHz, CDCl3) δ 
7.36-7.27 (7H, m, ArH), 6.85 (2H, d, J = 8.7 Hz, ArH), 4.65 (1H, d, J = 14.4 Hz, 
NCH2Ar), 4.57 (1H, d, J = 14.4 Hz, NCH2Ar), 3.78 (3H, s, OCH3), 3.32 (1H, ddd, J 
= 12.3, 6.7, 4.3 Hz, CH2CH2N), 3.07-2.99 (2H, m, CH2CH2N and CHCH2CH3), 2.80 
(1H, app dd, J = 4.7, 1.6 Hz, CHC=O), 2.05-1.83 (3H, m, CH2 and OH), 1.72-1.62 
(2H, m, CH2), 1.21 (3H, s, CH3COH), 0.70 (3H, t, J = 7.3 Hz, CH3CH2); 
13C NMR 
(62.9 MHz, CDCl3) δ 170.4 (C), 158.0 (C), 137.5 (C), 137.0 (C), 129.7 (2 x CH), 
128.5 (2 x CH), 128.4 (2 x CH), 127.4 (CH), 113.9 (2 x CH), 71.3 (C), 59.7 (CH), 
55.2 (CH3), 50.1 (CH2), 45.4 (CH), 43.3 (CH2), 32.5 (CH2), 28.4 (CH3), 27.4 (CH2), 
12.5 (CH3); HRMS (EI) Exact mass calcd for C23H29NO3 [M]
+: 367.2142, found: 
367.2138. 
(±)-(3R,4R)-1-Benzyl-4-hydroxy-4-methyl-3-[(R)-1-(4-
methylphenyl)propyl]piperidin-2-one (193b). The title 
compound was prepared according to General Procedure C 
from 182 (32 mg, 0.10 mmol) for a reaction time of 18 h followed by Workup C and 
purification by column chromatography (40% EtOAc/hexane) to give a white solid 
(25 mg, 71%). Rf = 0.37 (40% EtOAc/hexane); m.p. 148-150 °C; IR (CHCl3) 3427 
(OH), 1632 (C=O), 1453, 1381, 1265, 1095, 907, 849, 730, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.36-7.28 (7H, m, ArH), 7.13 (2H, d, J = 7.9 Hz, ArH), 4.62 (1H, d, 
J = 14.4 Hz, NCH2Ar), 4.54 (1H, d, J = 14.4 Hz, NCH2Ar), 3.33 (1H, ddd, J = 12.4, 
6.8, 4.1 Hz, CH2CH2N), 3.09-3.00 (2H, m, CH2CH2N and CHCH2CH3), 2.84 (1H, 
app dd, J = 5.1, 1.7 Hz, CHC=O), 2.33 (3H, s, CH3Ar), 2.03 (1H, ddd, J = 13.4, 9.2, 
6.8 Hz, CH2CH2N), 1.89 (1H, qdd, J = 14.5, 11.6, 7.3 Hz, CHCH2CH3), 1.71-1.63 
(3H, m, CH2CH2N, CHCH2CH3 and OH), 1.21 (3H, s, CH3COH), 0.70 (3H, t, J = 
7.3 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.4 (C), 142.4 (C), 137.1 (C), 





















(CH), 71.4 (C), 59.8 (CH), 50.2 (CH2), 45.8 (CH), 43.4 (CH2), 32.5 (CH2), 28.4 
(CH3), 27.4 (CH2), 21.0 (CH3), 12.5 (CH3); HRMS (EI) Exact mass calcd for 
C23H29NO2 [M]
+: 351.2193, found: 351.2192. 
 
(±)-(3R,4R)-1-Benzyl-3-[(R)-1-(4-chlorophenyl)propyl]4-
hydroxy-4-methylpiperidin-2-one (193c). The title 
compound was prepared according to General Procedure C 
from 183 (34 mg, 0.10 mmol) for a reaction time of 18 h followed by Workup C and 
purification by column chromatography (40% EtOAc/hexane) to give a white solid 
(18 mg, 48%). Rf = 0.35 (40% EtOAc/hexane); m.p. 165-168 °C; IR (CHCl3) 3020 
(OH), 1631 (C=O), 1522, 1476, 1424, 1218, 1015, 929, 771, 669 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.42 (2H, d, J = 8.4 Hz, ArH), 7.34-7.26 (7H, m, ArH), 4.68 (1H, d, 
J = 14.4 Hz, NCH2Ar), 4.57 (1H, d, J = 14.4 Hz, NCH2Ar), 3.35 (1H, ddd, J = 12.4, 
6.4, 4.7 Hz, CH2CH2N), 3.10-3.02 (2H, m, CH2CH2N and CHCH2CH3), 2.77 (1H, 
app dd, J = 3.7, 1.6 Hz, CHC=O), 2.02-1.83 (2H, m, CH2), 1.72-1.60 (3H, m CH2 
and OH), 1.25 (3H, s, CH3COH), 0.71 (3H, t, J = 7.3 Hz, CH3CH2); 
13C NMR (62.9 
MHz, CDCl3) δ 169.9 (C), 144.8 (C), 137.0 (C), 130.3 (2 x CH), 128.6 (2 x CH), 
128.5 (2 x CH), 128.4 (2 x CH), 127.5 (CH), 71.3 (C), 59.5 (CH), 50.2 (CH2), 45.5 
(CH), 43.3 (CH2), 32.7 (CH2), 28.7 (CH3), 27.0 (CH2), 12.6 (CH3); HRMS (EI) Exact 
mass calcd for C22H26NO2Cl [M]
+: 371.1647, found: 371.1643. 
 
(±)-(3R,4R)-1-Benzyl-3-[(R)-(1-furan-2-yl)propyl]-4-hydroxy-
4-methylpiperidin-2-one (193d). The title compound was 
prepared according to General Procedure C from 184 (30 mg, 
0.10 mmol) for a reaction time of 3 h followed by Workup C to give an off-white 
solid (25 mg, 76%) that required no further purification. Rf = 0.31 (50% 
EtOAc/hexane); m.p. 168-170 °C; IR (CHCl3) 3434 (OH), 1629 (C=O), 1454, 1381, 
1262, 1096, 906, 736, 651, 506 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.34-7.25 (6H, 
m, ArH and CH), 6.32 (1H, dd, J = 3.2, 1.9 Hz, CH), 6.17-6.16 (1H, m, CH), 4.67 
(1H, d, J = 14.6 Hz, NCH2Ar), 4.53 (1H, d, J = 14.6 Hz, NCH2Ar), 3.64-3.58 (1H, 
m, CHCH2CH3), 3.29-3.23 (1H, m, CH2CH2N), 3.03 (1H, ddd, J = 12.4, 7.8, 5.9 Hz, 




















Hz, CH2CH3), 2.06 (1H, s, OH), 1.82 (1H, dqd, J = 14.6, 7.5, 4.6 Hz, CH2CH3), 
1.69-1.62 (1H, m, CH2CH2N), 1.45 (1H, ddd, J = 13.6, 7.8, 6.1 Hz, CH2CH2N), 1.32 
(3H, s, CH3COH), 0.90 (3H, t, J = 7.5 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) 
δ 170.3 (C), 156.6 (C), 140.9 (CH), 137.1 (C), 128.5 (2 x CH), 128.1 (2 x CH), 127.3 
(CH), 110.7 (CH), 107.3 (CH), 70.9 (C), 57.1 (CH), 50.4 (CH2), 43.2 (CH2), 40.7 
(CH), 34.2 (CH2), 28.9 (CH3), 26.5 (CH2), 13.0 (CH3); HRMS (ES) Exact mass calcd 
for C20H26NO3 [M+H]




one (193e). The title compound was prepared according to 
General Procedure C from 185 (63 mg, 0.20 mmol) for a reaction time of 23 h 
followed by Workup B and purification by column chromatography (25% 
EtOAc/hexane
50% EtOAc/hexane) to give a white solid (58 mg, 85%). Rf = 0.41 
(40% EtOAc/hexane); m.p. 174-175 °C; IR (CHCl3) 3402 (OH), 1797, 1649 (C=O), 
1450, 1383, 1262, 1095, 908, 737, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.35-
7.25 (5H, m, ArH), 7.20 (1H, dd, J = 5.1, 1.2 Hz, CH), 6.99 (1H, dd, J = 3.5, 1.2, 
CH), 6.94 (1H, dd, J = 5.1, 3.5 Hz, CH), 4.68 (1H, d, J = 14.5 Hz, NCH2Ar), 4.61 
(1H, d, J = 14.5 Hz, NCH2Ar), 3.63 (1H, ddd, J = 11.1, 3.7, 3.4 Hz, CHCH2CH3), 
3.42-3.35 (1H, m, CH2CH2N), 3.05 (1H, ddd, J = 12.4, 6.3, 6.3 Hz, CH2CH2N), 2.80 
(1H, app d, J = 3.4 Hz, CHC=O), 2.06 (1H, ddq, J = 14.4, 11.1, 7.3 Hz, 
CHCH2CH3), 1.88-1.69 (3H, m, CHCH2CH3 and CH2CH2N), 1.48 (1H, s, OH), 1.35 
(3H, s, CH3COH), 0.88 (3H, t, J = 7.3 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) 
δ 169.7 (C), 149.0 (C), 137.0 (C), 128.5 (2 x CH), 128.2 (2 x CH), 127.3 (CH), 126.4 
(CH), 125.0 (CH), 124.2 (CH), 71.4 (C), 58.8 (CH), 50.3 (CH2), 43.0 (CH2), 41.4 
(CH), 34.4 (CH2), 28.9 (CH3), 28.4 (CH2), 12.9 (CH3); HRMS (EI) Exact mass calcd 
for C20H25NO2S [M]


















methylpiperidin-2-one (193f) and (±)-(3R,4R)-1-benzyl-4-hydroxy-3-(2-
methoxybenzyl)-4-methylpiperidin-2-one (193k) 
 
General Procedure C was followed using substrate 186 (67 mg, 0.20 mmol) for a 
reaction time of 30 h and the reaction mixture was subjected to Workup B followed 
by purification by column chromatography (20% 
EtOAc/hexane
50%EtOAc/hexane) to give the unreacted starting material 186 (11 
mg, 16%), followed by the alkylative aldol product 193f (15 mg, 21%) as a white 
solid, followed by the reductive aldol product 193k (19 mg, 28%) as a white solid. 
Data for 193f: Rf = 0.12 (30% EtOAc/hexane); m.p. 133-135 °C; IR (CHCl3) 3389 
(OH), 2924, 2854, 1625 (C=O), 1462, 1377, 1242, 1058, 846, 742 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.53 (1H, dd, J = 7.6, 1.4 Hz, ArH), 7.35-7.28 (5H, m, ArH), 
7.20 (1H, ddd, J = 7.6, 4.8, 0.9 Hz, ArH), 7.03 (1H, t, J = 7.6 Hz, ArH), 6.88 (1H, d, 
J = 8.1 Hz, ArH), 4.70 (1H, d, J = 14.3 Hz, NCH2Ar), 4.53 (1H, d, J = 14.3 Hz, 
NCH2Ar), 3.87 (3H, s, OCH3), 3.46-3.41 (1H, m, CHCH2CH3), 3.31 (1H, ddd, J = 
12.3, 7.0, 3.0 Hz, CH2CH2N), 3.05 (1H, ddd, J = 12.3, 10.1, 6.4 Hz, CH2CH2N), 
2.79 (1H, app dd, J = 5.0, 1.5 Hz, CHC=O), 2.62 (1H, s, OH), 2.13 (1H, ddd, J = 
13.2, 10.1, 7.0 Hz, CH2CH2N), 2.02-1.89 (1H, m, CH2), 1.75-1.65 (2H, m, CH2), 
1.16 (3H, s, CH3COH), 0.68 (3H, t, J = 7.3 Hz, CH3CH2); 
13C NMR (62.9 MHz, 
CDCl3) δ 170.4 (C), 156.3 (C), 137.1 (C), 133.6 (C), 128. 8 (CH), 128.5 (4 x CH), 
127.4 (CH), 127.1 (CH), 121.7 (CH), 110.5 (CH), 70.9 (C), 59.8 (CH), 55.5 (CH3), 
53.4 (CH), 50.0 (CH2), 43.5 (CH2), 32.3 (CH2), 27.5 (CH3), 26.0 (CH2), 12.1 (CH3); 
HRMS (ES) Exact mass calcd for C23H30NO3 [M+H]
+: 368.2200, found: 368.2219. 
Data for 193k: Rf = 0.06 (30% EtOAc/hexane); m.p. 145-147 °C; IR (CHCl3) 3464 
(OH), 3054, 2925, 1635 (C=O), 1495, 1453, 1265, 1111, 909, 737 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.38-7.19 (7H, m, ArH), 6.93 (1H, dt, J = 7.5, 1.0 Hz, ArH), 
6.88 (1H, d, J = 8.2 Hz, ArH), 4.72 (1H, d, J = 14.6 Hz, NCH2Ar), 4.50 (1H, d, J = 
14.6 Hz, NCH2Ar), 3.90 (3H, s, OCH3), 3.38-3.29 (3H, m, CH2CH2N and CHCH2 





Hz, CH2CH2N), 2.75 (1H, app dd, J = 7.6, 4.8 Hz, CHC=O), 1.76-1.66 (2H, m, 
CH2CH2N), 1.07 (3H, s, CH3COH); 
13C NMR (62.9 MHz, CDCl3) δ 171.1 (C), 
156.3 (C), 137.2 (C), 131.6 (CH), 129.4 (C), 128.5 (2 x CH), 128.0 (2 x CH), 127.6 
(CH), 127.2 (CH), 121.5 (CH), 110.7 (CH), 69.9 (C), 55.5 (CH3), 54.0 (CH), 50.4 
(CH2), 43.0 (CH2), 34.9 (CH2), 28.5 (CH3), 27.4 (CH2); HRMS (ES) Exact mass 
calcd for C21H26NO3 [M+H]
+: 340.1907, found: 340.1909. 
 
(±)-(3R,4R)-1-Benzyl-4-hydroxy-3-(1-ethylpropyl)-4-
methylpiperidin-2-one (193g). General Procedure C was followed 
using substrate from 187 (70 mg, 0.20 mmol) for a reaction time of 
16 h followed by Workup B and purification by column chromatography (30% 
EtOAc/hexane) to give unreacted starting material 187 (17 mg, 35%) followed by the 
alkylative aldol product 193g (20 mg, 35%) as a white solid. Rf = 0.18 (30% 
EtOAc/hexane); m.p. 132-135 °C; IR (CHCl3) 3419 (OH), 2959, 2872, 1622 (C=O), 
1455, 1426, 1378, 1264, 911, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.34-7.24 
(5H, m, ArH), 4.65 (1H, d, J = 14.5 Hz, NCH2Ar), 4.53 (1H, d, J = 14.5 Hz, 
NCH2Ar), 3.47 (1H, ddd, J = 12.3, 9.0, 4.9 Hz, CH2CH2N), 3.04 (1H, ddd, J = 12.3, 
5.5, 5.5 Hz, CH2CH2N), 2.42 (1H, app s, CHC=O), 1.89-1.42 (7H, m, CH2CH2N and 
CH(CH2CH3)2), 1.39 (1H, s, OH), 1.29 (3H, s, CH3COH), 0.98 (3H, t, J = 6.2 Hz, 
CH3CH2), 0.94 (3H, t, J = 6.2 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.5 
(C), 137.3 (C), 128. 5 (2 x CH), 128.2 (2 x CH), 127.3 (CH), 71.2 (C), 52.9 (CH), 
50.0 (CH2), 42.8 (CH2), 41.4 (CH), 35.3 (CH2), 29.2 (CH3), 26.6 (CH2), 25.3 (CH2), 
13.2 (CH3), 12.3 (CH3); HRMS (ES) Exact mass calcd for C18H28NO2 [M+H]
+: 
290.2115, found 290.2114. 
 
(±)-(3R,4R)-1-Benzyl-4-ethyl-4-hydroxy-3-[(R)-1-
phenylpropyl]piperidin-2-one (193h). The title compound was 
prepared according to General Procedure C from 188 (64 mg, 0.20 
mmol) for a reaction time of 16 h followed by Workup B and purification by column 
chromatography (25% EtOAc and 0.5% Et3N in hexane) to give a white solid (42 
mg, 60%). Slow diffusion of petrol into a solution of 193h in CH2Cl2 gave colourless 




















m.p. 188-189 °C; IR (CHCl3) 3580 (OH), 2967, 1631 (C=O), 1494, 1452, 1380, 
1096, 908, 732, 649 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.43 (2H, d, J = 7.9 Hz, 
ArH), 7.38-7.29 (7H, m, ArH), 7.20 (1H, t, J = 7.3 Hz, ArH), 4.68 (1H, d, J = 14.4 
Hz, NCH2Ar), 4.56 (1H, d, J = 14.4 Hz, NCH2Ar), 3.29 (1H, ddd, J = 12.4, 6.7, 3.7 
Hz, CH2CH2N), 3.07-2.96 (2H, m, CH2CH2N and CHCH2CH3), 2.90 (1H, app dd, J 
= 5.1, 1.8 Hz, CHC=O), 2.01-1.82 (2H, m, CH2), 1.77-1.62 (2H, m, CH2), 1.55-1.36 
(2H, m, CH3CH2COH), 1.16 (1H, s, OH), 0.83 (3H, t, J = 7.4 Hz, CH3CH2COH), 
0.69 (3H, t, J = 7.3 Hz, CH3CH2CH); 
13C NMR (62.9 MHz, CDCl3) δ 170.4 (C), 
146.0 (C), 137.1 (C), 128.7 (2 x CH), 128.6 (2 x CH), 128.5 (2 x CH), 128.4 (2 x 
CH), 127.4 (CH), 126.2 (CH), 73.2 (C), 58.7 (CH), 50.1 (CH2), 46.2 (CH), 43.2 
(CH2), 32.5 (CH2), 28.9 (CH2), 27.4 (CH2), 12.5 (CH3), 7.0 (CH3); HRMS (EI) Exact 
mass calcd for C23H29NO2 [M]
+: 351.2193, found: 351.2196. 
 
(±)-(3R,4R)-1-Benzyl-4-ethyl-4-hydroxy-3-[(R)-1-(4-
methoxyphenyl)propyl]piperidin-2-one (193i). The title 
compound was prepared according to General Procedure C 
from 189 (70 mg, 0.20 mmol) for a reaction time of 16 h followed by Workup B and 
purification by column chromatography (30% EtOAc and 0.5% Et3N in hexane) to 
give a white solid (53 mg, 70%). Rf = 0.41 (40% EtOAc/hexane); m.p. 178-179 °C; 
IR (CHCl3) 3583 (OH), 2966, 1632 (C=O), 1511, 1453, 1251, 1179, 902, 740, 651 
cm-1; 1H NMR (360 MHz, CDCl3) δ 7.36-7.28 (7H, m, ArH), 6.85 (2H, d, J = 8.8 
Hz, ArH), 4.68 (1H, d, J = 14.4 Hz, NCH2Ar), 4.54 (1H, d, J = 14.4 Hz, NCH2Ar), 
3.79 (3H, s, OCH3), 3.28 (1H, ddd, J = 12.4, 6.7, 3.7 Hz, CH2CH2N), 3.03-2.97 (2H, 
m, CH2CH2N and CHCH2CH3), 2.86 (1H, app dd, J = 5.3, 1.7 Hz, CHC=O), 2.00-
1.80 (2H, m, CH2), 1.76-1.63 (2H, m, CH2), 1.52-1.37 (2H, m, CH3CH2COH), 1.24 
(1H, s, OH), 0.84 (3H, t, J = 7.4 Hz, CH3CH2COH), 0.69 (3H, t, J = 7.3 Hz, 
CH3CH2CH); 
13C NMR (62.9 MHz, CDCl3) δ 170.6 (C), 158.0 (C), 137.6 (C), 137.1 
(C),  129.6 (2 x CH), 128.6 (2 x CH), 128.4 (2 x CH), 127.4 (CH), 114.0 (2 x CH), 
73.2 (C), 58.7 (CH), 55.2 (CH3), 50.1 (CH2), 45.5 (CH), 43.2 (CH2), 32.6 (CH2), 29.1 
(CH2), 27.6 (CH2), 12.5 (CH3), 7.0 (CH3); HRMS (ES) Exact mass calcd for 
C24H32NO3 [M+H]















diastereomers 193ja and 193jb) and (±)-(3R,4R)-1,3-dibenzyl-4-hydroxy-4-
phenylpiperidin-2-one (193l) 
 
General Procedure C was followed using substrate 192 (74 mg, 0.20 mmol) for a 
reaction time of 48 h and the reaction mixture was subjected to Workup B followed 
by purification by column chromatography (10% EtOAc/hexane) to give one 
diastereomer of the alkylative aldol product 193ja (21 mg, 27%) as a white solid, 
followed by a second diastereomer of the alkylative aldol product 193jb (20 mg, 
25%) as a white solid, followed by the reductive aldol product 193l (19 mg, 26%) as 
a white solid.  
Data for 193ja: Rf = 0.37 (20% EtOAc/hexane); m.p. 146-148 °C; IR (CHCl3) 3367 
(OH), 1793, 1631 (C=O), 1489, 1452, 1377, 1093, 906, 737, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.43-7.39 (5H, m, ArH), 7.35-7.19 (10H, m, ArH), 4.77 (1H, d, J = 
14.8 Hz, NCH2Ar), 4.53 (1H, d, J = 14.8 Hz, NCH2Ar), 3.41-3.33 (2H, m, 
CH2CH2N and CHC=O), 2.94 (1H, ddd, J = 12.0, 5.8, 3.7 Hz, CH2CH2N), 2.81 (1H, 
ddd, J = 9.1, 6.5, 2.8 Hz, CHCH2CH3), 2.34-2.14 (2H, m, CH2), 2.10-2.02 (2H, m, 
CH2 and OH), 1.83 (1H, ddd, J = 13.9, 5.1, 3.7 Hz, CH2CH2N), 0.72 (3H, t, J = 7.4 
Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.0 (C), 146.2 (C), 143.3 (C), 
137.0 (C), 130.1 (2 x CH), 128.8 (2 x CH), 128.6 (2 x CH), 128.5 (2 x CH), 127.8 (2 
x CH), 127.2 (CH), 127.1 (CH), 127.1 (CH), 124.7 (2 x CH), 76.3 (C), 54.9 (CH), 
50.5 (CH2), 47.0 (CH), 43.7 (CH2), 36.8 (CH2), 30.8 (CH2), 13.0 (CH3); HRMS (EI) 
Exact mass calcd for C27H29NO2 [M]
+: 399.2193, found: 399.2193. 
Data for 193jb: Rf = 0.34 (20% EtOAc/hexane); m.p. 169-171 °C; IR (CHCl3) 3394 
(OH), 1631 (C=O), 1497, 1452, 1383, 1099, 1028, 908, 733, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.42-7.15 (15H, m, ArH), 4.71 (1H, d, J = 14.6 Hz, NCH2Ar), 4.62 
(1H, d, J = 14.6 Hz, NCH2Ar), 3.46 (1H, ddd, J = 12.2, 8.5, 5.2 Hz, CH2CH2N), 
3.33-3.26 (2H, m, CHC=O and CHCH2CH3), 2.93-2.87 (1H, m, CH2CH2N), 2.18 
(1H, ddd, J = 14.4, 7.3, 3.5 Hz, CH2CH3), 2.05-1.90 (2H, m, CH2), 1.83 (1H, s, OH), 
1.66-1.60 (1H, m, CH2), 0.72 (3H, t, J = 7.3 Hz, CH3CH2); 





CDCl3) δ 170.0 (C), 145.5 (C), 145.2 (C), 137.0 (C), 129.0 (2 x CH), 128.5 (2 x CH), 
128.4 (2 x CH), 128.3 (2 x CH), 128.1 (2 x CH), 127.5 (CH), 127.3 (CH), 126.2 
(CH), 125.1 (2 x CH), 75.7 (C), 57.4 (CH), 50.5 (CH2), 45.5 (CH), 43.4 (CH2), 35.6 
(CH2), 26.5 (CH2), 13.0 (CH3); HRMS (ES) Exact mass calcd for C27H30NO2 
[M+H]+: 400.2271, found: 400.2267. 
Data for 193l: Rf = 0.17 (20% EtOAc/hexane); m.p. 180-182 °C; IR (CHCl3) 3397 
(OH), 1635 (C=O), 1494, 1453, 1382, 1265, 1095, 908, 734, 651 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.43-7.26 (10H, m, ArH), 7.21-7.10 (3H, m, ArH), 7.07-7.05 (2H, 
m, ArH), 4.74 (1H, d, J = 14.8 Hz, NCH2Ar), 4.68 (1H, d, J = 14.8 Hz, NCH2Ar), 
3.56 (1H, ddd, J = 11.5, 11.1, 5.1 Hz, CH2CH2N), 3.23 (1H, dd, J = 6.0, 3.7 Hz, 
CHCH2Ph), 3.18-3.11 (1H, m, CH2CH2N), 3.09-3.01 (2H, m, CHCH2Ph), 2.25 (1H, 
ddd, J = 14.0, 11.1, 6.1 Hz, CH2CH2N), 2.02 (1H, s, OH), 1.94 (1H, ddd, J = 14.0, 
5.1, 2.9 Hz, CH2CH2N); 
13C NMR (62.9 MHz, CDCl3) δ 171.0 (C), 145.5 (C), 141.1 
(C), 137.1 (C), 129.5 (2 x CH), 128.5 (4 x CH), 128.3 (2 x CH), 127.8 (2 x CH), 
127.3 (2 x CH), 126.0 (CH), 124.7 (2 x CH), 75.9 (C), 53.4 (CH), 50.5 (CH2), 43.5 
(CH2), 37.0 (CH2), 31.9 (CH2); HRMS (EI) Exact mass calcd for C25H22NO2 [M]
+: 
371.1880, found: 371.1880. 
 
 (±)-(3R,4R)-1-Benzyl-4-hydroxy-4-methyl-3-[(R)-1-
phenylethyl]piperidin-2-one (194a). The title compound was 
prepared according to General Procedure D from 173 (31 mg, 0.10 
mmol) for a reaction time of 24 h followed by Workup C and purification by column 
chromatography (90% Et2O/hexane) to give a white solid (14 mg, 43%). Rf = 0.28 
(90% Et2O/hexane); m.p. 166-167 °C; IR (CHCl3) 3155 (OH), 1793, 1632 (C=O), 
1494, 1382, 1095, 902, 722, 651, 623 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.47 (2H, 
d, J = 8.3 Hz, ArH), 7.35-7.30 (7H, m, ArH), 7.20 (1H, t, J = 7.2 Hz, ArH), 4.67 
(1H, d, J = 14.4 Hz, NCH2Ar), 4.60 (1H, d, J = 14.4 Hz, NCH2Ar), 3.47-3.31 (2H, 
m, CHCH3 and CH2CH2N), 3.06 (1H, ddd, J = 12.5, 9.0, 6.3 Hz, CH2CH2N), 2.85 
(1H, dd, J = 4.6, 1.7 Hz, CHC=O), 2.04 (1H, ddd, J = 13.4, 9.0, 6.7 Hz, CH2CH2N), 
1.71 (1H, dddd, J = 13.4, 6.3, 4.6, 1.7 Hz, CH2CH2N), 1.38 (3H, d, J = 7.6 Hz, 
CH3CH), 1.29 (1H, s, OH), 1.27 (3H, s, CH3COH); 
13C NMR (62.9 MHz, CDCl3) δ 













127.8 (2 x CH), 127.5 (CH), 126.2 (CH), 71.4 (C), 59.3 (CH), 50.1 (CH2), 43.3 
(CH2), 38.2 (CH), 32.7 (CH2), 28.6 (CH3), 21.0 (CH3); HRMS (ES) Exact mass calcd 
for C21H26NO2 [M+H]
+: 324.1958, found: 324.1956. 
 
(±)-(3R,4R)-1-Benzyl-4-hydroxy-3-[(R)-1-(4-
methoxyphenyl)ethyl]-4-methylpiperidin-2-one  (194b). 
The title compound was prepared according to General 
Procedure D from 181 (67 mg, 0.20 mmol) for a reaction time of 22 h followed by 
Workup A and purification by column chromatography (50% EtOAc/hexane) to give 
a white solid (34 mg, 48%). Rf = 0.28 (50% EtOAc/hexane); m.p. 165-166 °C; IR 
(CHCl3) 3389 (OH), 1624 (C=O), 1511, 1453, 1246, 1179, 1036, 908, 732, 649 cm
-1; 
1H NMR (360 MHz, CDCl3) δ 7.36-7.23 (7H, m, ArH), 6.83 (2H, d, J = 8.8 Hz, 
ArH), 4.63 (1H, d, J = 14.4 Hz, NCH2Ar), 4.56 (1H, d, J = 14.4 Hz, NCH2Ar), 3.76 
(3H, s, OCH3), 3.38-3.29 (2H, m, CH2CH2N and CHCH3), 3.02 (1H, ddd, J = 12.5, 
8.8, 6.3 Hz, CH2CH2N), 2.76 (1H, app dd, J = 4.6, 1.5 Hz, CHC=O), 1.99 (1H, ddd, 
J = 13.6, 8.8, 6.7 Hz, CH2CH2N), 1.69-1.63 (1H, m, CH2CH2N), 1.41 (1H, s, OH), 
1.33 (3H, d, J = 7.3 Hz, CH3CH), 1.24 (3H, s, CH3COH); 
13C NMR (62.9 MHz, 
CDCl3) δ 170.3 (C), 158.0 (C), 139.9 (C), 137.1 (C), 128.8 (2 x CH), 128.6 (2 x CH), 
128.4 (2 x CH), 127.4 (CH), 114.0 (2 x CH), 71.4 (C), 59.4 (CH), 55.2 (CH3), 50.1 
(CH2), 43.3 (CH2), 37.4 (CH), 32.9 (CH2), 28.5 (CH3), 21.2 (CH3); HRMS (EI) Exact 
mass calcd for C22H27NO3 [M]
+: 353.1985, found: 353.1988. 
 
 (±)-(3R,4R)-1-Benzyl-4-hydroxy-4-methyl-3-(1-p-
tolylethyl)piperidin-2-one (194c). The title compound was 
prepared according to General Procedure D from 182 (64 mg, 
0.20 mmol) for a reaction time of 16 h followed by Workup A and purification by 
column chromatography (30% EtOAc/hexane) to give a white solid (31 mg, 46%). Rf 
= 0.34 (50% EtOAc/hexane); m.p. 161-163 °C; IR (CHCl3) 3583 (OH), 2972, 1632 
(C=O), 1453, 1381, 1265, 1094, 907, 731, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 
7.36-7.28 (7H, m, ArH), 7.14 (2H, d, J = 7.8 Hz, ArH), 4.66 (1H, d, J = 14.4 Hz, 
NCH2Ar), 4.59 (1H, d, J = 14.4 Hz, NCH2Ar), 3.41-3.32 (2H, m, CH2CH2N and 





















Hz, CHC=O), 2.33 (3H, s, CH3Ar), 2.04 (1H, ddd, J = 13.5, 9.0, 6.7 Hz, CH2CH2N), 
1.73-1.66 (1H, m, CH2CH2N), 1.36 (3H, d, J = 7.3 Hz, CH3CH), 1.35 (1H, s, OH), 
1.25 (3H, s, CH3COH); 
13C NMR (62.9 MHz, CDCl3) δ 170.3 (C), 144.9 (C), 137.1 
(C), 135.8 (C), 129.4 (2 x CH), 128.6 (2 x CH), 128.4 (2 x CH), 127.6 (2 x CH), 
127.4 (CH), 71.4 (C), 59.4 (CH), 50.1 (CH2), 43.3 (CH2), 37.9 (CH), 32.7 (CH2), 
28.5 (CH3), 21.2 (CH3), 20.9 (CH3); HRMS (EI) Exact mass calcd for C22H27NO2 
[M]+: 337.2036, found: 337.2034. 
 
 (±)-(3R,4R)-1-Benzyl-3-[1-(4-chlorophenyl)ethyl]-4-
hydroxy-4-methylpiperidin-2-one (194d). The title 
compound was prepared according to General Procedure D 
from 183 (103 mg, 0.30 mmol) for a reaction time of 24 h followed by Workup C 
and purification by column chromatography (40% EtOAc/hexane) to give a white 
solid (19 mg, 18%). Rf = 0.32 (40% EtOAc/hexane); m.p. 169-171 °C; IR (CHCl3) 
3155 (OH), 2980, 1793, 1634 (C=O), 1468, 1381, 1091, 903, 737, 650 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.42 (2H, d, J = 8.4 Hz, ArH), 7.36-7.26 (7H, m, 
ArH), 4.65 (1H, d, J = 14.5 Hz, NCH2Ar), 4.60 (1H, d, J = 14.5 Hz, NCH2Ar), 3.44-
3.34 (2H, m, CH2CH2N and CHCH3), 3.06 (1H, ddd, J = 12.5, 8.5, 6.1 Hz, 
CH2CH2N), 2.76 (1H, dd, J = 3.6, 1.5 Hz, CHC=O), 2.06 (1H, s, OH), 2.05-1.96 
(1H, m, CH2CH2N), 1.75-1.67 (1H, m, CH2CH2N), 1.36 (3H, d, J = 7.3 Hz, 
CH3CH), 1.29 (3H, s, CH3COH); 
13C NMR (62.9 MHz, CDCl3) δ 169.8 (C), 147.0 
(C), 137.0 (C), 131.7 (C), 129.3 (2 x CH), 128.6 (2 x CH), 128.5 (2 x CH), 128.3 (2 x 
CH), 127.5 (CH), 71.3 (C), 58.9 (CH), 50.1 (CH2), 43.2 (CH2), 37.4 (CH), 33.0 
(CH2), 28.8 (CH3), 20.3 (CH3); HRMS (EI) Exact mass calcd for C21H24NO2Cl [M]
+: 
357.1490, found: 357.1492. 
  
 (±)-(3R,4R)-1-Benzyl-3-(1-furan-2-ylethyl)-4-hydroxy-4-
methylpiperidin-2-one (194e). The title compound was prepared 
according to General Procedure D from 184 (59 mg, 0.20 mmol) 
for a reaction time of 18 h followed by Workup C and purification by column 
chromatography (50% EtOAc/hexane) to give a white solid (25 mg, 40%). Rf = 0.24 




















1494, 1368, 1266, 1226, 909, 736, 702 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.32-
7.27 (6H, m, ArH and CH), 6.32 (1H, dd, J = 3.2, 1.9 Hz, CH), 6.15 (1H, dt, J = 3.2, 
0.9 Hz, CH), 4.69 (1H, d, J = 14.6 Hz, NCH2Ar), 4.53 (1H, d, J = 14.6 Hz, 
NCH2Ar), 3.75 (1H, dq, J = 7.4, 2.6 Hz, CHCH3), 3.35 (1H, ddd, J = 12.6, 6.8, 5.9 
Hz, CH2CH2N), 3.05 (1H, ddd, J = 12.6, 6.9, 6.0 Hz, CH2CH2N), 2.83 (1H, app d, J 
= 2.6 Hz, CHC=O), 1.75-1.61 (3H, m, CH2CH2N and OH), 1.50 (3H, d, J = 7.4 Hz, 
CH3CH), 1.36 (3H, s, CH3COH); 
13C NMR (62.9 MHz, CDCl3) δ 169.6 (C), 159.1 
(C), 140.6 (CH), 137.1 (CH), 128.5 (2 x CH), 128.2 (2 x CH), 127.3 (CH), 110.6 
(CH), 105.1 (CH), 71.1 (C), 56.4 (CH), 50.2 (CH2), 43.0 (CH2), 34.5 (CH2), 32.0 
(CH), 29.1 (CH3), 17.7 (CH3); HRMS (ESI) Exact mass calcd for C19H24NO3 
[M+H]+: 314.1751, found: 314.1747. 
 
 (±)-(3R,4R)-1-Benzyl-4-ethyl-4-hydroxy-3-(1-
phenylethyl)piperidin-2-one (194f). The title compound was 
prepared according to General Procedure D from 188 (96 mg, 0.30 
mmol) for a reaction time of 48 h followed by Workup C and purification by column 
chromatography (30% EtOAc/hexane, then a second column using 20% 
acetone/petrol) to give a white solid (26 mg, 26%). Rf = 0.39 (40% EtOAc/hexane); 
m.p. 161-164 °C; IR (CHCl3) 3583 (OH), 2970, 2253, 1631 (C=O), 1494, 1452, 
1094, 905, 728, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.45 (2H, d, J = 7.9 Hz, 
ArH), 7.35-7.29 (7H, m, ArH), 7.20 (1H, t, J = 7.3 Hz, ArH), 4.75 (1H, d, J = 14.4 
Hz, NCH2Ar), 4.50 (1H, d, J = 14.4 Hz, NCH2Ar), 3.41-3.28 (2H, m, CH2CH2N), 
3.05-2.97 (1H, m, CHCH3), 2.89 (1H, dd, J = 5.0, 1.7 Hz, CHC=O), 2.03-1.95 (1H, 
m, CH2CH2N), 1.79-1.67 (1H, m, CH2CH2N), 1.57-1.43 (2H, m, CH3CH2COH), 
1.36 (3H, d, J = 7.3 Hz, CH3CH), 1.19 (1H, s, OH), 0.86 (3H, t, J = 7.4 Hz, 
CH3CH2COH); 
13C NMR (62.9 MHz, CDCl3) δ 170.3 (C), 148.3 (C), 137.1 (C), 
128.6 (3 x CH), 128.4 (2 x CH), 127.7 (2 x CH), 127.4 (2 x CH), 126.1 (CH), 73.1 
(C), 58.1 (CH), 50.1 (CH2), 43.1 (CH2), 38.3 (CH), 32.6 (CH2), 29.2 (CH2), 21.2 

















(194ga and 194gb).   
 
General Procedure D was followed using substrate 189 (105 mg, 0.30 mmol) for a 
reaction time of 46 h and the reaction mixture was subjected to Workup B followed 
by purification by column chromatography (40% EtOAc/hexane) to give the major 
diastereomeric product 194ga (26 mg, 34%) as a white solid, followed by the minor 
diastereomeric product 194gb (19 mg, 17%) as a white solid. 
Data for 194ga: Rf = 0.35 (40% EtOAc/hexane); m.p. 136-138 
oC; IR (CHCl3) 3583 
(OH), 2967, 2252, 1630 (C=O), 1512, 1453, 1248, 907, 732, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.37-7.28 (7H, m, ArH), 6.86 (2H, t, J = 8.8 Hz, ArH), 4.74 (1H, d, 
J = 14.4 Hz, NCH2Ar), 4.48 (1H, d, J = 14.4 Hz, NCH2Ar), 3.79 (3H, s, OCH3), 
3.37-3.27 (2H, m, CH2CH2N and CHCH3), 3.04-2.96 (1H, m, CH2CH2N), 2.84 (1H, 
dd, J = 5.1, 1.6 Hz, CHC=O), 2.01-1.93 (1H, m, CH2CH2N), 1.77-1.70 (1H, m, 
CH2CH2N), 1.56-1.43 (2H, m, CH3CH2COH), 1.34 (3H, d, J = 7.3 Hz, CH3CH), 
1.31 (1H, s, OH), 0.86 (3H, t, J = 7.4 Hz, CH3CH2COH); 
13C NMR (62.9 MHz, 
CDCl3) δ 170.5 (C), 157.9 (C), 140.2 (C), 137.1 (C), 128.7 (2 x CH), 128.6 (2 x CH), 
128.4 (2 x CH), 127.4 (CH), 114.1 (2 x CH), 73.2 (C), 58.2 (CH), 55.2 (CH3), 50.1 
(CH2), 43.1 (CH), 37.5 (CH3), 32.6 (CH2), 29.3 (CH2), 21.5 (CH2), 7.1 (CH3); HRMS 
(ES) Exact mass calcd for C23H30NO3 [M+H]
+: 368.2220, found: 368.2223. 
Data for 194gb: Rf = 0.21 (40% EtOAc/hexane); m.p. 118-120 
oC; IR (CHCl3) 3399 
(OH), 2929, 1620 (C=O), 1512, 1453, 1249, 908, 731, 649 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.32-7.13 (7H, m, ArH), 6.75 (2H, d, J = 8.7 Hz, ArH), 4.52 (1H, d, 
J = 14.6 Hz, NCH2Ar), 4.47 (1H, d, J = 14.6 Hz, NCH2Ar), 3.79 (3H, s, OCH3), 
3.65-3.62 (1H, m, CHCH3), 2.90-2.85 (2H, m, CH2CH2N), 2.74-2.73 (1H, m, 
CHC=O), 1.61 (3H, d, J = 7.4 Hz, CH3CH), 1.53-1.46 (4H, m, CH2CH2N and 
CH3CH2COH), 1.26 (1H, s, OH), 0.87 (3H, t, J = 7.4 Hz, CH3CH2COH); 
13C NMR 
(62.9 MHz, CDCl3) δ 170.1 (C), 158.1 (C), 142.3 (C), 136.9 (C), 129.9 (2 x CH), 
128.5 (2 x CH), 128.4 (2 x CH), 127.3 (CH), 113.6 (2 x CH), 72.8 (C), 57.9 (CH), 





7.1 (CH3); HRMS (ES) Exact mass calcd for C23H30NO3 [M+H]
+: 368.2220, found: 
368.2217. 
 
1-Benzyl-4-hydroxy-4-phenyl-3-(1-phenyl-ethyl)-piperidin-2-one (194ha and 
194hb).   
 
General Procedure D was followed using substrate 192 (148 mg, 0.40 mmol) for a 
reaction time of 28 h and the reaction mixture was subjected to Workup B followed 
by purification by column chromatography (20% EtOAc/hexane) to give a 8:5 
mixture of two diastereomers and then recolumned (2% Et2O/CH2Cl2) to give the 
minor diastereomeric product 194hb (28 mg, 18%) as a white solid, followed by the 
major diastereomeric product 194ha (37 mg, 24%) as an off-white solid. 
Data for 194hb: Rf = 0.29 (20% EtOAc/hexane); m.p. 166-168 °C; IR (CHCl3) 3584 
(OH), 2252, 1632 (C=O), 1494, 1450, 1352, 1092, 908, 731, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.46-7.13 (15H, m, ArH), 4.76 (1H, d, J = 14.7 Hz, NCH2Ar), 4.57 
(1H, d, J = 14.7 Hz, NCH2Ar), 3.56-3.46 (2H, m, CH2CH2N and CHCH3), 3.31 (1H, 
app d, J = 2.4 Hz, CHC=O), 2.97-2.91 (1H, m, CH2CH2N), 2.27-2.19 (1H, m, 
CH2CH2N), 2.05-1.98 (1H, m, CH2CH2N), 1.89 (1H, s, OH), 1.39 (3H, d, J = 7.4 
Hz, CH3CH); 
13C NMR (62.9 MHz, CDCl3) δ 169.8 (C), 147.5 (C), 145.6 (C), 137.0 
(C), 128.5, 128.3, 128.0, 127.5, 127.3, 126.0 and 125.0 (15 x CH), 75.9 (C), 57.9 
(CH), 50.8 (CH2), 43.7 (CH2), 37.3 (CH), 35.8 (CH2), 19.3 (CH3); HRMS (EI) Exact 
mass calcd for C26H27NO2 [M]
+: 385.2036, found: 385.2034. 
Data for 194ha: Rf = 0.28 (20% EtOAc/hexane); m.p. 182-184 °C; IR (CHCl3) 3547 
(OH), 2928, 2252, 1630 (C=O), 1493, 1452, 1350, 907, 732, 650 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.43-7.19 (15H, m, ArH), 4.73 (1H, d, J = 14.7 Hz, NCH2Ar), 4.56 
(1H, d, J = 14.7 Hz, NCH2Ar), 3.39-3.24 (3H, m, CH2CH2N, CHCH3 and CHC=O), 
2.96-2.90 (1H, m, CH2CH2N), 2.09 (1H, s, OH), 2.09-2.00 (1H, m, CH2CH2N), 
1.88-1.82 (1H, m, CH2CH2N), 1.69 (3H, d, J = 7.3 Hz, CH3CH); 
13C NMR (62.9 
MHz, CDCl3) δ 170.1 (C), 146.2 (C), 144.6 (C), 137.0 (C), 129.4 (2 x CH), 128.7 (2 





(CH), 124.6 (2 x CH), 76.1 (C), 56.9 (CH), 50.4 (CH2), 43.5 (CH2), 39.3 (CH), 36.7 





phenylbutyl]piperidin-2-one (195a). The title compound was 
prepared according to General Procedure E from 173 (61 mg, 0.20 
mmol) for a reaction time of 19 h followed by Workup B and purification by column 
chromatography (30% EtOAc/hexane) to give a white solid (41 mg, 58%). Rf = 0.18 
(30% EtOAc/hexane); m.p. 133-135 °C; IR (CHCl3) 3583 (OH), 2959, 1629 (C=O), 
1495, 1453, 1380, 1265, 1145, 1029, 910 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.46 
(2H, d, J = 8.3 Hz, ArH), 7.33-7.29 (7H, m, ArH), 7.20 (1H, t, J = 7.3 Hz, ArH), 
4.73 (1H, d, J = 14.4 Hz, NCH2Ar), 4.54 (1H, d, J = 14.4 Hz, NCH2Ar), 3.35 (1H, 
ddd, J = 12.4, 6.7, 4.0 Hz, CH2CH2N), 3.18 (1H, ddd, J = 11.7, 4.2, 4.0 Hz, 
CHCH2CH2CH3), 3.06 (1H, ddd, J = 12.4, 9.4, 6.3 Hz, CH2CH2N), 2.83 (1H, app dd, 
J = 4.2, 1.6 Hz, CHC=O), 2.06-1.87 (2H, m, CH2), 1.68 (1H, dddd, J = 12.2, 6.0, 4.0, 
1.7 Hz, CH3CH2CH2), 1.59-1.50 (1H, m, CH2), 1.44 (1H, s, OH), 1.23 (3H, s, 
CH3COH), 1.11-1.01 (2H, m, CH3CH2), 0.82 (3H, t, J = 7.3 Hz, CH3CH2); 
13C NMR 
(62.9 MHz, CDCl3) δ 170.2 (C), 146.4 (C), 137.1 (C), 128.6 (2 x CH), 128.5 (4 x 
CH), 128.5 (2 x CH), 127.4 (CH), 126.2 (CH), 71.3 (C), 59.8 (CH), 50.1 (CH2), 44.0 
(CH), 43.4 (CH2), 36.6 (CH2), 32.2 (CH2), 28.4 (CH3), 21.1 (CH2), 14.0 (CH3); 
HRMS (ES) Exact mass calcd for C23H30NO2 [M+H]
+: 352.2271, found: 352.2269. 
 
 (±)-(3R,4R)-1-Benzyl-4-hydroxy-4-methyl-3-[(R)-1-
phenylheptyl]piperidin-2-one (195b). The title compound was 
prepared according to General Procedure F from 173 (61 mg, 0.20 
mmol) for a reaction time of 14 h followed by Workup A and purification by column 
chromatography (20% EtOAc/hexane
30% EtOAc/hexane) to give an off-white 
solid (59 mg, 75%). Rf = 0.18 (30% EtOAc/hexane); m.p. 122-124 °C; IR (CHCl3) 
3583 (OH), 2928, 1632 (C=O), 1495, 1453, 1380, 908, 733, 651 cm-1; 1H NMR (360 
MHz, CDCl3) δ 7.45 (2H, dd, J = 7.9, 1.2 Hz, ArH), 7.33-7.28 (7H, m, ArH), 7.20 





















Hz, NCH2Ar), 3.35 (1H, ddd, J = 12.4, 6.7, 4.1 Hz, CH2CH2N), 3.16 (1H, ddd, J = 
11.7, 4.3, 4.1 Hz, CHCH2), 3.06 (1H, ddd, J = 12.4, 9.4, 6.3 Hz, CH2CH2N), 2.83  
(1H, app dd, J = 4.3, 1.8 Hz, CHC=O), 2.06-1.87 (2H, m, CH2), 1.68 (1H, dddd, J = 
13.2, 6.1, 4.1, 1.8 Hz, CHCH2CH2), 1.63-1.53 (1H, m, CH2), 1.35 (1H, s, OH), 1.27-
1.14 (6H, m, CH3CH2CH2CH2CH2), 1.23 (3H, s, CH3COH), 1.06-0.98 (2H, m, 
CH3CH2), 0.84 (3H, t, J = 7.0 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.2 
(C), 146.4 (C), 137.1 (C), 128.7 (2 x CH), 128.5 (4 x CH), 128.5 (2 x CH), 127.4 
(CH), 126.2 (CH), 71.3 (C), 59.8 (CH), 50.1 (CH2), 44.2 (CH), 43.4 (CH2), 34.3 
(CH2), 32.3 (CH2), 31.7 (CH2), 29.3 (CH2), 28.4 (CH3), 27.9 (CH2), 22.6 (CH2), 14.0 
(CH3); HRMS (ES) Exact mass calcd for C26H36NO2 [M+H]





The title compound was prepared according to General 
Procedure E from 181 (67 mg, 0.20 mmol) for a reaction time of 19 h followed by 
Workup B and purification by column chromatography (40% EtOAc/hexane) to give 
a white solid (47 mg, 62%). Rf = 0.28 (40% EtOAc/hexane); m.p. 138-140 °C; IR 
(CHCl3) 3483 (OH), 2959, 1633 (C=O), 1511, 1454, 1380, 1247, 1178, 1045, 909 
cm-1; 1H NMR (360 MHz, CDCl3) δ 7.37-7.28 (7H, m, ArH), 6.85 (2H, d, J = 8.6 
Hz, ArH), 4.72 (1H, d, J = 14.4 Hz, NCH2Ar), 4.52 (1H, d, J = 14.4 Hz, NCH2Ar), 
3.79 (3H, s, OCH3), 3.34 (1H, ddd, J = 12.2, 6.6, 4.1 Hz, CH2CH2N), 3.15 (1H, ddd, 
J = 11.6, 4.2, 4.0 Hz, CHCH2CH2CH3), 3.05 (1H, ddd, J = 12.2, 9.3, 6.4 Hz, 
CH2CH2N), 2.79 (1H, app dd, J = 4.2, 1.5 Hz, CHC=O), 2.05-1.83 (2H, m, CH2), 
1.70-1.64 (1H, m, CH2), 1.59-1.48 (2H, m, CH2 and OH), 1.22 (3H, s, CH3COH), 
1.06 (2H, app sextet, app J = 7.5 Hz, CH2CH2CH3), 0.82 (3H, t, J = 7.2 Hz, 
CH3CH2); 
13C NMR (62.9 MHz, CDCl3) δ 170.4 (C), 158.0 (C), 138.0 (C), 137.1 
(C), 129.6 (2 x CH), 128.5 (2 x CH), 128.4 (2 x CH), 127.4 (CH), 113.9 (2 x CH), 
71.3 (C), 59.8 (CH), 55.2 (CH3), 50.1 (CH2), 43.4 (CH2), 43.2 (CH), 36.8 (CH2), 32.4 
(CH2), 28.4 (CH3), 21.0 (CH2), 14.0 (CH3); HRMS (ES) Exact mass calcd for 
C24H32NO3 [M+H]
















The title compound was prepared according to a slight 
modification of General Procedure F (an extra 1 equiv of Hex3Al added after 18 h) 
from 181 (67 mg, 0.20 mmol) for a reaction time of 22 h followed by Workup A and 
purification by column chromatography (40% EtOAc/hexane) to give a white solid 
(51 mg, 61%). Rf = 0.12 (30% EtOAc/hexane); m.p. 110-112 °C; IR (CHCl3) 3210 
(OH), 2929, 1631 (C=O), 1510, 1265, 910, 733, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.36-7.28 (7H, m, ArH), 6.86 (2H, d, J = 8.7 Hz, ArH), 4.76 (1H, d, J = 
14.4 Hz, NCH2Ar), 4.49 (1H, d, J = 14.4 Hz, NCH2Ar), 3.80 (3H, s, OCH3), 3.34 
(1H, ddd, J = 12.3, 6.8, 4.2 Hz, CH2CH2N), 3.15-3.01 (2H, m, CH2CH2N and 
CHCH2CH2), 2.79 (1H, app dd, J = 4.7, 1.5 Hz, CHC=O), 2.00 (1H, ddd, J = 13.4, 
9.1, 6.8 Hz, CH2CH2N), 1.94-1.83 (1H, m, CH2), 1.71-1.53 (2H, m, CH2), 1.34 (1H, 
s, OH), 1.27-1.13 (6H, m, CH3CH2CH2CH2CH2), 1.23 (3H, s, CH3COH), 1.07-0.99 
(2H, m, CH2CH3), 0.84 (3H, t, J = 7.0 Hz, CH3CH2); 
13C NMR (62.9 MHz, CDCl3) 
δ 170.4 (C), 158.0 (C), 137.9 (C), 137.1 (C), 129.6 (2 x CH), 128.6 (2 x CH), 128.5 
(2 x CH), 127.4 (CH), 114.0 (2 x CH), 71.4 (C), 59.9 (CH), 55.2 (CH3), 50.1 (CH2), 
43.5 (CH), 43.4 (CH2), 34.6 (CH2), 32.5 (CH2), 31.8 (CH2), 29.3 (CH2), 28.5 (CH3), 
27.9 (CH2), 22.6 (CH2), 14.0 (CH3); HRMS (ES) Exact mass calcd for C27H38NO3 
[M+H]+: 424.2846, found: 424.2848. 





Saturated aqueous Na2CO3 solution (40 mL) and cinnamoyl chloride (3.14 g, 18.9 
mmol) were added to a solution of 1-benzylaminopropan-2-ol (2.57 g, 15.6 mmol) in 
CH2Cl2 (50 mL). The mixture was stirred at room temperature for 16 h and then 
partitioned between saturated aqueous NaHCO3 solution and CH2Cl2. The aqueous 
layer was separated and extracted with CH2Cl2 (x 3), and the combined organic 













vacuo. Purification of the residue by column chromatography (50-60% 
EtOAc/petrol) gave N-Benzyl-N-(2-hydroxypropyl)-3-phenylacrylamide (196a) as a 
colourless oil (3.54 g, 77%) as a 2:1 mixture of rotamers. Rf = 0.12 (40% 
EtOAc/petrol); IR (CHCl3) 3376, 2973, 2252, 1797 (C=O), 1646 (C=C), 1596, 1472, 
1212, 907, 732 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.80 (1H, d, J = 
15.3 Hz, PhCH=), 7.52-7.23 (10H, m, ArH), 6.82 (1H, d, J = 15.3 Hz, PhCH=CH), 
4.99-4.63 (2H, m, CH2Ph), 4.19 (1H, s, OH), 4.16-4.07 (1H, m, CHOH), 3.71 (1H, 
dd, J = 8.4, 14.2 Hz, CHOHCH2N), 3.31 (1H, dd, J = 2.3, 14.2 Hz, CHOHCH2N), 
1.20 (3H, d, J = 6.3 Hz, CH3CHOH); (Minor rotamer) δ 7.76 (1H, d, J = 15.3 Hz, 
PhCH=), 7.52-7.23 (10H, m, ArH), 7.10 (1H, d, J = 15.3 Hz, PhCH=CH), 4.99-4.63 
(2H, m, CH2Ph), 4.19 (1H, s, OH), 4.16-4.07 (1H, m, CHOH), 3.48 (1H, dd, J = 8.9, 
15.2 Hz, CHOHCH2N), 3.30-3.24 (1H, m, CHOHCH2N), 1.20 (3H, d, J = 6.3 Hz, 
CH3CHOH); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully 
assigned) δ 169.3 (C), 144.2 (CH), 136.5 (C), 134.9 (C), 129.8 (CH), 129.0 (CH), 
128.7 (2 x CH), 128.6 (2 x CH), 127.9 (2 x CH), 127.8 (2 x CH), 116.8 (CH), 67.6 
(CH), 55.6 (CH2), 53.0 (CH2), 21.5 (CH3); HRMS (EI) Exact mass calcd for 
C19H21NO2 [M]
+: 295.1567, found: 295.1566. 
 
A solution of oxalyl chloride (0.86 g, 6.77 mmol) in CH2Cl2 (15 mL) was cooled to 
−78 oC and stirred for 5 min.  DMSO (1.06 g, 13.56 mmol) was added slowly as a 
solution in CH2Cl2 (3 mL).  After 15 min N-benzyl-N-(2-hydroxypropyl)-3-
phenylacrylamide (196a) (1.00 g, 3.39 mmol) was added as a solution in CH2Cl2 (7 
mL) and the reaction mixture was stirred for a further 15 min before adding Et3N 
(1.37 g, 13.56 mmol).  After 5 min the reaction mixture was warmed to rt and water 
(20 mL) was added.  After 1 h the organic layer was separated and the aqueous layer 
was extracted with CH2Cl2 (2 x 30 mL).  The combined organic layers were dried 
(MgSO4) and the filtrate was concentrated in vacuo.  Purification of the crude residue 
by silica column chromatography (45% EtOAc/petrol) gave the title compound as a 
colourless oil (1.63 mmol, 48%). as a 5:1 mixture of rotamers. Rf = 0.15 (40% 
EtOAc/petrol); IR (CHCl3) 3031, 2252, 1732 (C=O), 1650 (C=C), 1606, 1434, 1204, 
907, 731, 650 cm-1; 1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.78 (1H, d, J = 





4.76 (2H, s, CH2Ph), 4.22 (2H, s, O=CCH2N), 2.17 (3H, s, CH3C=O); (Minor 
rotamer) δ 7.78 (1H, d, J = 15.4 Hz, PhCH=), 7.49-7.24 (7H, m, ArH), 6.57 (1H, d, J 
= 15.4 Hz, PhCH=CH), 4.76 (2H, s, CH2Ph), 4.15 (2H, s, O=CCH2N), 2.10 (3H, s, 
CH3C=O); 
13C NMR (62.9 MHz, CDCl3) (Mixture of rotamers – not fully assigned) 
δ 203.1 (C), 167.2 (C), 144.0 (CH), 136.3 (C), 134.9 (C), 129.7 (2 x CH), 128.9 (2 x 
CH), 128.7 (2 x CH), 127.8 (2 x CH), 126.7 (2 x CH), 116.4 (CH), 55.7 (CH2), 52.3 




3-Benzyl-(E)-(3-phenylacryloyl)aminopropionic acid methyl ester (200). 
 
Methyl acrylate (991 L, 11 mmol) was added to a stirred solution of benzylamine 
(1.09 mL, 10 mmol) in MeOH (8 mL).  The reaction mixture was stirred at room 
temperature for 46 h then concentrated in vacuo to afford 199a as a yellow oil (1.60 
g), which was used directly in the next step. 
Cinnamoyl chloride (2.01 g, 12.1 mmol) was added to a mixture of the amine 199a 
(10 mmol) in CH2Cl2 (25 mL) and saturated aqueous Na2CO3 solution (25 mL) at 
room temperature. After 24 h the reaction was partitioned between saturated aqueous 
NaHCO3 solution and CH2Cl2. The aqueous layer was separated and extracted with 
CH2Cl2 (x 3), and the combined organic layers were dried (MgSO4) and concentrated 
in vacuo to afford a yellow residue. Purification by silica column chromatography 
(30% EtOAc/hexane) gave the title compound as a white solid (2.71 g, 84%) as a 3:2 
mixture of rotamers. Rf = 0.31 (30% EtOAc/petrol); m.p. 58-60 °C; IR (CHCl3) 
3439, 2953, 1734 (C=O), 1647 (C=C), 1604, 1438, 1203, 908, 732, 650 cm-1; 
1H NMR (360 MHz, CDCl3) (Major rotamer) δ 7.85-7.75 (1H, m, PhCH=), 7.58-
7.23 (10H, m, ArH), 6.83 (1H, d, J = 15.4 Hz, PhCH=CH), 4.78 (2H, s, CH2Ph), 
3.75 (2H, t, J = 7.0 Hz, CH2CH2N), 3.66 (3H, s, OCH3), 2.73 (2H, t, J = 6.8 Hz, 
CH2CH2N; (Minor rotamer) δ 7.85-7.75 (1H, m, PhCH=), 7.58-7.23 (10H, m, ArH), 
7.00 (1H, d, J = 15.3 Hz, PhCH=CH), 4.75 (2H, s, CH2Ph), 3.75 (2H, t, J = 7.0 Hz, 
CH2CH2N), 3.66 (3H, s, OCH3), 2.62 (2H, t, J = 6.7 Hz, CH2CH2N); 





MHz, CDCl3) (Mixture of rotamers – not fully assigned) δ 172.5 (C), 167.1 (C), 
166.6 (C), 143.8 (CH), 143.3 (CH), 137.3 (C), 137.0 (C), 135.0 (C), 129.6 (CH), 
128.9 (CH), 128.7 (CH), 128.0 (CH), 127.8 (CH), 127.6 (CH), 127.4 (CH), 126.4 
(CH), 117.1 (CH), 116.7 (CH), 52.2 (CH2), 51.6 (CH3), 49.1 (CH2), 43.4 (CH2), 42.8 
(CH2), 33.9 (CH2), 32.6 (CH2); HRMS (ES) Exact mass calcd for C20H22NO3 






A solution of 2-bromophenylacetone (1.06 g, 5.0 mmol), N,N-dimethylacrylamide 
(743 mg, 7.5 mmol), Pd(OAc)2 (56 mg, 0.25 mmol) and tri-o-tolylphosphine (122 
mg, 0.40 mmol) in Et3N (3.5 mL) was stirred under reflux at 80 
oC for 23 h.  The 
reaction residue was partitioned between CH2Cl2 and 10 % HCl solution and the 
aqueous layer was separated and extracted with CH2Cl2 (x 2).  The combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification by silica column 
chromatography (10% acetone/CH2Cl2
20% acetone/CH2Cl2) gave the title 
compound as a pale yellow solid (995 mg, 86%). Rf = 0.20 (10% acetone/CH2Cl2); 
m.p. 78-80 °C; IR (CHCl3) 3430, 2932, 1720 (C=O), 1647 (C=C), 1606, 1493, 1398, 
1145, 761, 725 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.75 (1H, d, J = 15.2 Hz, 
ArCH=), 7.61-7.58 (1H, m, ArH), 7.29-7.25 (2H, m, ArH), 7.15-7.13 (1H, m, ArH), 
6.82 (1H, d, J = 15.2 Hz, ArCH=CH), 3.86 (2H, s, CH2), 3.09 (3H, s, N(CH3)2), 3.01 
(3H, s, N(CH3)2), 2.17 (3H, s, COCH3); 
13C NMR (62.9 MHz, CDCl3) δ 204.6 (C), 
165.6 (C), 138.5 (CH), 134.3 (C), 133.2 (C), 130.5 (CH), 128.8 (CH), 126.9 (CH), 
126.1 (CH), 119.3 (CH), 47.3 (CH2), 36.6 (CH3), 35.1 (CH3), 29.1 (CH3); HRMS 
(EI) Exact mass calcd for C14H17NO2 [M]












The title compound was prepared according to General Procedure D from 205 (54 
mg, 0.20 mmol) for a reaction time of 17 h followed by Workup C. Purification by 
column chromatography (10% EtOAc/hexane
20% EtOAc/hexane) gave the title 
compound as a white solid (44 mg, 77%). Rf = 0.26 (20% EtOAc/hexane); m.p. 125-
127 °C; IR (CHCl3) 3473 (OH), 2956, 1734, 1655 (C=O), 1448, 1354, 1227, 1059, 
891, 690 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.94 (2H, d, J = 8.0 Hz, ArH), 7.65 
(1H, t, J = 7.4 Hz, ArH), 7.52 (2H, t, J = 7.9 Hz, ArH), 5.06 (1H, s, OH), 3.05 (1H, 
d, J = 11.1 Hz, CHC=OPh), 2.56 (1H, ddd, J = 19.6, 10.6, 1.5 Hz, CH2C=O), 2.26 
(1H, app dd, J = 19.6, 10.0 Hz, CH2C=O), 2.19-1.98 (3H, m, CH2CH2C=O and 
CHCH3), 1.63-1.50 (3H, m, CH2CH2CHCH3), 1.10-0.98 (1H, m, CH2CH2CHCH3), 
1.06 (3H, s, CCH3), 0.71 (3H, d, J = 6.6 Hz, CHCH3); 
13C NMR (62.9 MHz, CDCl3) 
δ 218.0 (C), 207.8 (C), 138.7 (C), 134.3 (CH), 129.1 (2 x CH), 128.1 (2 x CH), 78.3 
(C), 53.5 (C), 53.2 (CH), 34.6 (CH2), 32.0 (CH), 31.6 (CH2), 31.4 (CH2), 28.0 (CH2), 
20.5 (CH3), 19.4 (CH3); HRMS (ES) Exact mass calcd for C18H23O3 [M+H]
+: 








































Ynamides 394b, 394c, 394g, and 395c were prepared by Benoit Gourdet as described 
previously.160 
 
3-(4-Phenylbut-1-ynyl)oxazolidin-2-one (394a)  
 
Following a slight modification of the procedure of Hsung and co-workers,162a a 
mixture of 1-bromo-4-phenyl-1-butyne (1.93 g, 9.24 mmol), 2-oxazolidinone (731 
mg, 8.40 mmol), K3PO4 (3.57 g, 16.8 mmol), CuSO4·5H2O (210 mg, 0.84 mmol), 
and 1,10-phenanthroline (303 mg, 1.68 mmol) in toluene (20 mL) was heated at 70 
°C for 40 h. After cooling to room temperature, the mixture was filtered through a 
short pad of silica gel using CH2Cl2 (40 mL) as the eluent, and the filtrate was 
concentrated in vacuo. Purification of the residue by column chromatography (20% 
EtOAc/hexane
30%EtOAc/hexane) gave the ynamide 394a (1.11 g, 62%) as a pale 
yellow solid that displayed identical spectroscopic data to those reported 
previously.160 Rf = 0.46 (50% EtOAc/hexane); IR (CHCl3) 2956, 2929, 2304 (CC), 
1773 (C=O), 1653, 1481, 1419, 1265, 1115, 1040, 738 cm-1; 1H NMR (360 MHz, 
CDCl3) 	 7.33-7.29 (2H, m, ArH), 7.24-7.20 (3H, m, ArH), 4.42-4.38 (2H, m, 
CH2O), 3.85-3.81 (2H, m, CH2N), 2.86 (2H, t, J = 7.6 Hz, CCH2), 2.61 (2H, t, J = 
7.6 Hz, CH2Ph); 





CH), 128.3 (2 x CH), 126.2 (C), 70.7 (C), 70.3 (C), 62.8 (CH2), 46.8 (CH2), 35.1 
(CH2), 20.6 (CH2). 
 
3-[3-(tert-Butyldimethylsilyloxy)prop-1-ynyl]oxazolidin-2-one (394d)  
 
Following a slight modification of the procedure of Hsung and co-workers,162a a 
mixture of 1-bromo-3-tert-butyldimethylsilyloxyprop-1-yne (4.51 g, 18.1 mmol), 2-
oxazolidinone (1.44 g, 16.5 mmol), K2CO3 (4.56 g, 33.0 mmol), CuSO4·5H2O (412 
mg, 1.65 mmol), 1,10-phenanthroline (595 mg, 3.30 mmol) in toluene (30 mL) was 
heated at 70 °C for 40 h. After cooling to room temperature, the mixture was filtered 
through a short pad of silica gel using CH2Cl2 (100 mL) as the eluent, and the filtrate 
was concentrated in vacuo. Purification of the residue by column chromatography 
(30% EtOAc/hexane) gave the ynamide 394d (2.78 g, 66%) as a white solid that 
displayed spectroscopic data consistent with those observed previously.162c Rf = 0.20 
(30% EtOAc/hexane); m.p. 68-70 °C; IR (CHCl3) 2930, 2858, 2253 (CC), 1773 
(C=O), 1480, 1422, 1209, 1114, 907, 837 cm-1; 1H NMR (360 MHz, CDCl3) δ 4.46 
(2H, s, CH2OSi), 4.46-4.41 (2H, m, CH2O), 3.93-3.89 (2H, m, CH2N), 0.91 (9H, s, 
C(CH3)3), 0.12 (6H, s, Si(CH3)2; 
13C NMR (62.9 MHz, CDCl3) δ 156.0 (C), 74.7 
(C), 70.3 (C), 62.9 (CH2), 51.6 (CH2), 46.6 (CH2), 25.8 (3 x CH3), 18.2 (C), -5.1 (2 x 
CH3); HRMS (ES) Exact mass calcd for C12H22NO3Si [M+H





Following the procedure of Hsung and co-workers,162a a mixture of 1-bromo-4-tert-
butyldimethylsilyloxy-1-butyne (3.93 g, 14.9 mmol), 2-oxazolidinone (1.18 g, 13.5 
mmol), K3PO4 (5.73 g, 27.0 mmol), CuSO4·5H2O (337 mg, 1.35 mmol), and 1,10-





h. After cooling to room temperature, the mixture was filtered through a short pad of 
silica gel using CH2Cl2 (40 mL) as the eluent, and the filtrate was concentrated in 
vacuo. Purification of the residue by column chromatography (25% EtOAc/hexane) 
gave the ynamide 394e (1.10 g, 31%) as a colourless oil which displayed 
spectroscopic data consistent with those observed previously.160 Rf = 0.21 (25% 
EtOAc/hexane); IR (film) 2955, 2929, 2253 (CC), 1772 (C=O), 1480, 1419, 1256, 
1112, 1040, 733 cm-1; 1H NMR (250 MHz, CDCl3) 	 4.46-4.39 (2H, m, 
NCH2CH2O), 3.91-3.85 (2H, m, CH2N), 3.74 (2H, t, J = 7.1 Hz, CH2OSi), 2.53 (2H, 
t, J = 7.1 Hz, CCH2), 0.90 (9H, s, SiC(CH3)3), 0.08 (6H, s, Si(CH3)2); 
13C NMR 
(62.9 MHz, CDCl3) δ 156.4 (C), 70.9 (C), 68.0 (C), 62.8 (CH2), 61.8 (CH2), 46.8 
(CH2), 25.7 (3 x CH3), 22.6 (CH2), 18.2 (C), –5.4 (2 x CH3). 
 






CuSO4·5H2O (10 mol %)
NN
(20 mol %)






Following a slight modification of the procedure of Hsung and co-workers,162a a 
mixture of 1-bromo-5-tert-butyldimethylsilyloxypent-1-yne (4.66 g, 16.8 mmol), 2-
oxazolidinone (1.33 g, 15.3 mmol), K3PO4 (6.50 g, 30.6 mmol), CuSO4·5H2O (382 
mg, 1.53 mmol), 1,10-phenanthroline (551 mg, 3.06 mmol) in toluene (30 mL) was 
heated at 65 °C for 40 h. After cooling to room temperature, the mixture was filtered 
through a short pad of silica gel using CH2Cl2 (100 mL) as the eluent, and the filtrate 
was concentrated in vacuo. Purification of the residue by column chromatography 
(25% EtOAc/hexane) gave the ynamide 394f (945 mg, 22%) as a pale yellow oil that 
displayed spectroscopic data consistent with those observed previously.162c Rf = 0.17 
(20% EtOAc/hexane); IR (film) 2956, 2929, 2857, 2258 (CC), 1770 (C=O), 1481, 
1418, 1213, 1114, 911, 733 cm-1; 1H NMR (360 MHz, CDCl3) δ 4.41 (2H, dd, J = 
8.7, 7.3 Hz, CH2O), 3.91-3.81 (2H, m, CH2N), 3.69 (2H, t, J = 6.0 Hz, 
CH2CH2OSi), 2.44-2.36 (2H, m, CH2CH2CH2OSi), 1.79-1.67 (2H, m, 
CH2CH2CH2OSi), 0.90 (9H, s, C(CH3)3), 0.06 (6H, s, Si(CH3)2); 
13C NMR 





(CH2), 31.7 (CH2), 25.9 (3 x CH3), 18.3 (C), 14.8 (CH2), -5.4 (2 x CH3); HRMS (ES) 
Exact mass calcd for C14H26NO3Si [M+H




Following the procedure of Hsung and co-workers,162a a mixture of 1-bromo-2-
phenylacetylene (7.97 g, 44.0 mmol), 2-pyrrolidinone (3.40 g, 40.0 mmol), K2CO3 
(11.1 g, 80.0 mmol), CuSO4·5H2O (998 mg, 4.00 mmol), and 1,10-phenanthroline 
(1.44 g, 8.00 mmol) in toluene (100 mL) was heated at 65 °C for 40 h. After cooling 
to room temperature, the mixture was filtered through a short pad of silica gel using 
CH2Cl2 (20 mL) as the eluent, and the filtrate was concentrated in vacuo. Purification 
of the residue by column chromatography (25% EtOAc/hexane) gave the ynamide 
394h (1.93 g, 35%) as a red oil that displayed identical spectroscopic data to those 
reported previously.160 Rf = 0.12 (25% EtOAc/hexane); IR (film) 2955, 2924, 2259 
(CC), 1759 (C=O), 1481, 1417, 1256, 1233, 1051, 729 cm-1; 
1H NMR (360 MHz, 
CDCl3) 	 7.46-7.44 (2H, m, ArH), 7.31-7.27 (3H, m, ArH), 3.78 (2H, dd, J = 7.4 Hz, 
6.9 Hz, CH2N), 2.49 (2H, t, J = 8.0 Hz, CH2C(O)), 2.18 (2H, quint, J = 7.5 Hz, 
CH2CH2CH2); 
13C NMR (62.9 MHz, CDCl3) δ 175.7 (C), 131.5 (2 x CH),  128.2 (2 








To a solution of 2-imidazolidinone (6.02 g, 70 mmol) in 1,4-dioxane (80 mL) was 
added NaH (3.32 g, 82.6 mmol, 60 wt% in paraffin) under an atmosphere of nitrogen 
with vigorous stirring. The solution was heated to 65 °C and stirred at this 
temperature for 2 h and then cooled to 0 °C. CH3I was added slowly via syringe 





through a celite plug and the filtrate was concentrated in vacuo. Purification by silica 
column chromatography (10% MeOH/CH2Cl2) gave the title compound as a white 
solid (1.94 g, 28%) which displayed identical spectroscopic data to those described 
previously.182 Rf = 0.44 (10% MeOH/CH2Cl2); mp = 108-110 °C; 
1H NMR (360 
MHz, CDCl3) 	 4.73 (1H, br s, NH), 3.41 (4H, s, CH2), 2.79 (3H, s, CH3N); 
13C 




Following a slight modification of the procedure of Stahl and co-workers,162c in a 
three-neck flask, CuCl2·2H2O (409 mg, 2.16 mmol), Na2CO3 (2.33 g, 22.0 mmol) 
and 1-methylimidazolidin-2-one (5.40 g, 54.0 mmol) were combined. The reaction 
flask was purged with O2 for 15 min. A solution of pyridine (1.74 g, 22.0 mmol) in 
toluene (100 mL) was then added. A balloon filled with O2 was connected to the 
flask, and the mixture was heated to 70 °C. A solution of phenylacetylene (1.11 g, 
10.8 mmol) in toluene (20 mL) was added to the mixture over 7 h via syringe pump. 
The mixture was stirred at 70 °C for 16 h, cooled to room temperature and then 
filtered through a short pad of silica gel using CH2Cl2 (40 mL) as eluent. The filtrate 
was concentrated in vacuo and purification by column chromatography (50% 
EtOAc/hexane
70%EtOAc/hexane) gave the ynamide 394i (1.24 g, 57%) as a 
colourless solid that displayed identical spectroscopic data to those reported 
previously.162c Rf = 0.25 (50% EtOAc/hexane); mp = 86-88 °C; IR (CHCl3) 2929, 
2277 (CC), 1765 (C=O), 1481, 1433, 1256, 1202, 1122, 1040, 731 cm-1;
 1H NMR 
(360 MHz, CDCl3) 	 7.45-7.42 (2H, m, ArH), 7.29-7.25 (3H, m, ArH), 3.82-3.78 
(2H, m, CH2N), 3.49-3.45 (2H, m, CH2N), 2.88 (3H, s, CH3N); 
13C NMR (62.9 
MHz, CDCl3) δ 157.5 (C), 131.2 (2 x CH), 128.1 (2 x CH), 127.3 (CH), 123.4 (C), 








Benzyloct-1-ynylcarbamic acid benzyl ester (395a) 
 
Following a slight modification of the procedure of Hsung and co-workers,162a a 
mixture of 1-bromooct-1-yne (3.17 g, 16.8 mmol), benzylcarbamic acid benzyl 
ester183 (3.69 g, 15.3 mmol), K3PO4 (6.50 g, 30.6 mmol), CuSO4·5H2O (382 mg, 1.53 
mmol), 1,10-phenanthroline (551 mg, 3.06 mmol) in toluene (30 mL) was heated at 
80 °C for 40 h. After cooling to room temperature, the mixture was filtered through a 
short pad of silica gel using CH2Cl2 (100 mL) as the eluent, and the filtrate was 
concentrated in vacuo. Purification of the residue by column chromatography (10% 
EtOAc/hexane) gave the ynamide 395a (2.07 g, 39%) as a yellow oil. Rf = 0.28 (20% 
EtOAc/hexane); IR (film) 3054, 2986, 1719 (C=O), 1496, 1421, 1265, 1126, 896, 
740, 705 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.38-7.31 (10H, m, ArH), 5.23 (2H, s, 
OCH2Ph), 4.62 (2H, s, NCH2Ph), 2.25 (2H, t, J = 6.9 Hz, CH2), 1.49-1.41 (2H, m, 
CH2CH2), 1.36-1.22 (6H, m, CH2CH2CH2CH3), 0.88 (3H, t, J = 6.9 Hz, CH3); 
13C 
NMR (90.6 MHz, CDCl3) δ 155.6 (C), 136.2 (C), 128.4 (4 x CH), 128.3 (CH), 128.1 
(2 x CH), 127.9 (C), 127.8 (2 x CH), 127.7 (CH), 77.2 (C), 70.6 (C), 68.2 (CH2), 
53.8 (CH2), 31.3 (CH2), 28.8 (CH2), 28.3 (CH2), 22.5 (CH2),  18.3 (CH2),  14.0 
(CH3); HRMS (ES) Exact mass calcd for C23H31N2O2 [M+NH4]
+: 367.2380, found: 
367.2376. 
 
Phenyl(phenylethynyl)carbamic acid tert-butyl ester 
 
 
Following the procedure of Hsung and co-workers,162a a mixture of 1-bromo-2-
phenylacetylene (3.14 g, 17.3 mmol), N-Boc-aniline (3.04 g, 15.7 mmol), K3PO4 
(6.67 g, 31.4 mmol), CuSO4·5H2O (392 mg, 1.57 mmol), and 1,10-phenanthroline 
(566 mg, 3.14 mmol) in toluene (30 mL) was heated at 65 °C for 44 h. After cooling 





CH2Cl2 (40 mL) as the eluent, and the filtrate was concentrated in vacuo. Purification 
of the residue by column chromatography (1% EtOAc/hexane) gave the ynamide 
395b (1.17 g, 25%) as a yellow solid that displayed identical spectroscopic data to 
those reported previously.160 Rf = 0.61 (20% EtOAc/hexane); mp = 62-64 °C; IR 




 1H NMR (360 MHz, CDCl3) 	 7.61-7.59 (1H, m, ArH), 7.57-7.55 (1H, m, ArH), 
7.48-7.41 (5H, m, ArH), 7.38-7.29 (4H, m, ArH), 1.62 (9H, s, O(CH3)3); 
13C NMR 
(62.9 MHz, CDCl3) δ 152.9 (C), 139.6 (C), 130.8 (2 x CH), 128.8 (2 x CH), 128.2 (2 
x CH), 127.3 (CH), 126.6 (CH), 124.6 (CH), 123.3 (C), 83.6 (C), 83.5 (C), 70.1 (C), 
28.0 (3 x CH3).  
 




General Procedure G  
To a solution of the appropriate ynamide (1.0 equiv) and Rh(cod)(acac) (0.05 equiv) 
in THF (10 mL/mmol of ynamide) at 0 °C was added the appropriate organozinc 
halide (2 equiv) over 1 min, and the reaction was then stirred at room temperature 
until complete consumption of starting material was observed by TLC analysis.  
 
Workup D 
The reaction mixture was filtered through a short pad of silica gel using CH2Cl2 as 
eluent, and the filtrate was concentrated in vacuo.  
 
Workup E 
The reaction was quenched with saturated NH4Cl solution (10 mL) and the mixture 
was stirred vigorously for 15 min. The aqueous layer was separated and extracted 
with EtOAc (3 x 10 mL) and the combined organic layers were dried (MgSO4), and 







phenylpropyl}benzoic acid ethyl ester (396a). The title 
compound was prepared according to General Procedure G 
using ynamide 394a (43 mg, 0.20 mmol) and 3-(ethoxycarbonyl)phenylzinc iodide 
(0.5 M in THF, 0.80 mL, 0.40 mmol) for a reaction time of 1.5 h. Workup D and 
purification by column chromatography (30% EtOAc/hexane) gave the enamide 
396a as a yellow oil (55 mg, 75%). Rf = 0.18 (30% EtOAc/hexane); IR (film) 2985, 
1755 (C=O), 1714 (C=O), 1479, 1404, 1265, 1088, 1043, 908, 735 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 8.09 (1H, t, J = 1.6 Hz, ArH), 7.99 (1H, dt, J = 7.8, 1.4 Hz, 
ArH), 7.59 (1H, ddd, J = 7.8, 1.8, 1.2 Hz, ArH), 7.45 (1H, t, J = 7.8 Hz, ArH), 7.30-
7.26 (2H, m, ArH), 7.22-7.18 (1H, m, ArH), 7.15-7.12 (2H, m, ArH), 6.44 (1H, s, 
=CH), 4.42 (2H, q, J = 7.1 Hz, OCH2CH3), 4.33 (2H, app dd, J = 8.7, 7.2 Hz, 
OCH2CH2N), 3.66-3.58 (2H, m, CH2N), 2.92 (2H, t, J = 7.6 Hz) and 2.68 (2H, t, J = 
7.6 Hz, CH2CH2Ph), 1.43 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (62.9 MHz, 
CDCl3) δ 166.5 (C), 157.0 (C), 141.2 (C), 140.5 (C), 131.2 (CH), 130.8 (C), 130.0 
(C), 128.6 (CH), 128.5 (3 x CH), 128.4 (2 x CH), 127.9 (CH), 126.2 (CH), 123.4 
(CH), 62.3 (CH2), 61.1 (CH2), 45.9 (CH2), 34.3 (CH2), 31.5 (CH2), 14.3 (CH3); 
HRMS (ES) Exact mass calcd for C22H27N2O4 [M+NH4]




acid ethyl ester (396b). The title compound was prepared 
according to General Procedure G from ynamide 394b (94 
mg, 0.50 mmol) and 3-(ethoxycarbonyl)phenylzinc iodide (0.5 M in THF, 2.00 mL, 
1.00 mmol) for a reaction time of 5 h. Workup E and purification by column 
chromatography (15% EtOAc/hexane
30% EtOAc/hexane) gave the enamide 396b 
as a pale yellow solid (98 mg, 58%). Slow diffusion of petrol into a solution of 396b 
in CH2Cl2 gave colourless crystals that were suitable for X-ray crystallography. Rf = 
0.52 (50% EtOAc/hexane); m.p. 116-118 °C; IR (CHCl3) 3055, 2986, 1758 (C=O), 
1714 (C=O), 1614, 1402, 1413, 1266, 1216, 739, 705 cm-1; 1H NMR (360 MHz, 













(2H, q, J = 7.1 Hz, OCH2CH3), 4.27-4.16 (2H, m, OCH2CH2N), 3.22-3.10 (2H, m, 
CH2N), 1.38 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (90.6 MHz, CDCl3) δ 166.5 
(C), 157.2 (C), 141.3 (C), 137.5 (C), 131.6 (CH), 130.8 (2 x CH), 130.6 (C), 128.4 (2 
x CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 127.9 (CH), 125.3 (C), 123.3 (CH), 
62.7 (CH2), 61.0 (CH2), 44.8 (CH2), 14.3 (CH3); HRMS (ES) Exact mass calcd for 
C20H20NO4 [M+H]
+: 338.1387, found: 338.1390. 
 
3-{3-(tert-Butyldimethylsilyloxy)-1-[1-(2-oxooxazolidin-3-
yl)meth-(E)-ylidene]propyl}benzoic acid ethyl ester 
(396c). The title compound was prepared according to 
General Procedure G using ynamide 394e (54 mg, 0.20 mmol) and 3-
(ethoxycarbonyl)phenylzinc iodide (0.5 M in THF, 0.80 mL, 0.40 mmol) for a 
reaction time of 2.5 h. Workup D and purification by column chromatography (30% 
EtOAc/hexane) gave the enamide 396c as a brown oil (55 mg, 66%). Rf = 0.55 (50% 
EtOAc/hexane); IR (film) 2956, 1755 (C=O), 1714 (C=O), 1651, 1471, 1254, 1099, 
908, 735, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.00 (1H, dd, J = 2.3, 1.2 Hz, 
ArH), 7.95 (1H, dt, J = 7.8, 1.2 Hz, ArH), 7.53 (1H, ddd, J = 7.8, 2.3, 1.2 Hz, ArH), 
7.40 (1H, t, J = 7.8 Hz, ArH), 6.65 (1H, s, =CH), 4.47-4.43 (2H, m, OCH2CH2N), 
4.39 (2H, q, J = 7.1 Hz, OCH2CH3), 4.15 (2H, app dd, J = 9.0, 7.0 Hz, CH2N), 3.60 
(2H, t, J = 6.4 Hz, CH2OSi), 2.86 (2H, t, J = 6.4 Hz, CH2CH2OSi), 1.41 (3H, t, J = 
7.1 Hz, OCH2CH3), 0.84 (9H, s, C(CH3)3), –0.05 (6H, s, Si(CH3)2); 
13C NMR 
(62.9 MHz, CDCl3) δ 166.5 (C), 157.3 (C), 141.0 (C), 131.4 (CH), 130.6 (C), 128.4 
(CH), 128.3 (CH), 127.9 (CH), 125.0 (C), 124.6 (CH), 62.5 (CH2), 61.0 (CH2), 60.9 
(CH2), 46.2 (CH2), 32.7 (CH2), 25.8 (3 x CH3), 18.2 (C), 14.3 (CH3), –5.5 (2 x CH3); 
HRMS (ES) Exact mass calcd for C22H37N2O5Si [M+NH4]




one (396d). The title compound was prepared according to 
General Procedure G from ynamide 394g (43 mg, 0.20 mmol) 
and 3-chlorophenylzinc iodide (0.5 M in THF, 0.80 mL, 0.40 mmol) for a reaction 













EtOAc/hexane) gave the enamide 396d as a brown oil (50 mg, 77%). Rf = 0.40 (60% 
EtOAc/hexane); IR (film) 3054, 1699 (C=O), 1641, 1591, 1460, 1415, 1265, 1226, 
736, 701 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.39 (1H, dt, J = 2.6, 1.2 Hz, ArH), 
7.32-7.24 (5H, m, ArH), 7.23-7.17 (1H, m, ArH), 7.15-7.13 (2H, m, ArH), 6.55 (1H, 
s, =CH), 3.55-3.50 (2H, m, CH2N), 2.86 (2H, app dd, J = 9.1, 6.5 Hz) and 2.68 (2H, 
app dd, J = 9.1, 6.5 Hz, CH2CH2Ph), 2.43 (2H, t, J = 8.1 Hz, CH2C=O), 2.09-2.01 
(2H, m, CH2CH2N); 
13C NMR (90.6 MHz, CDCl3) δ 174.9 (C), 142.8 (C), 141.3 (C), 
134.3 (C), 129.6 (CH), 129.1 (C), 128.4 (4 x CH), 127.2 (CH), 127.0 (CH), 126.1 
(CH), 125.0 (CH), 123.8 (CH), 48.9 (CH2), 34.5 (CH2), 31.9 (CH2), 30.4 (CH2), 18.8 
(CH2); HRMS (ES) Exact mass calcd for C20H20ClNONa [M+Na]




methylimidazolidin-2-one (396e). The title compound was 
prepared according to General Procedure G from ynamide 
394i (40 mg, 0.20 mmol) and 3-chlorophenylzinc iodide (0.5 M in THF, 0.80 mL, 
0.40 mmol) for a reaction time of 5 h. Workup E and purification by column 
chromatography (40% EtOAc/hexane) gave the enamide 396e as a yellow oil (51 
mg, 82%). Rf = 0.40 (60% EtOAc/hexane); IR (film) 3054, 1711 (C=O), 1634, 1589, 
1483, 1435, 1362, 1265, 896, 737 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.40-7.28 
(4H, m, ArH), 7.26-7.21 (2H, m, ArH), 7.18-7.09 (3H, m, ArH and =CH), 7.05 (1H, 
ddd, J = 6.7, 2.8, 1.2 Hz, ArH), 3.24-3.17 (2H, m, CH2N), 3.01-2.93 (2H, m, CH2N), 
2.86 (3H, s, CH3); 
13C NMR (90.6 MHz, CDCl3) δ 158.4 (C), 144.1 (C), 138.4 (C), 
134.0 (C), 131.2 (2 x CH), 129.2 (CH), 128.1 (2 x CH), 127.4 (CH), 126.7 (CH), 
125.9 (CH), 125.1 (CH), 124.8 (CH), 119.4 (C), 44.8 (CH2), 42.6 (CH2), 31.0 (CH3); 
HRMS (ES) Exact mass calcd for C18H17ClN2ONa [M+Na]




phenylheptanoic acid ethyl ester (396f). The enamide 396f 



















General Procedure G was followed using ynamide 394a (43 mg, 0.20 mmol) and 5-
cyano-5-methylhexylzinc bromide (0.5 M in THF, 0.80 mL, 0.40 mmol) for a 
reaction time of 4 h. Workup E and purification by column chromatography (30% 
EtOAc/hexane
40% EtOAc/hexane) gave the enamide 401 (5 mg, 12%) as a brown 
oil followed by the enamide 396g (30 mg, 45%) as a yellow oil. 
Data for 401: See page 173. 
Data for 396g: Rf = 0.44 (50% EtOAc/hexane); IR (film) 3055, 2305 (CN), 1753 
(C=O), 1670, 1603, 1410, 1265, 1088, 895, 739 cm-1; 1H NMR (360 MHz, CDCl3) δ 
7.33-7.25 (2H, m, ArH), 7.23-7.16 (3H, m, ArH), 5.87 (1H, s, =CH), 4.30-4.22 (2H, 
m, CH2O), 3.51-3.45 (2H, m, CH2N), 2.74 (2H, app dd, J = 8.8, 6.9 Hz) and 2.41 
(2H, app dd, J = 8.8, 6.9 Hz, CH2CH2Ph), 2.15 (2H, t, J = 6.1 Hz, 
CH2(CH2)3C(CH3)2), 1.67-1.49 (6H, m, (CH2)3C(CH3)2CN), 1.35 (6H, s, 
C(CH3)2CN); 
13C NMR (62.9 MHz, CDCl3) δ 157.1 (C), 141.5 (C), 134.1 (C), 131.4 
(C), 128.4 (2 x CH), 128.4 (2 x CH), 126.1 (CH), 119.8 (CH), 62.1 (CH2), 46.3 
(CH2), 40.8 (CH2), 34.0 (CH2), 33.9 (CH2), 32.4 (C), 31.4 (CH2), 27.9 (CH2), 26.6 (2 
x CH3), 24.9 (CH2); HRMS (ES) Exact mass calcd for C21H32N3O2 [M+NH4]
+: 
358.2489, found: 358.2486. 
 
3-[(Z)-3-(2-Oxopyrrolidin-1-yl)-2-phenylallyl]benzonitrile 
(396h). The title compound was prepared according to a 
slight modification of General Procedure G, in which 
[Rh(cod)Cl]2 (4.9 mg, 0.01mmol) and rac-BINAP (12.5 mg, 0.02 mmol) were used 
in place of Rh(cod)(acac), using ynamide 394h (37 mg, 0.20 mmol) and 3-
cyanobenzylzinc bromide (0.5 M in THF, 0.80 mL, 0.40 mmol) at 60 °C for a 










50%EtOAc/hexane) gave the enamide 396h as a pale orange solid 
(20 mg, 35%). Rf = 0.36 (60% EtOAc/hexane); m.p. 86-88 °C; IR (CHCl3) 2923, 
2228 (CN), 1695 (C=O), 1483, 1398, 1299, 1266, 789, 727, 704 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.40-7.34 (1H, m, ArH), 7.37-7.29 (3H, m, ArH), 7.24-7.21 
(3H, m, ArH), 6.99-6.93 (3H, m, ArH and =CH), 3.67 (2H, s, CH2Ar), 2.93-2.86 
(2H, m, CH2N), 2.37 (2H, t, J = 8.1 Hz, CH2C=O), 1.87-1.78 (2H, m, CH2CH2N); 
13C NMR (90.6 MHz, CDCl3) δ 175.2 (C), 140.8 (C), 138.3 (C), 133.5 (CH), 132.4 
(CH), 130.1 (CH), 129.1 (2 x CH), 129.0 (CH), 127.9 (2 x CH), 127.5 (CH), 123.9 
(C), 122.6 (CH), 118.9 (C), 112.1 (C), 48.1 (CH2), 44.1 (CH2), 30.3 (CH2), 18.6 
(CH2); HRMS (ES) Exact mass calcd for C20H19N2O [M+H]
+: 303.1492, found: 
303.1489. 
 






General Procedure G was followed using ynamide 394h (37 mg, 0.20 mmol) and 4-
ethoxy-4-oxobutylzinc bromide (0.5 M in THF, 0.80 mL, 0.40 mmol) for a reaction 
time of 6 h. Workup E and purification by column chromatography (30% 
EtOAc/hexane
50% EtOAc/hexane) to gave enamide 399 (5 mg, 15%) as a yellow 
oil followed by the enamide 398 (14 mg, 25%) as a yellow oil. 
Data for 398: Rf = 0.31 (50% EtOAc/hexane); IR (film) 2983, 1724 (C=O), 1682 
(C=O), 1404, 1321, 1265, 1095, 1026, 912, 744, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.36-7.24 (3H, m, ArH), 7.19-7.15 (2H, m, ArH), 6.75 (1H, s, =CH), 4.10 
(2H, q, J = 7.1 Hz, OCH2CH3), 2.92-2.85 (2H, m, CH2N), 2.43-2.26 (6H, m, 
CH2CH2CH2N and CH2CH2CH2CO2Et), 1.84-1.76 (2H, m) and 1.71-1.59 (2H, m, 
CH2CH2N and CH2CH2CO2Et), 1.24 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR 
(90.6 MHz, CDCl3) δ 175.0 (C), 173.4 (C), 139.2 (C), 129.0 (2 x CH), 128.0 (2 x 





(CH2), 30.4 (CH2), 23.5 (CH2), 18.7 (CH2), 14.2 (CH3); HRMS (ES) Exact mass 
calcd for C18H24NO3 [M+H]
+: 302.1751, found: 302.1749. 
Data for 399: Rf = 0.47 (50% EtOAc/hexane); IR (film) 2925, 1691 (C=O), 1462, 
1412, 1383, 1265, 1095, 908, 737, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.42-
7.11 (5H, m, ArH), 6.81 (1H, d, J = 9.9 Hz, CH=CHPh), 6.01 (1H, d, J = 9.9 Hz, 
CH=CHPh), 3.25-3.16 (2H, m, CH2N), 2.45-2.38 (2H, m, CH2C=O), 1.99-1.91 (2H, 
m, CH2CH2N); 
13C NMR (90.7 MHz, CDCl3) δ 175.6 (C), 136.3 (C), 129.2 (2 x 
CH), 127.8 (2 x CH), 126.9 (CH), 123.9 (CH), 113.8 (CH), 48.0 (CH2), 30.3 (CH2), 
18.8 (CH2). Spectroscopic data were consistent with those observed previously.
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To a solution of the ynamide 394h (93 mg, 0.50 mmol) and Cu(acac)2 (13.1 mg, 0.05 
mmol) in THF (5 mL) at 0 °C was added 4-ethoxy-4-oxobutylzinc bromide (0.5 M in 
THF, 2.0 mL, 1.0 mmol). The reaction was stirred at room temperature for 5 h, 
quenched with saturated NH4Cl solution (10 mL), and the mixture stirred vigorously 
for 30 min. The aqueous layer was separated and extracted with CH2Cl2 (3 x 20 mL) 
and the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography (30% EtOAc/hexane
50% 





6.2.3 Carbozincation of Acyclic Ynamides 
 
N-Phenyl-N-[(Z)-2-phenylbut-1-enyl]carbamic acid tert-butyl ester (400a) and 






To a solution of ynamide 395b (88 mg, 0.30 mmol) and Rh(cod)(acac) 4.6 mg, 0.015 
mmol) in THF (3 mL) at –78 °C was added Et2Zn (0.5 M in THF, 1.20 mL, 0.60 
mmol) dropwise over 2 min, and the reaction was then stirred at –78 °C for 5 min. 
The mixture was quenched with saturated aqueous NH4Cl solution (10 mL) and 
extracted with CH2Cl2 (3 x 10 mL). The organic layers were combined, dried 
(MgSO4), and concentrated in vacuo. Purification of the residue by column 
chromatography (1/20 EtOAc/hexane) afforded a 1:2.3 inseparable mixture of 
enamides 400a and 400b (77 mg, 80%) as a pale orange oil. Rf = 0.60 (20% 
EtOAc/hexane); IR (film) 2974, 2934, 2360 (C=C), 1709 (C=O), 1493, 1367, 1302, 
1161, 1018, 754 cm-1.  
NMR data for minor isomer 400a: 1H NMR (360 MHz, CDCl3) δ 7.57-6.98 (10H, m, 
ArH), 6.51 (1H, br s, =CH), 2.46 (2H, dq, J = 7.4, 1.3 Hz, CH2CH3), 1.42 (9H, s, 
C(CH3)3), 1.08 (3H, t, J = 7.4 Hz, CH2CH3); 
13C NMR (62.9 MHz, CDCl3) δ 153.6 
(C), 142.0 (C), 138.9 (C), 127.8 (4 x CH and C), 126.6 (2 x CH), 125.8 (2 x CH), 
124.6 (2 x CH), 124.3 (CH), 80.8 (C), 29.3 (CH2), 28.1 (3 x CH3), 13.2 (CH3). 
NMR data for major isomer 400b: 1H NMR (360 MHz, CDCl3) δ 7.57-6.98 (10H, m, 
ArH), 6.41 (1H, s, =CH), 2.26 (2H, q, J = 7.4 Hz, CH2CH3), 1.24 (9H, s, C(CH3)3), 
1.15 (3H, t, J = 7.4 Hz, CH2CH3); 
13C NMR (62.9 MHz, CDCl3) δ 152.7 (C), 140.4 
(C), 140.0 (C), 136.0 (C), 128.7 (2 x CH), 128.6 (2 x CH), 127.4 (2 x CH), 127.2 
(CH), 125.1 (CH), 124.7 (CH), 124.1 (2 x CH), 80.5 (C), 28.6 (CH2), 27.7 (3 x CH3), 
11.7 (CH3).  
                                                 





HRMS (ES) Exact mass calcd for C21H26NO2 [M+H]
+: 324.1958, found: 324.1956. 
 




To a solution of ynamide 395b (147 mg, 0.50 mmol) and Cu(acac)2 (13.1 mg, 0.05 
mmol) in Et2O (5 mL) at 0 °C was added Et2Zn (1.0 M in hexane, 1.00 mL, 1.00 
mmol) over 1 min and the mixture was then stirred at room temperature for 16 h. The 
reaction was quenched with saturated aqueous NH4Cl solution (10 mL) and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layers were dried (MgSO4), and 
concentrated in vacuo. Purification of the residue by column chromatography (1% 
EtOAc/hexane) gave the enamide 400a (106 mg, 66%) as a pale orange oil. Rf = 0.60 
(20% EtOAc/hexane); IR (film) 2975, 1700 (C=O), 1597, 1493, 1340, 1266, 1160, 
1018, 864, 741 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.16-7.04 (5H, m, ArH), 7.03-
6.92 (5H, m, ArH), 6.46 (1H, br s, =CH), 2.41 (2H, dq, J = 7.4, 1.3 Hz, CH2CH3), 
1.37 (9H, s, C(CH3)3), 1.03 (3H, t, J = 7.4 Hz, CH2CH3); 
13C NMR (62.9 MHz, 
CDCl3) δ 153.6 (C), 142.0 (C), 138.9 (C), 127.8 (4 x CH and C), 126.6 (2 x CH), 
125.8 (2 x CH), 124.6 (2 x CH), 124.3 (CH), 80.8 (C), 29.3 (CH2), 28.1 (3 x CH3), 
13.2 (CH3); HRMS (ES) Exact mass calcd for C21H26NO2 [M+H]
+: 324.1958, found: 
324.1956. 
 
6.2.4 Hydrometallation of Ynamides 
 
 
General Procedure H 
To a stirred solution of the appropriate ynamide (1.0 equiv), [Rh(cod)Cl]2 (0.025 





°C was added Et2Zn (1.0 M in hexane, 2.0 equiv) over 1 min and the reaction was 
then stirred at room temperature until complete consumption of starting material was 
observed by TLC analysis (up to 6 h). The mixture was filtered through a short pad 
of silica gel using CH2Cl2 (30 mL) as eluent, and the filtrate was concentrated in 
vacuo. Purification of the residue by column chromatography afforded the desired 
enamide. 
 
3-[(Z)-4-Phenylbut-1-enyl]oxazolidin-2-one (401). The title 
compound was prepared according to General Procedure H from 
ynamide 394a (43 mg, 0.20 mmol) for a reaction time of 1.5 h. 
Purification by column chromatography (40% EtOAc/hexane) gave a 9:1 mixture of 
the enamide 401 and the carbometallation product 392b (26 mg, 60%) as a brown 
oil. Rf = 0.55 (50% EtOAc/hexane); IR (film) 2930, 1753 (C=O), 1668, 1481, 1419, 
1246, 1078, 908, 737, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.32-7.28 (2H, m, 
ArH), 7.24-7.18 (3H, m, ArH), 6.26 (1H, dt, J = 9.5, 1.6 Hz, CH=CHCH2), 4.89 
(1H, dt, J = 9.5, 7.6 Hz, CH=CHCH2), 4.34-4.29 (2H, m, CH2O), 3.78-3.74 (2H, m, 
CH2N), 2.73 (2H, t, J = 7.6 Hz, CH2Ph), 2.50 (2H, app qd, J = 7.4, 1.5 Hz, 
CH2CH2Ph); 
13C NMR (62.9 MHz, CDCl3) δ 156.8 (C), 141.2 (C), 128.5 (2 x CH), 
128.4 (2 x CH), 126.1 (CH), 122.9 (CH), 114.5 (CH), 62.1 (CH2), 45.4 (CH2), 36.2 
(CH2), 28.6 (CH2); HRMS (ES) Exact mass calcd for C13H16NO2 [M+H]
+: 218.1176, 
found: 218.1179.  
 
 
(Z)-3-Oct-1-enyl]oxazolidin-2-one (402a). The title compound was 
prepared according to General Procedure H from ynamide 394c (39 
mg, 0.20 mmol) for a reaction time of 30 min. Purification by column 
chromatography (20% EtOAc/hexane) gave an 11:1 mixture of the enamide 402a 
and the corresponding carbometallation product (18 mg, 46%) as a yellow oil. Rf = 
0.58 (40% EtOAc/hexane); IR (film) 2927, 1753 (C=O), 1668, 1481, 1419, 1265, 
1078, 908, 737, 650, 447 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.23 (1H, dt, J = 9.4, 
1.6 Hz, CH=CHCH2), 4.84 (1H, dt, J = 9.4, 7.6 Hz, CH=CHCH2), 4.43-4.35 (2H, m, 
CH2O), 3.96 (2H, app dd, J = 8.9, 7.1 Hz, CH2N), 2.16 (2H, app qd, J = 7.6, 1.6 Hz, 












(62.9 MHz, CDCl3) δ 156.9 (C), 122.3 (CH), 116.0 (CH), 62.1 (CH2), 45.7 (CH2), 
31.6 (CH2), 30.1 (CH2), 28.9 (CH2), 26.5 (CH2), 22.6 (CH2), 14.0 (CH3); HRMS 
(ES) Exact mass calcd for C11H20NO2 [M+H]
+: 198.1489, found: 198.1487. 
 
3-[(Z)-3-(tert-Butyldimethylsilyloxy)propenyl]oxazolidin-2-one 
(402b). The title compound was prepared according to General 
Procedure H from ynamide 394d (128 mg, 0.50 mmol) for a 
reaction time of 4.5 h. Purification by column chromatography (15% EtOAc/hexane) 
gave a 9:1 mixture of the enamide 402b and the corresponding carbometallation 
product (74 mg, 58%) as a yellow oil. Rf = 0.17 (20% EtOAc/hexane); IR (film) 
2929, 2858, 1756 (C=O), 1665, 1398, 1251, 1081, 909, 838, 733 cm-1; 1H NMR (360 
MHz, CDCl3) δ 6.31 (1H, dt, J = 9.7, 1.2 Hz, CH=CHCH2), 5.00 (1H, dt, J = 9.7, 
7.0 Hz, CH=CHCH2), 4.40-4.35 (2H, m, CH2O), 4.24 (2H, dd, J = 7.0, 1.2 Hz, 
CH2OSi), 4.00 (2H, app dd, J = 8.9, 7.1 Hz, CH2N), 0.87 (9H, s, C(CH3)3), 0.05 
(6H, s, Si(CH3)2); 
13C NMR (62.9 MHz, CDCl3) δ 156.5 (C), 123.8 (CH), 113.0 
(CH), 62.1 (CH2), 57.7 (CH2), 45.1 (CH2), 25.8 (3 x CH3), 18.1 (C), –5.1 (2 x CH3); 
m/z: No mass ion peaks observed under a range of mass spectroscopic techniques. 
 
3-[(Z)-4-(tert-Butydimethylsilyloxy)but-1-enyl]oxazolidin-2-
one (402c). The title compound was prepared according to 
General Procedure H from ynamide 394e (133 mg, 0.50 mmol) 
for a reaction time of 2 h. Purification by column chromatography (15% 
EtOAc/hexane) gave the enamide 402c as a yellow oil (79 mg, 58%). Rf = 0.40 (30% 
EtOAc/hexane); IR (film) 2956, 2929, 2858, 1753 (C=O), 1671, 1251, 1099, 909, 
736 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.35 (1H, dt, J = 9.7, 1.5 Hz, CH=CHCH2), 
4.81 (1H, dt, J = 9.7, 7.8 Hz, CH=CHCH2), 4.38 (2H, app dd, J = 9.0, 7.0 Hz, 
CH2O), 4.02 (2H, app dd, J = 9.0, 7.0 Hz, CH2N), 3.64 (2H, t, J = 6.5 Hz, CH2OSi), 
2.39 (2H, dtd, J = 7.8, 6.5, 1.5 Hz, CH2CH2OSi), 0.89 (9H, s, C(CH3)3), 0.05 (6H, s, 
Si(CH3)2); 
13C NMR (62.9 MHz, CDCl3) δ 156.8 (C), 123.8 (CH), 110.7 (CH), 62.6 
(CH2), 62.2 (CH2), 45.5 (CH2), 30.1 (CH2), 25.9 (3 x CH3), 18.3 (C), –5.4 (2 x CH3); 
HRMS (ES) Exact mass calcd for C13H26NO3Si [M+H]













2-one (402d). The title compound was prepared according to 
General Procedure H from ynamide 394f (142 mg, 0.50 mmol) 
for a reaction time of 4.5 h. Purification by column chromatography (15% 
EtOAc/hexane) gave a 6:1 mixture of the enamide 402d and the corresponding 
carbometallation product (59 mg, 42%) as a brown oil. Rf = 0.18 (20% 
EtOAc/hexane); IR (film) 2959, 2930, 1751 (C=O), 1419, 1251, 1099, 908, 836, 735, 
650 cm-1; 1H NMR (360 MHz, CDCl3) δ 6.27 (1H, dt, J = 9.5, 1.4 Hz, CH=CHCH2), 
4.81 (1H, dt, J = 9.5, 7.8 Hz, CH=CHCH2), 4.42-4.31 (2H, m, OCH2CH2N), 4.00 
(2H, app dd, J = 9.0, 7.0 Hz, CH2N), 3.62 (2H, t, J = 6.0 Hz, CH2OSi), 2.25 (2H, 
app qd, J = 7.8, 1.4 Hz, =CHCH2), 1.64-1.56 (2H, m, CH2CH2OSi), 0.88 (9H, s, 
C(CH3)3), 0.04 (6H, s, Si(CH3)2; 
13C NMR (62.9 MHz, CDCl3) δ 156.9 (C), 122.8 
(CH), 114.5 (CH), 62.1 (CH2), 61.9 (CH2), 45.5 (CH2), 33.1 (CH2), 25.8 (3 x CH3), 
22.7 (CH2), 18.2 (C), –5.4 (2 x CH3); HRMS (ES) Exact mass calcd for C14H28NO3Si 
[M+H]+: 286.1833, found: 286.1829. 
 
1-[(Z)-4-Phenylbut-1-enyl]pyrrolidin-2-one (402f). The title 
compound was prepared according to General Procedure H from 
ynamide 394g (64 mg, 0.30 mmol) for a reaction time of 30 min. 
Purification by column chromatography (50% EtOAc/hexane) gave the enamide 402f 
as a yellow oil (34 mg, 53%). Rf = 0.37 (50% EtOAc/hexane); IR (film) 2985, 1687 
(C=O), 1460, 1417, 1387, 1265, 1095, 908, 739, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.31-7.2 (2H, m, ArH), 7.22-7.18 (3H, m, ArH), 6.39 (1H, dt, J = 9.6, 1.4 
Hz, CH=CHCH2), 4.90 (1H, dt, J = 9.6, 7.6 Hz, CH=CHCH2), 3.62 (2H, t, J = 7.5 
Hz, CH2N), 2.72 (2H, t, J = 7.6 Hz, CH2CH2Ph), 2.52 (2H, app qd, J = 7.6, 1.4 Hz, 
CH2CH2Ph), 2.39 (2H, t, J = 7.5 Hz, CH2C=O), 2.03 (2H, app quintet, J = 7.5 Hz, 
CH2CH2CH2N); 
13C NMR (62.9 MHz, CDCl3) δ 174.5 (C), 141.4 (C), 128.4 (2 x 
CH), 128.3 (2 x CH), 126.0 (CH), 122.7 (CH), 115.5 (CH), 48.4 (CH2), 36.3 (CH2), 
30.2 (CH2), 29.2 (CH2), 18.5 (CH2); HRMS (ES) Exact mass calcd for C14H18NO 











6.2.5 Functionalisation of Alkenylzinc Intermediates 
 




General Procedure I 
To a solution of the appropriate ynamide (1.0 equiv) and Rh(cod)(acac) (0.05 equiv) 
in THF (10 mL/mmol of ynamide) at 0 °C was added Et2Zn (1.0 M in hexane, 0.55 
equiv) over 0.5 min, and the reaction was then stirred at room temperature for 15 min 
to produce the alkenylzinc species. After addition of the appropriate electrophile and 
other catalysts/reagents and completion of the reaction, the mixture was quenched 
with saturated NH4Cl solution (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were dried (MgSO4), and concentrated in vacuo. 
Purification of the residue by column chromatography afforded the desired enamide.    
 




General Procedure J 
To a solution of the appropriate ynamide (1.0 equiv), [Rh(cod)Cl]2 (0.025 equiv) and 
tri(2-furyl)phosphine (0.10 equiv) in THF (10 mL/mmol of ynamide) at 0 °C was 
added Et2Zn (1.0 M in hexane, 0.55 equiv) and the reaction was then stirred at room 
temperature until complete consumption of starting material was observed by TLC 
analysis (2-6 h). After addition of the appropriate electrophile and other 
catalysts/reagents and completion of the reaction, the mixture was filtered through a 





concentrated in vacuo. Purification of the residue by column chromatography 
afforded the desired enamide.    
 
 
Benoit Gourdet prepared enamides 412, 416a and 416c as described previously.160 
 
3-[(Z)-1-Allyl-2-ethyl-4-phenylbut-1-enyl]oxazolidin-2-one 
(414). General Procedure I was followed using ynamide 394a (109 
mg, 0.50 mmol) to produce alkenylzinc species 413. To this 
solution was added a solution of allyl bromide (217 L, 2.50 mmol) and the resulting 
mixture was stirred at room temperature for 4.5 h. The standard workup and 
purification of the residue by column chromatography (25% EtOAc/hexane) gave the 
enamide 414 (80 mg, 56%) as a pale yellow oil. Rf = 0.33 (30% EtOAc/hexane); IR 
(film) 2968, 1750 (C=O), 1637, 1454, 1408, 1227, 1123, 1039, 916, 757 cm-1; 
1H 
NMR (360 MHz, CDCl3) δ 7.32-7.25 (2H, m, ArH), 7.22-7.13 (3H, m, ArH), 5.79 
(1H, ddt, J = 16.8, 10.1, 6.5 Hz, CH=CH2), 5.12 (1H, ddt, J = 16.8, 3.3, 1.7 Hz,  
CH=CH2), 5.06 (1H, ddt, 10.1, 3.3, 1.4 Hz, CH=CH2), 4.23 (2H, app t, J = 8.0 Hz, 
CH2O), 3.38-3.18 (2H, m, CH2N), 3.03 (2H, d, J = 6.5 Hz CH2CH=CH2), 2.78-2.71 
(2H, m, CH2CH2Ph), 2.42-2.34 (2H, m, CH2CH2Ph), 2.23 (2H, q, J = 7.6 Hz, 
CH2CH3), 1.11 (3H, t, J = 7.6 Hz, CH2CH3); 
13C NMR (90.6 MHz, CDCl3) δ 156.8 
(C), 142.1 (C), 141.3 (C), 134.9 (CH), 128.4 (2 x CH), 128.3 (2 x CH), 126.9 (C), 
125.9 (CH), 116.8 (CH2), 62.0 (CH2), 46.1 (CH2), 34.0 (CH2), 33.9 (CH2), 33.2 
(CH2), 23.9 (CH2), 13.1 (CH3); HRMS (ES) Exact mass calcd for C18H24NO2 




ylbut-1-enyl]oxazolidin-2-one (416b). General Procedure I was 














the corresponding alkenylzinc species. To this solution was added a solution of 
Pd2dba3 (11 mg, 0.0125 mmol), tri(2-furyl)phosphine (11.0 mg, 0.05 mmol) and 2-
iodothiophene (168 mg, 0.80 mmol) in THF (3 mL + 2 mL rinse) via cannula and the 
resulting mixture was heated at 65 °C for 40 h. The standard workup and purification 
of the residue by column chromatography (10% EtOAc/hexane
50% 
EtOAc/hexane) gave the enamide 416b (85 mg, 45%) as a yellow-brown oil. Rf = 
0.47 (30% EtOAc/hexane); IR (film) 2929, 2360, 1751 (C=O), 1469, 1410, 1415, 
1410, 1263, 1092, 908, 835, 735 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.30 (1H, dd, J 
= 4.9, 1.5 Hz, ArH), 7.02-6.98 (2H, m, ArH), 4.39-4.31 (2H, m, OCH2CH2N), 3.80 
(2H, t, J = 7.0 Hz, CH2OSi), 3.60 (2H, app dd, J = 8.7, 7.3 Hz, CH2N), 2.52 (1H, t, J 
= 7.0 Hz, CH2CH2OSi), 2.29 (2H, q, J = 7.5 Hz, CH2CH3), 1.07 (3H, t, J = 7.5 Hz, 
CH2CH3), 0.91 (9H, s, C(CH3)3), 0.08 (6H, s, Si(CH3)2); 
13C NMR (62.9 MHz, 
CDCl3) δ 156.7 (C), 144.8 (C), 137.7 (C), 127.5 (CH), 126.8 (CH), 125.8 (CH), 
123.7 (C), 62.0 (CH2), 61.2 (CH2), 45.7 (CH2), 34.4 (CH2), 25.9 (3 x CH3), 25.3 
(CH2), 18.3 (C), 13.1 (CH3), –5.3 (2 x CH3); HRMS (ES) Exact mass calcd for 
C19H32NO3SSi [M+H]
+: 382.1867, found: 382.1863. 
 
3-[(E)-2-(4-Nitrophenyl)-2-(2-oxooxazolidin-3-yl)-1-phenylvinyl]benzoic acid 
ethyl ester (418) and 3-(E)-2-(2-oxooxazolidin-3-yl)-1-phenylvinylbenzoic acid 
ethyl ester (396b)  
 
To a solution of ynamide 394b (94 mg, 0.50 mmol) and Rh(cod)(acac) (7.8 mg, 
0.025 mmol) in THF (5 mL) at 0 °C was added 3-(ethoxycarbonyl)phenylzinc iodide 





room temperature for 15 min to produce the alkenylzinc species 417. To this solution 
was added a solution of Pd2dba3 (11 mg, 0.0125 mmol), tri(2-furyl)phosphine (11 
mg, 0.05 mmol) and 1-iodo-4-nitrobenzene (199 mg, 0.80 mmol) in THF (3 mL + 2 
mL rinse) via cannula and the resulting mixture was heated at 65 °C for 48 h. The 
standard workup and purification of the residue by column chromatography (40% 
EtOAc/hexane) gave the enamide 396b (34 mg, 20%) as a brown oil followed by the 
enamide 418 (42 mg, 18%) as an orange solid. 
Data for 396b: See page 165. 
Data for 418: Rf = 0.28 (40% EtOAc/hexane); m.p. 146-148 °C; IR (CHCl3) 3055, 
2986, 1758 (C=O), 1716 (C=O), 1595, 1520, 1347, 1265, 896, 740 cm-1; 
1H NMR 
(360 MHz, CDCl3) δ 8.04 (2H, d, J = 8.9 Hz, ArH), 7.89 (1H, dt, J = 7.5, 1.6 Hz, 
ArH), 7.69 (1H, t, J = 1.6 Hz, ArH), 7.42-7.32 (5H, m, ArH), 7.30-7.16 (4H, m, 
ArH), 4.33-4.23 (4H, m, OCH2CH2N and OCH2CH3), 3.52 (2H, app dd, J = 8.6, 7.3 
Hz, CH2N), 1.31 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (90.6 MHz, CDCl3) δ 
165.9 (C), 155.8 (C), 147.0 (C), 143.3 (C), 142.1 (C), 140.1 (C), 140.0 (C), 135.2 
(CH), 131.9 (CH), 131.4 (C), 130.7 (C), 130.4 (2 x CH), 129.1 (CH), 129.0 (2 x CH), 
128.9 (2 x CH), 128.9 (CH), 128.5 (CH), 123.6 (2 x CH), 62.5 (CH2), 61.1 (CH2), 
45.8 (CH2), 14.2 (CH3); HRMS (ES) Exact mass calcd for C26H26N3O6 [M+NH4]
+: 
476.1816, found: 476.1818. 
 
3-[(Z)-1-(4-Nitrophenyl)-2-phenylbut-1-enyl]oxazolidin-2-one 
(420a). General Procedure J was followed using ynamide 394a (43 
mg, 0.20 mmol) to produce the corresponding alkenylzinc species. 
To this solution was added a solution of Pd2dba3 (11 mg, 0.0125 
mmol), tri(2-furyl)phosphine (11 mg, 0.05 mmol), and 1-iodo-4-
nitrobenzene (199 mg, 0.80 mmol) in THF (3 mL + 2 mL rinse) via cannula and the 
resulting mixture was heated at 65 °C for 45 h. The standard workup and purification 
of the residue by column chromatography (2% EtOAc/hexane
20% EtOAc/hexane) 
gave the enamide 420a (24 mg, 36%) as a brown solid. Rf = 0.19 (30% 
EtOAc/hexane); m.p. decomposition observed before melting. IR (CHCl3) 1755 
(C=O), 1599, 1520 (NO2), 1415, 1346, 1265, 1041, 908, 735, 650 cm
-1; 
1H NMR 









7.34-7.30 (2H, m, ArH), 7.24-7.19 (3H, m, ArH), 6.22 (1H, t, J = 7.5 Hz, =CH), 
4.45-4.41 (2H, m, CH2O), 3.34-3.30 (2H, m, CH2N), 2.88 (2H, t, J = 7.3 Hz, 
CH2Ph), 2.60 (2H, app q, J = 7.3 Hz, CH2CH2Ph); 
13C NMR (62.9 MHz, CDCl3) δ 
156.3 (C), 147.5 (C), 142.2 (C), 141.1 (C), 133.6 (CH), 133.1 (C), 128.5 (2 x CH), 
128.5 (2 x CH), 126.5 (2 x CH), 126.3 (CH), 124.1 (2 x CH), 62.3 (CH2), 45.3 (CH2), 
34.7 (CH2), 30.6 (CH2); HRMS (ES) Exact mass calcd for C19H22N3O4 [M+NH4]
+: 
356.1605, found: 356.1602. 
 
1-[(Z)-1-(4-Methoxyphenyl)-4-phenylbut-1-enyl]pyrrolidin-2-
one (420b). General Procedure J was followed using ynamide 394g 
(43 mg, 0.20 mmol) to produce the corresponding alkenylzinc 
species. To this solution was added a solution of Pd2dba3 (11 mg, 
0.0125 mmol), tri(2-furyl)phosphine (11 mg, 0.05 mmol), and 4-
iodoanisole (187 mg, 0.80 mmol) in THF (3 mL + 2 mL rinse) via cannula and the 
resulting mixture was heated at 65 °C for 45 h. The standard workup and purification 
of the residue by column chromatography (10% EtOAc/hexane
40% 
EtOAc/hexane) gave the hydrometallation product 402f (44 mg, 41%) as a yellow 
oil, followed by the enamide 420b (25 mg, 18%) as a brown oil. 
Data for 402f: See page 175. 
Data for 420b: Rf = 0.21 (50% EtOAc/hexane); IR (film) 2927, 1683 (C=O), 1608, 
1511, 1461, 1418, 1250, 1175, 908, 733 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.40-
7.36 (2H, m, ArH), 7.32-7.27 (5H, m, ArH), 6.94 (2H, d, J = 8.9 Hz, ArH), 6.01 
(1H, t, J = 7.3 Hz, =CH), 3.89 (3H, s, OCH3), 3.27 (2H, t, J = 7.0 Hz, CH2N), 2.90 
(2H, t, J = 7.5 Hz, CH2C=O), 2.64 (3H, t, J = 8.1 Hz, CH2Ph), 2.52 (2H, app q, J = 
7.4 Hz, CH2CH2Ph), 2.16 (2H, app quintet, J = 7.5 Hz, CH2CH2N); 
13C NMR 
(90.6 MHz, CDCl3) δ 174.1 (C), 159.5 (C), 141.7 (C), 135.0 (C), 128.6 (C), 128.5 (2 
x CH), 128.3 (2 x CH), 127.0 (2 x CH), 126.2 (CH), 125.9 (CH), 113.9 (2 x CH), 
55.3 (CH3), 48.4 (CH2), 35.1 (CH2), 31.1 (CH2), 30.4 (CH2), 18.9 (CH2); HRMS 
(ES) Exact mass calcd for C21H24NO2 [M+H]










6.2.6 Regio-/Stereochemical Determinations 
 
• The regioselectivities of the rhodium-catalysed carbozincation reactions of 
alkyl-substituted ynamides 396a, 396c, 396d, 396f and 396g using organozinc 
halide reagents were obvious from the 1H NMR spectra of the corresponding 
enamide products (by consideration of the signals of the alkene proton, which 
did not exhibit vicinal proton–proton coupling). 
• The regio- and stereoselectivity of carbometallation of ynamide 394b with 
arylzinc halide 397a was established through X-ray crystallography of the 











• The regio-/stereoselectivities of the remaining carbozincation reactions using 
organozinc halide reagents were assigned by analogy. 
• The regiochemical outcome of the copper-catalysed carbozincation of ynamide 
395b to produce enamide 400a was determined through hydrolysis of 400a 




A solution of the enamide 400a (32 mg, 0.10 mmol) in aqueous HCl (6 M, 1 
mL, 6 mmol) and CHCl3 (2 mL) was stirred at room temperature for 4 h. The 





extracted with CHCl3 (3 x 5 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo to afford a pale yellow oil. 
1H NMR 
analysis of the unpurified reaction mixture revealed that enamide 400a had 
been partially converted into the known aldehyde, phenylbutyraldehyde 
(400c).185 
• The regiochemical outcome of the rhodium-catalysed carbozincation of 
ynamide 395b to produce enamides 400a and 400b was determined through 




A solution of the mixture of 400a and 400b (16 mg, 0.05 mmol) in HCl (6 M, 
0.50 mL, 3.0 mmol) and CHCl3 (1.0 mL) was stirred at room temperature for 4 
h. The reaction was quenched carefully with saturated NaHCO3 solution (5 
mL) and extracted with CHCl3 (3 x 5 mL). The combined organic layers were 
dried (MgSO4) and concentrated in vacuo to afford a pale yellow oil. 
1H NMR 
analysis of the unpurified reaction mixture revealed that presence of the known 
aldehyde, 2-phenylbutyraldehyde (400c),185 and the commercially available 
ketone, 1-phenyl-2-butanone (400d), confirming that the enamide mixture 















2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde (446).174a Pinacol 
(2.17 g, 18.4 mmol) was added to a suspension of 2-formylphenylboronic acid (2.50 
g, 16.7 mmol) in toluene (30 mL) and a Dean-Stark trap was attached. The mixture 
was refluxed for 19 h and then filtered through a plug of MgSO4. The filtrate was 
concentrated in vacuo to afford the title compound as a yellow oil (3.94 g, 16.9 
mmol, >99%) that displayed identical spectroscopic data to those reported 
previously.174a The compound was used in subsequent steps without further 
purification. Rf = 0.63 (30% EtOAc/hexane); IR (film) 2980, 1697 (C=O), 1347, 
1258, 1203, 1114, 1069, 910, 858, 734 cm-1; 1H NMR (360 MHz, CDCl3) δ 10.58 
(1H, s, CHO), 8.01-7.98 (1H, m, ArH), 7.91-7.89 (1H, m, ArH), 7.65-7.57 (2H, m, 
ArH), 1.43 (12H, s, 4 x CH3); 
13C NMR (90.6 MHz, CDCl3) δ 194.6 (CH), 141.2 
(C), 135.4 (CH), 132.9 (CH), 130.7 (CH), 127.9 (CH), 84.4 (2 x C), 24.8 (4 x CH3). 




General Procedure K 
The ylide (1.3 equiv) was added to a stirred solution of 2-(4,4,5,5-tetramethyl-1,3,2-





ester). The reaction mixture was heated to 90 oC until TLC analysis indicated 
complete consumption of starting material, then cooled to room temperature and 
concentrated in vacuo. The residue was suspended in ether, filtered to remove 
triphenylphosphine oxide and the filtrate was then concentrated in vacuo. 
Purification by silica column chromatography gave the desired product. 
 
 (E)-4-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]but-3-en-2-one (444).174a The title compound was 
prepared according to General Procedure K using 
triphenylphosphoranylidene-2-propanone (2.67 g, 8.40 mmol) and 
2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 446 (1.50 g, 6.46 
mmol) for a reaction time of 18 h. Purification by silica column chromatography 
(30% EtOAc/hexane) gave the title compound as a white solid (1.50 g, 85%, >19:1 
E/Z) that displayed identical spectroscopic data to those reported previously.174a Rf = 
0.60 (30% EtOAc/hexane); IR (CHCl3) 2981, 1652 (C=O), 1558, 1507, 1348, 1264, 
1144, 908, 738, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.45 (1H, d, J = 16.5 Hz, 
CH=CHCOCH3), 7.82 (1H, dd, J = 7.9, 1.2 Hz, ArH), 7.62 (1H, dd, J = 7.9, 1.2 Hz, 
ArH), 7.40 (1H, td, J = 7.9, 1.2 Hz, ArH), 7.31 (1H, td, J = 7.9, 1.2 Hz, ArH), 6.51 
(1H, d, J = 16.5 Hz, CH=CHCOCH3), 2.35 (3H, s, COCH3), 1.31 (12H, s, 2 x 
C(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 199.6 (C), 145.6 (CH), 140.5 (C), 136.5 
(CH), 131.3 (CH), 129.2 (CH), 128.7 (CH), 125.6 (CH), 84.1 (2 x C), 26.2 (CH3), 




yl)phenylpropenone (447a). The title compound was prepared 
according to General Procedure K using 1-phenyl-2-
triphenylphosphanylidene ethanone (745 mg, 1.96 mmol) and 2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)benzaldehyde 446 (350 mg, 1.50 mmol) for a reaction time 
of 16 h. Purification by silica column chromatography (30% EtOAc/hexane) gave the 
title compound as an orange solid (312 mg, 62%). Rf = 0.69 (30% EtOAc/hexane); 





















735, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.51 (1H, d, J = 16.0 Hz, 
CH=CHCOPh), 7.90 (2H, d, J = 7.4 Hz, ArH), 7.79 (1H, d, J = 7.4 Hz, ArH), 7.74 
(1H, d, J = 7.9 Hz, ArH), 7.49 (1H, t, J = 7.4 Hz, ArH), 7.41 (3H, app t, J = 7.7 Hz, 
ArH), 7.31 (1H, t, J = 7.4 Hz, ArH), 7.25 (1H, d, J = 16.0 Hz, CH=CHCOPh ), 1.25 
(12H, s, 2 x C(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 192.5 (C), 146.5 (CH), 140.7 
(C), 138.4 (C), 136.3 (CH), 132.2 (CH), 131.1 (CH), 129.2 (CH), 128.7 (2 x CH), 
128.4 (2 x CH), 125.6 (CH), 124.4 (CH), 84.1 (2 x C), 24.8 (4 x CH3). A signal for 
the C attached to B is not observed due to complex splitting.; HRMS (ES) Exact 
mass calcd for C21H24BO3 [M+H]
+: 335.1813, found: 335.1814. 
 
(E)-3-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]propenal (447b).174a The title compound was prepared 
according to slightly modified General Procedure K using 
(triphenylphosphoranylidene)acetaldehyde (1.98 g, 6.5 mmol) and 
2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 446 (1.16 g, 5.0 
mmol). The reaction mixture was stirred at rt overnight and then heated to 50 oC for 
4 h, then cooled to room temperature and concentrated in vacuo. Purification by 
silica column chromatography (20% EtOAc/hexane) gave the title compound as a 
pale yellow solid (894 mg, 69%) that displayed identical spectroscopic data to those 
reported previously.174a Rf = 0.53 (20% EtOAc/hexane); IR (CHCl3) 2981, 1675 
(C=O), 1445, 1380, 1347, 1274, 1144, 909, 732, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 9.74 (1H, d, J = 7.8 Hz, CHO), 8.49 (1H, d, J = 15.9 Hz, CH=CHCHO), 
7.93 (1H, d, J = 7.4 Hz, ArH), 7.73 (1H, d, J = 7.4 Hz, ArH), 7.50 (1H, t, J = 7.4 
Hz, ArH), 7.43 (1H, t, J = 7.4 Hz, ArH), 6.68 (1H, dd, J = 15.9, 7.8 Hz, 
CH=CHCHO), 1.39 (12H, s, 2 x C(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 194.5 
(CH), 154.1 (CH), 139.8 (C), 136.7 (CH), 131.3 (CH), 129.9 (CH), 129.4 (CH), 
126.1 (CH), 84.2 (2 x C), 24.9 (4 x CH3). A signal for the C attached to B is not 
observed due to complex splitting. 
 
Methyl (2E)-3-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]acrylate (447c).174a The title compound was prepared 





















(triphenylphosphoranylidene) acetate (2.81 g, 8.40 mmol) and 2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)benzaldehyde 446 (1.50 g, 6.46 mmol) for a reaction time of 
20 h. Purification by silica column chromatography (30% EtOAc/hexane) gave the 
title compound as a pale yellow solid (1.52 g, 82%) as a mixture of the E- and Z-
isomers (10:1) that displayed identical spectroscopic data to those reported 
previously.174a Rf = 0.63 (30% EtOAc/hexane); IR (CHCl3) 2982, 1716 (C=O), 1635, 
1350, 1320, 1265, 1145, 909, 741, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.58 
(1H, d, J = 16.0 Hz, CH=CHCO2CH3), 7.84 (1H, dd, J = 7.3, 1.2 Hz, ArH), 7.68 
(1H, app d, J = 8.0 Hz, ArH), 7.45 (1H, td, J = 7.6, 1.2 Hz, ArH), 7.37 (1H, td, J = 
7.6, 1.2 Hz, ArH), 6.39 (1H, d, J = 16.0 Hz, CH=CHCO2CH3), 3.82 (3H, s, 
CO2CH3), 1.39 (12H, s, 2 x C(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 167.6 (C), 
145.9 (CH), 140.1 (C), 136.1 (CH), 131.0 (CH), 129.0 (CH), 125.6 (CH), 118.5 
(CH), 84.1 (2 x C), 51.5 (CH3), 24.8 (4 x CH3). A signal for the C attached to B is 
not observed due to complex splitting. 
 
 (E)-3-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]acrylonitrile (447d).174a (Triphenylphosphanylidene) 
acetonitrile (1.04 g, 3.45 mmol) was added to a stirred solution of 2-
(4,4,5,5,-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 446 (615 mg, 2.65 
mmol) in toluene (10 mL). The reaction mixture was heated to 90 oC for 20 h, then 
cooled to room temperature and concentrated in vacuo. Purification by silica column 
chromatography (15
30% EtOAc/hexane) gave the title compound as a pale yellow 
solid (620 mg, 92%) as a mixture of the E- and Z-isomers (6:1). that displayed 
identical spectroscopic data to those reported previously.174a Rf = 0.62 (30% 
EtOAc/hexane); IR (CHCl3) 2982, 2929, 2219 (CN), 1381, 1348, 1273, 1144, 908, 
739, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.38 (1H, d, J = 16.7 Hz, CH=CHCN), 
7.91 (1H, d, J = 7.3 Hz, ArH), 7.59 (1H, d, J = 7.9 Hz, ArH), 7.52-7.37 (2H, m, 
ArH), 5.84 (1H, d, J = 16.7 Hz, CH=CHCN), 1.38 (12H, s, 2 x C(CH3)2); 
13C NMR 
(62.9 MHz, CDCl3) δ 1151.7 (CH), 139.3 (C), 136.7 (CH), 131.3 (CH), 129.8 (CH), 
124.7 (CH), 118.7 (C), 96.8 (CH), 84.2 (2 x C), 24.8 (4 x CH3). A signal for the C 


















Triphenylphosphoranylidene-2-propanone (207 mg, 0.65 mmol) was added to a 
stirred solution of (E)-3-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]propenal 447b (129 mg, 0.50 mmol) in toluene (0.50 mL). The reaction 
mixture was heated to 90 oC for 16 h, then cooled to room temperature and 
concentrated in vacuo. The residue was was purified by silica column 
chromatography (20% EtOAc/hexane) to give the title compound as a yellow solid 
(122 mg, 82%, >19:1 E/Z). Rf = 0.47 (30% EtOAc/hexane); m.p. 105-106 °C; IR 
(CHCl3) 2979, 1662 (C=O), 1590, 1481, 1346, 1252, 1145, 999, 862, 658 cm
-1; 1H 
NMR (360 MHz, CDCl3) δ 7.92-7.81 (2H, m, ArH and CH=CHCH=CHCOCH3), 
7.70 (1H, d, J = 8.0 Hz, ArH), 7.44 (1H, t, J = 7.6 Hz, ArH), 7.36 (1H, dd, J = 15.4, 
10.9, CH=CHCH=CHCOCH3), 7.31 (1H, td, J = 7.4, 1.1 Hz, ArH), 6.86 (1H, ddd, J 
= 15.5, 10.9, 0.6 Hz, CH=CHCH=CHCOCH3), 6.28 (1H, d, J = 15.5 Hz, 
CH=CHCOCH3), 2.34 (3H, s, COCH3), 1.38 (12H, s, 2 x C(CH3)2); 
13C NMR 
(90.6 MHz, CDCl3) δ 198.5 (C), 144.1 (CH), 142.4 (CH), 141.8 (C), 136.5 (CH), 
131.1 (CH), 129.9 (CH), 128.1 (CH), 127.4 (CH), 125.0 (CH), 83.9 (2 x C), 27.7 
(CH3), 24.9 (4 x CH3). A signal for the C attached to B is not observed due to 








6.3.2 Rhodium-Catalysed Carbometallation−Conjugate Addition 
Reactions 
 
General Procedure L 
The THF/H2O solvent (2 mL, 40:1) was added to a flask containing the ynamide 
(0.20 mmol), boronate ester (0.24 mmol), [Rh(cod)Cl]2 (4.9 mg, 0.01 mmol) and 
KOH (3.4 mg, 0.06 mmol) at 0 oC. The reaction mixture was stirred at 0 °C until the 
reaction had stopped progressing as observed by TLC analysis. The mixture was 
filtered through a short pad of silica gel gel using CH2Cl2 (10 mL) as eluent, and the 
filtrate was concentrated in vacuo. Purification of the residue by column 
chromatography afforded the desired enamide. 
 
3-[1-(2-Oxo-2-phenylethyl)-3-phenylindan-2-yl]oxazolidin-2-
one (449a).  The title compound was prepared according to 
General Procedure L using ynamide 394a (43 mg, 0.20 mmol) and 
boronate 447a (80 mg, 0.24 mmol) for a reaction time of 2.5 h. The 
residue was purified by column chromatography (90% CH2Cl2/hexane) to afford the 
title compound as a mixture of regioisomers (10:1) as a yellow oil (82 mg, 97%). Rf 
= 0.33 (100% CH2Cl2); IR (film) 3027, 2922, 1750 (C=O), 1682 (C=O), 1420, 1469, 
1224, 1044, 908, 736, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.96-7.75 (2H, m, 
ArH), 7.48 (1H, t, J = 7.4 Hz, ArH), 7.41-7.32 (3H, m, ArH), 7.27 (2H, m, ArH), 
7.21-7.02 (6H, m, ArH), 4.27 (1H, app t, J = 6.6 Hz, CHCH2C=O), 4.13-4.00 (2H, 
m, CH2O), 3.65-3.58 (1H, m, CH2N), 3.18 (1H, dd, J = 17.7, 6.6 Hz, CH2C=O), 
3.07 (1H, dd, J = 17.7, 6.6 Hz, CH2C=O), 2.99-2.93 (1H, m, CH2N), 2.85-2.72 (3H, 
m, CH2CH2Ph), 2.61 (1H, td, J = 8.7, 6.8 Hz, CH2CH2Ph); 
13C NMR (62.9 MHz, 
CDCl3) δ 199.1 (C), 156.1 (C), 144.4 (C), 142.4 (C), 141.9 (C), 138.8 (C), 136.7 (C), 
136.5 (C), 133.5 (CH), 128.7 (2 x CH), 128.7 (2 x CH), 128.2 (2 x CH), 128.1 (2 x 









(CH2), 42.8 (CH), 39.7 (CH2), 33.8 (CH2), 27.6 (CH2); HRMS (ES) Mass calculated 
for C28H26NO3 [M+H]
+: 424.1907, found: 424.1907. 
 
 [2-(2-Oxooxazolidin-3-yl)-3-phenethyl-1H-inden-1-
yl]acetaldehyde (449b). The title compound was prepared 
according to General Procedure L using ynamide 394a (43 mg, 
0.20 mmol) and boronate 447b (62 mg, 0.24 mmol) for a reaction 
time of 1.5 h. The residue was purified by column chromatography (100% 
CH2Cl2
5% acetone/CH2Cl2 then recolumned 40% EtOAc/hexane) to afford the 
title compound as a mixture of regioisomers (6.7:1) as a yellow oil (52 mg, 75%). Rf 
= 0.19 (40% EtOAc/hexane); IR (film) 2920, 1748 (C=O), 1640, 1418, 1223, 1137, 
1046, 907, 731, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 9.63 (1H, s, CHO), 7.35-
7.24 (3H, m, ArH), 7.18 (3H, t, J = 6.2 Hz, ArH), 7.10 (1H, t, J = 7.3 Hz, ArH), 
7.04 (2H, d, J = 7.3 Hz, ArH), 4.25-4.09 (3H, m, CHCH2C=O and CH2O), 3.61 (1H, 
dd, J = 16.6, 8.5 Hz, CH2N), 2.98-2.87 (1H, m, CH2N), 2.84-2.69 (5H, m, 
CH2CH2Ph and CH2C=O), 2.64 (1H, dd, J = 17.8, 6.0 Hz, CH2C=O); 
13C NMR 
(62.9 MHz, CDCl3) δ 201.1 (CH), 156.3 (C), 143.4 (C), 142.4 (C), 141.5 (C), 138.5 
(C), 136.3 (C), 128.6 (2 x CH), 128.3 (2 x CH), 127.3 (CH), 126.1 (CH), 125.9 (CH), 
123.2 (CH), 119.8 (CH), 62.5 (CH2), 46.5 (CH2), 44.5 (CH2), 41.5 (CH), 33.9 (CH2), 
27.5 (CH2); HRMS (ES) Mass calculated for C22H22NO3 [M+H]




(449c). The title compound was prepared according to General 
Procedure L using ynamide 394c (39 mg, 0.20 mmol) and boronate 
447b (62 mg, 0.24 mmol) for a reaction time of 1.5 h. The residue was purified by 
column chromatography (5% acetone/CH2Cl2 then 20% EtOAc/hexane) to afford the 
title compound as a yellow oil (44 mg, 67%). Rf = 0.21 (40% EtOAc/hexane); IR 
(film) 2928, 1750 (C=O), 1638, 1416, 1264, 1095, 1045, 909, 736, 650 cm-1; 1H 
NMR (360 MHz, CDCl3) δ 9.62 (1H, s, CHO), 7.31-7.12 (4H, m, ArH), 4.41 (2H, t, 
J = 8.0 Hz, CH2O), 4.28 (1H, app t, J = 6.1 Hz, CHCH2C=O), 4.11-4.00 (1H, m, 













CHCH2C=O), 2.70 (1H, dd, J = 17.4, 5.7 Hz, CHCH2C=O), 2.52-2.35 (2H, m, 
CH2), 1.58-1.45 (2H, m, CH2), 1.37-1.14 (6H, m, (CH2)3), 0.82 (3H, t, J = 6.7 Hz, 
CH3); 
13C NMR (62.9 MHz, CDCl3) δ 201.4 (CH), 156.7 (C), 143.3 (C), 142.8 (C), 
138.0 (C), 137.6 (C), 127.1 (CH), 125.8 (CH), 123.0 (CH), 119.9 (CH), 62.6 (CH2), 
47.3 (CH2), 44.6 (CH2), 41.8 (CH), 31.6 (CH2), 29.6 (CH2), 28.2 (CH2), 25.4 (CH2), 
22.6 (CH2), 14.0 (CH3); HRMS (ES) Mass calculated for C20H26NO3 [M+H]
+: 
328.1926, found: 328.1907. 
 
3-[3-[2-(tert-Butyldimethylsilanyloxy)ethyl]-1-(2-oxopropyl)-
1H-inden-2-yl]oxazolidin-2-one (449d).  The title compound 
was prepared according to General Procedure L using ynamide 
394e (54 mg, 0.20 mmol) and boronate 444 (65 mg, 0.24 mmol) 
for a reaction time of 2.5 h. The residue was purified by column chromatography 
(0
5% acetone/CH2Cl2 then 30% EtOAc/hexane) to afford a yellow oil (79 mg, 
95%). Rf = 0.50 (50% EtOAc/hexane); IR (film) 3055, 2955, 1753 (C=O), 1717 
(C=O), 1636, 1469, 1418, 1265, 1095, 740 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.47-
7.10 (4H, m, ArH), 4.46 (2H, t, J = 8.0 Hz, CH2O), 4.25 (1H, app t, J = 6.7 Hz, 
CHCH2COCH3), 4.11 (1H, app q, J = 8.3 Hz, CH2OSi), 3.91-3.81 (2H, m, CH2N), 
3.73 (1H, app q, J = 7.9 Hz, CH2OSi), 2.85-2.69 (4H, m, CH2CH2OSi and 
CH2COCH3), 2.17 (3H, s, COCH3), 0.86 (9H, s, C(CH3)3), 0.00 (6H, s, Si(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 207.9 (C), 156.8 (C), 143.9 (C), 142.6 (C), 139.9 
(C), 135.5 (C), 127.0 (CH), 125.8 (CH), 122.9 (CH), 120.1 (CH), 62.6 (CH2), 61.5 
(CH2), 47.4 (CH2), 44.7 (CH2), 42.8 (CH3), 30.5 (CH), 29.1 (CH2), 25.9 (3 x CH3), 
18.4 (C), -5.4 (2 x CH3); HRMS (ES) Mass calculated for C23H37N2O4Si [M+NH4]
+: 
433.2517, found: 433.2516. 
 
3-(tert-Butyldimethylsilanyloxymethyl)-2-(2-oxooxazolidin-3-
yl)-1H-inden-1-yl acetic acid methyl ester (449e). The title 
compound was prepared according to General Procedure L using 
ynamide 394d (51 mg, 0.20 mmol) and boronate 447c (69 mg, 0.24 
mmol) for a reaction time of 1.5 h. The residue was purified by column 
chromatography (90
100% CH2Cl2/hexane













title compound as a mixture of regioisomers (10:1) as a yellow solid (79 mg, 96%). 
Rf = 0.24 (100% CH2Cl2); IR (CHCl3) 2954, 2857, 1753 (C=O), 1469, 1418, 1264, 
1095, 908, 734, 650 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.33 (1H, d, J = 7.4 Hz, 
ArH), 7.26 (1H, d, J = 7.4 Hz, ArH), 7.21 (1H, t, J = 7.4 Hz, ArH), 7.11 (1H, t, J = 
7.4 Hz, ArH), 4.61 (1H, dd, J = 13.3, 1.2 Hz, CH2OSi), 4.53 (1H, dd, J = 13.3, 1.2 
Hz, CH2OSi), 4.40-4.35 (2H, m, CH2O), 4.21 (1H, t, J = 6.8 Hz, CHCH2CO2CH3), 
4.13 (1H, m, CH2N), 3.73 (1H, dt, J = 15.8, 7.9 Hz, CH2N), 3.60 (3H, s, OCH3), 
2.61-2.46 (2H, m, CH2CO2CH3), 0.81 (9H, s, C(CH3)3), 0.00 (6H, d, J = 3.0 Hz, 
Si(CH3)2); 
13C NMR (90.6 MHz, CDCl3) δ 172.6 (C), 156.2 (C), 142.9 (C), 141.8 
(C), 139.3 (C), 134.2 (C), 127.1 (CH), 125.6 (CH), 122.9 (CH), 120.4 (CH), 62.6 
(CH2), 57.1 (CH2), 51.8 (CH3), 47.2 (CH2), 44.0 (CH), 35.6 (CH2), 25.9 (3 x CH3), 
18.3 (C), -5.3 (CH3), -5.5 (CH3); HRMS (ES) Mass calculated for C22H35N2O5Si 
[M+NH4]
+: 435.2310, found: 435.2312.  
 
3-[1-(2-Oxopropyl)-3-phenyl-1H-inden-2-yl]oxazolidin-2-one 
(445). The title compound was prepared according to General 
Procedure L using ynamide 394b (37 mg, 0.20 mmol) and boronate 
444 (65 mg, 0.24 mmol) for a reaction time of 2 h. The residue was purified by 
column chromatography (25% EtOAc/hexane) to afford the title compound as a 
yellow solid (47 mg, 71%). Rf = 0.26 (30% EtOAc/hexane); m.p. 148-150 °C; IR 
(CHCl3) 2955, 1749 (C=O), 1652, 1541, 1458, 1098, 1043, 908, 733, 650 cm
-1; 1H 
NMR (360 MHz, CDCl3) δ 7.52-7.35 (6H, m, ArH), 7.26-7.22 (2H, m, ArH), 7.19-
7.14 (1H, m, ArH), 4.76 (1H, dd, J = 6.9, 5.6 Hz, CHCH2COCH3), 4.33-4.25 (2H, 
m, CH2O), 3.69-3.60 (1H, m, CH2N), 3.39-3.32 (1H, m, CH2N), 3.08 (1H, dd, J = 
16.2, 5.6 Hz, CHCH2COCH3), 2.76 (1H, dd, J = 16.2, 6.9 Hz, CHCH2COCH3 ), 2.13 
(3H, s, COCH3); 
13C NMR (90.6 MHz, CDCl3) δ 207.1 (C), 156.7 (C), 143.1 (C), 
143.0 (C), 140.1 (C), 133.2 (C), 133.0 (C), 129.0 (2 x CH), 128.6 (2 x CH), 128.2 
(CH), 127.0 (CH), 125.5 (CH), 123.1 (CH), 120.1 (CH), 62.8 (CH2), 46.5 (CH2), 
44.6 (CH2), 44.0 (CH), 30.6 (CH3); HRMS (ES) Mass calculated for C21H23N2O3 
[M+NH4]











2-(2-Oxooxazolidin-3-yl)-3-phenyl-1H-inden-1-yl acetic acid 
methyl ester (449f). The title compound was prepared according to 
General Procedure L using ynamide 394b (37 mg, 0.20 mmol) and 
boronate 447c (69 mg, 0.24 mmol) for a reaction time of 2 h. The residue was 
purified by column chromatography (20% EtOAc/hexane) to afford the title 
compound as a yellow solid (52 mg, 75%). Slow diffusion of hexane into a solution 
of 449f in EtOAc gave colourless crystals that were suitable for X-ray 
crystallography. Rf = 0.29 (30% EtOAc/hexane); m.p. 117-119 °C; IR (CHCl3) 2958, 
1749 (C=O), 1699, 1458, 1407, 1264, 1043, 909, 734, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.50-7.41 (6H, m, ArH), 7.26-7.23 (2H, m, ArH), 7.16-7.14 (1H, m, ArH), 
4.79 (1H, app t, J = 6.3 Hz, CHCH2CO2CH3), 4.36-4.22 (2H, m, CH2O), 3.64 (3H, s, 
OCH3), 3.62-3.53 (1H, m, CH2N), 3.37 (1H, m, CH2N), 2.91 (1H, dd, J = 15.2, 6.3 
Hz, CHCH2CO2CH3), 2.74 (1H, dd, J = 15.2, 6.3 Hz, CHCH2CO2CH3); 
13C NMR 
(90.6 MHz, CDCl3) δ 171.9 (C), 156.5 (C), 143.0 (C), 142.5 (C), 139.9 (C), 133.4 
(C), 132.0 (C), 129.1 (2 x CH), 128.7 (2 x CH), 128.2 (CH), 127.1 (CH), 125.5 (CH), 
123.1 (CH), 119.9 (CH), 62.8 (CH2), 51.7 (CH3), 46.3 (CH2), 44.6 (CH), 35.7 (CH2); 
HRMS (ES) Mass calculated for C21H20NO4 [M+H]








Ynamide 394i (40 mg, 0.20 mmol) and boronate 447a (80 mg, 0.24 mmol) 
underwent General Procedure L for a reaction time of 1.5 h. The residue was purified 
by column chromatography (40% EtOAc/hexane then 10% acetone/CH2Cl2) to 
afford the enamide 449g (46 mg, 55%) as a yellow-orange solid followed by the 









Data for 449g: Rf = 0.37 (50% EtOAc/hexane); m.p. 128-130 °C; IR (CHCl3) 2900, 
1696 (C=O), 1598, 1494, 1404, 1265, 1091, 908, 733, 650 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 8.01 (2H, dd, J = 8.4, 1.1 Hz, ArH), 7.56 (1H, t, J = 7.4 Hz, ArH), 7.50-
7.33 (8H, m, ArH), 7.18 (1H, t, J = 7.4 Hz, ArH), 7.09 (2H, t, J = 7.4 Hz, ArH), 
5.19 (1H, dd, J = 8.8, 4.1 Hz, CHCH2C=O), 3.58 (1H, dd, J = 16.3, 4.1 Hz, 
CHCH2C=O), 3.46 (1H, ddd, J = 9.4, 9.2, 7.0 Hz, CH2CH2N), 3.28-3.05 (4H, m, 
CH2CH2N and CHCH2C=O), 2.78 (3H, s, NCH3); 
13C NMR (90.6 MHz, CDCl3) δ 
198.6 (C), 158.4 (C), 144.0 (C), 143.2 (C), 143.1 (C), 137.2 (C), 134.6 (C), 132.9 
(CH), 129.5 (2 x CH), 128.5 (2 x CH), 128.3 (2 x CH), 128.2 (2 x CH), 127.7 (C), 
127.5 (CH), 126.7 (CH), 124.4 (CH), 123.4 (CH), 119.1 (CH), 45.1 (CH2), 44.7 
(CH), 44.1 (CH2), 40.5 (CH2), 31.2 (CH3); HRMS (ES) Exact mass calcd for 
C27H25N2O2 [M+H]
+: 409.1911, found: 409.1915. 
Data for 449i: Rf = 0.23 (50% EtOAc/hexane); m.p. 64-66 °C; IR (CHCl3) 2984, 
1793, 1690 (C=O), 1445, 1265, 1226, 1094, 908, 735, 651 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.89 (2H, d, J = 7.4 Hz, ArH), 7.54-7.51 (3H, m, ArH), 7.44-7.36 (6H, m, 
ArH), 7.29 (2H, t, J = 7.8 Hz, ArH), 7.15 (1H, td, J = 7.4, 0.8 Hz, ArH), 4.84 (1H, 
dd, J = 8.5, 4.5 Hz, CHCH2C=O), 3.57-3.46 (2H, m, CH2), 3.46-3.34 (2H, m, CH2), 
3.19-3.16 (2H, m, CH2), 2.96 (3H, s, NCH3); 
13C NMR (90.6 MHz, CDCl3) δ 199.3 
(C), 159.9 (C), 145.7 (C), 142.2 (C), 140.9 (C), 136.8 (C), 135.2 (C), 133.8 (C), 
133.2 (CH), 128.7 (2 x CH), 128.6 (2 x CH), 128.5 (2 x CH), 128.2 (2 x CH), 127.8 
(CH), 127.0 (CH), 125.8 (CH), 124.0 (CH), 120.1 (CH), 45.9 (CH2), 43.8 (CH), 42.8 
(CH2), 40.6 (CH2), 31.6 (CH3); HRMS (ES) Exact mass calcd for C27H25N2O2 







methyl ester (449ha) and [3-(tert-Butoxycarbonylphenylamino)-2-phenyl-1H-




Ynamide 395b (59 mg, 0.20 mmol) and boronate 447c (69 mg, 0.24 mmol) 
underwent General Procedure L for a reaction time of 2.5 h. Purification of the 
residue by column chromatography (100% CH2Cl2
5% acetone/CH2Cl2 then 
1
2% EtOAc/petroleum ether) afforded a 2:1 inseparable mixture of enamides 
449ha and 449hb (90 mg, 95%) as a pale yellow solid. Rf = 0.38 (10% 
EtOAc/petroleum ether); m.p. 40-42 °C; IR (CHCl3) 3054, 2984, 1709 (C=O), 1597, 
1493, 1438, 1305, 1265, 1156, 739 cm-1; 1H NMR for major isomer 449ha (360 
MHz, CDCl3) δ 7.57-7.00 (13H, m, ArH), 6.83 (1H, d, J = 7.2 Hz, ArH), 4.49 (1H, 
dd, J = 9.4, 4.0 Hz, CHCH2), 3.64 (3H, s, OCH3), 2.89 (1H, dd, J = 16.0, 4.0 Hz, 
CHCH2), 2.38 (1H, dd, J = 16.0, 9.4 Hz, CHCH2), 1.00 (9H, s, C(CH3)3); 
1H NMR 
for minor isomer 449hb (360 MHz, CDCl3) δ 7.57-7.00 (13H, m, ArH), 6.94 (1H, t, 
J = 7.1 Hz, ArH), 4.40 (1H, dd, J = 10.2, 4.1 Hz, CHCH2), 3.64 (3H, s, OCH3), 2.71 
(1H, dd, J = 16.0, 4.1 Hz, CHCH2), 2.20 (1H, dd, J = 16.0, 10.2 Hz, CHCH2), 1.44 
(9H, s, C(CH3)3); 
13C NMR (90.6 MHz, CDCl3) Not fully assigned δ 172.9 (C), 
172.6 (C), 153.7 (C), 152.4 (C), 144.6 (C), 142.0 (C), 141.2 (C), 140.8 (C), 138.3 
(C), 135.6 (C), 134.1 (C), 133.1 (C), 129.1 (CH), 128.8 (CH), 128.7 (CH), 128.5 
(CH), 128.4 (CH), 128.2 (CH), 127.9 (CH), 127.7 (CH), 127.3 (CH), 127.1 (CH), 
125.8 (CH), 125.8 (CH), 125.6 (CH), 125.1 (CH), 124.7 (CH), 124.5 (CH), 123.7 
(CH), 123.5 (CH), 123.4 (CH), 123.2 (CH), 119.9 (CH), 119.2 (CH), 81.3 (C), 81.1 
(C), 51.8 (CH), 45.1 (CH3), 44.6 (CH3), 36.6 (CH2), 36.2 (CH2), 28.1 (CH3), 27.5 
(CH3); HRMS (ES) Mass calculated for C29H30NO4 [M+H]








2-one (450). The title compound was prepared according to 
General Procedure L using ynamide 394c (39 mg, 0.20 mmol) and 
boronate 448 (72 mg, 0.24 mmol) for a reaction time of 4 h. The 
residue was purified by column chromatography (10% 
acetone/CH2Cl2 then 20% EtOAc/hexane) to afford the title compound as an orange 
oil (34 mg, 47%). Rf = 0.40 (50% EtOAc/hexane); IR (film) 2928, 1751 (C=O), 1714 
(C=O), 1467, 1415, 1265, 1094, 907, 733, 651 cm-1; 1H NMR (360 MHz, CDCl3) δ 
7.31-7.22 (3H, m, ArH), 7.21-7.13 (1H, m, ArH), 5.99-5.88 (1H, m, 
CH=CHCH2COCH3), 5.16 (1H, dd, J = 15.3, 9.3 Hz, CH=CHCH2COCH3), 4.45 
(2H, app t, J = 8.0 Hz, CH2O), 4.40 (1H, d, J = 9.3 Hz, CHCH=CH), 4.04 (1H, app 
q, J = 8.3 Hz, CH2N), 3.75 (1H, app q, J = 7.8 Hz, CH2N), 3.21 (1H, dd, J = 16.9, 
6.6 Hz, CH2COCH3), 3.12 (1H, dd, J = 16.9, 7.5 Hz, CH2C=O), 2.56-2.45 (2H, m, 
C=CCH2(CH2)4), 2.14 (3H, s, CH3C=O), 1.66-1.52 (2H, m, CH2(CH2)3CH3), 1.40-
1.19 (6H, m, (CH2)3CH3), 0.86 (3H, t, J = 6.7 Hz, CH3); 
13C NMR (90.6 MHz, 
CDCl3) δ 206.5 (C), 156.5 (C), 143.2 (2 x C), 137.6 (C), 137.1 (C), 131.4 (CH), 
127.3 (CH), 127.1 (CH), 125.5 (CH), 123.7 (CH), 119.6 (CH), 62.5 (CH2), 52.0 
(CH3), 47.5 (CH2), 47.1 (CH2), 31.6 (CH2), 29.6 (CH2), 29.6 (CH), 28.0 (CH2), 25.6 
(CH2), 22.6 (CH2), 14.1 (CH3); HRMS (ES) Mass calculated for C23H30NO3 [M+H]
+: 
368.2207, found: 368.2212. 








A solution of [RhCl(C2H4)2]2 (1.6 mg, 0.004 mmol) and ligand 457e (1.0 mg, 0.0044 









of the ynamide 394b (19 mg, 0.10 mmol), boronate 444 (33 mg, 0.12 mmol) and 
KOH (1.7 mg, 0.03 mmol) in THF (0.50 mL) was then added, followed by H2O (24 
L). The reaction mixture was stirred at 0 °C for 1.5 h then warmed to rt. After 2 h, 
TLC analysis indicated complete consumption of starting material and the reaction 
mixture was filtered through a short pad of silica. Purification by column 
chromatography (25% EtOAc/hexane) gave a pure sample of the title compound 
suitable for HPLC analysis. For full data of 445 see page 191. Enantiomeric excess 
was determined by HPLC with a Chiralpak AD-H column (90:10 
hexanes:isopropanol, 0.8 mL/min, 210 nm, 25 °C); tr (major) = 25.4 min, tr (minor) = 






6.3.4 Regio-/Stereochemical Determinations 
 









• The regio-/stereoselectivities of the remaining enamides resulting from the 
carbometallation−conjugate reactions (Table 5.1) were assigned by analogy. 
• The regioselectivity and position of the pendant double bond of the enamide 
450 was assigned after COSY analysis. The key correlations have been 
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